0001437749-17-019266.txt : 20171114 0001437749-17-019266.hdr.sgml : 20171114 20171114114347 ACCESSION NUMBER: 0001437749-17-019266 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 56 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171114 DATE AS OF CHANGE: 20171114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TWINLAB CONSOLIDATED HOLDINGS, INC. CENTRAL INDEX KEY: 0001590695 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 463951742 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55181 FILM NUMBER: 171199483 BUSINESS ADDRESS: STREET 1: 632 BROADWAY STREET 2: SUITE 201 CITY: NEW YORK STATE: NY ZIP: 10012 BUSINESS PHONE: (212) 651-8500 MAIL ADDRESS: STREET 1: 632 BROADWAY STREET 2: SUITE 201 CITY: NEW YORK STATE: NY ZIP: 10012 FORMER COMPANY: FORMER CONFORMED NAME: MIRROR ME, INC. DATE OF NAME CHANGE: 20131031 10-Q 1 tlcc20170930_10q.htm FORM 10-Q tlcc20170930_10q.htm

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2017

OR

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________ to __________

 

Commission file number 000-55181

 

TWINLAB CONSOLIDATED HOLDINGS, INC.


(Exact name of registrant as specified in its charter)

 

Nevada

 

46-3951742

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

     

4800 T-Rex Avenue, Suite 305

Boca Raton, Florida

 

33431

(Address of principal executive offices)

 

(Zip Code)

 

(561) 443-5301


(Registrant’s telephone number, including area code)

 


(Former name, former address and former fiscal year, if changed since last report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes     No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes     No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.:

 

Large accelerated filer

Accelerated filer

   

Non-accelerated filer (Do not check if a smaller reporting company)

Smaller reporting company

   

Emerging growth company

 
   

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes    No ☒

The number of shares of common stock, $0.001 par value, outstanding on November 14, 2017 was 252,924,027 shares.

 

 

 

 

TABLE OF CONTENTS

     

Page No.

Part I - FINANCIAL INFORMATION

 
       

Item 1.

 

Financial Statements 

1

       
    Condensed Consolidated Balance Sheets (Unaudited) 2
       
    Condensed Consolidated Statements of Comprehensive Loss (Unaudited) 3
       
    Condensed Consolidated Statements of Cash Flows (Unaudited) 5
       
    Notes to Condensed Consolidated Financial Statements (Unaudited)  

 

 

 

 

Item 2.

 

Management's Discussion and Analysis of Financial Condition and Results of Operations

22

 

 

 

 

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

27

 

 

 

 

Item 4.

 

Controls and Procedures

27

       

Part II - OTHER INFORMATION

 
       

Item 1.

 

Legal Proceedings

29

       

Item1A.

 

Risk Factors

29

       

Item 6.

 

Exhibits

30

       
   

Signatures

31

 

 

 

 

PART I – FINANCIAL INFORMATION

 

Item 1.     Financial Statements.

TWINLAB CONSOLIDATED HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(AMOUNTS IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)

 

   

September 30,

   

December 31,

 
   

2017

   

2016

 

ASSETS

               
                 

Current assets:

               

Cash

  $ 2,233     $ 5,097  

Accounts receivable, net of allowance of $2,777 and $2,365, respectively

    8,737       7,768  

Inventories, net

    18,368       17,601  

Prepaid expenses and other current assets

    2,238       2,870  

Total current assets

    31,576       33,336  
                 

Property and equipment, net

    3,240       3,528  

Intangible assets, net

    28,450       30,197  

Goodwill

    24,098       24,098  

Other assets

    1,768       1,667  
                 

Total assets

  $ 89,132     $ 92,826  
                 

LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT)

               
                 

Current liabilities:

               

Accounts payable

  $ 4,607     $ 7,866  

Accrued expenses and other current liabilities

    10,266       11,434  

Derivative liabilities

    8,143       6,455  

Notes payable and current portion of long-term debt, net of discount of $1,871 and $2,297, respectively

    17,091       11,631  

Total current liabilities

    40,107       37,386  
                 

Long-term liabilities:

               

Deferred gain on sale of assets

    1,606       1,727  

Deferred tax liability

    959       959  

Notes payable and long-term debt, net of current portion and discount of $2,102 and $3,451, respectively

    57,162       50,988  

Total long-term liabilities

    59,727       53,674  
                 

Total liabilities

    99,834       91,060  
                 

Commitments and contingencies

               
                 

Stockholders’ equity (deficit):

               

Preferred stock, $0.001 par value, 500,000,000 shares authorized, no shares issued and outstanding

    -       -  

Common stock, $0.001 par value, 5,000,000,000 shares authorized, 387,730,078 shares issued

    388       388  

Additional paid-in capital

    226,766       226,380  

Stock subscriptions receivable

    (30 )     (30 )

Treasury stock, 134,806,051 and 134,163,685 shares at cost, respectively

    (500 )     (500 )

Accumulated deficit

    (237,326 )     (224,472 )

Total stockholders’ equity (deficit)

    (10,702 )     1,766  
                 

Total liabilities and stockholders' equity (deficit)

  $ 89,132     $ 92,826  

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

1

 

 

TWINLAB CONSOLIDATED HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF

COMPREHENSIVE LOSS (UNAUDITED)

(AMOUNTS IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)

 

   

Three Months Ended

   

Nine Months Ended

 
   

September 30,

   

September 30,

 
   

2017

   

2016

   

2017

   

2016

 
                                 

Net sales

  $ 20,612     $ 23,046     $ 66,130     $ 65,885  

Cost of sales

    17,103       15,963       50,368       49,405  
                                 

Gross profit

    3,509       7,083       15,762       16,480  
                                 

Selling, general and administrative expenses

    6,646       7,760       20,574       26,249  
                                 

Loss from operations

    (3,137 )     (677 )     (4,812 )     (9,769 )
                                 

Other income (expense):

                               

Interest expense, net

    (1,876 )     (2,423 )     (6,318 )     (6,530 )

Loss on stock purchase guarantee

    -       -       -       (3,210 )

Gain (loss) on change in derivative liabilities

    (393 )     14,065       (1,688 )     28,128  

Other income (expense), net

    (12 )     3       (36 )     (18 )
                                 

Total other income (expense)

    (2,281 )     11,645       (8,042 )     18,370  
                                 

Income (loss) before income taxes

    (5,418 )     10,968       (12,854 )     8,601  

Provision for income taxes

    -       -       -       (17 )
                                 

Total comprehensive income (loss)

  $ (5,418 )   $ 10,968     $ (12,854 )   $ 8,584  
                                 

Weighted average number of common shares outstanding – basic

    252,924,027       250,806,152       252,935,792       264,740,245  
                                 

Net income (loss) per common share – basic

  $ (0.02 )   $ 0.04     $ (0.05 )   $ 0.03  
                                 

Weighted average number of common shares outstanding – diluted (2016 corrected - see Note 1)

    252,924,027       264,224,781       252,935,792       277,221,732  
                                 

Net loss per common share – diluted (2016 corrected - see Note 1)

  $ (0.02 )   $ (0.01 )   $ (0.05 )   $ (0.07 )

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

2

 

 

TWINLAB CONSOLIDATED HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(AMOUNTS IN THOUSANDS)

 

   

Nine Months Ended

 
   

September 30,

 
   

2017

   

2016

 

Cash flows from operating activities:

               

Net income (loss)

  $ (12,854 )   $ 8,584  

Adjustments to reconcile net income (loss) to net cash used in operating activities:

               

Depreciation and amortization

    2,416       2,212  

Amortization of debt discount

    1,774       2,717  

Stock-based compensation

    386       540  

Provision for obsolete inventory

    466       1,194  

Provision for losses on accounts receivable

    167       267  

Loss on stock purchase price guarantee

    -       3,210  

(Gain) loss on change in derivative liabilities

    1,688       (28,128 )

Other non-cash items

    (121 )     (124 )

Changes in operating assets and liabilities:

               

Accounts receivable

    (1,136 )     (2,293 )

Inventories

    (1,233 )     (4,044 )

Prepaid expenses and other current assets

    632       (1,113 )

Other assets

    (101 )     63  

Accounts payable

    (3,259 )     (5,241 )

Accrued expenses and other current liabilities

    2,032       1,621  
                 

Net cash used in operating activities

    (9,143 )     (20,535 )
                 

Cash flows from investing activities:

               

Purchase of property and equipment

    (51 )     (119 )
                 

Cash flows from financing activities:

               

Proceeds from the exercise of warrants

    -       1  

Proceeds from the issuance of debt

    6,267       22,089  

Repayment of debt

    (1,583 )     (2,973 )

Net borrowings from revolving credit facility

    1,646       3,342  
                 

Net cash provided by financing activities

    6,330       22,459  
                 

Net increase (decrease) in cash

    (2,864 )     1,805  

Cash at the beginning of the period

    5,097       1,240  
                 

Cash at the end of the period

  $ 2,233     $ 3,045  

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

3

 

 

TWINLAB CONSOLIDATED HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(AMOUNTS IN THOUSANDS) - Continued

 

   

Nine Months Ended

 
   

September 30,

 
   

2017

   

2016

 
                 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

               

Cash paid for interest

  $ 982     $ 3,818  

Cash paid for income taxes

    -       27  
                 

SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING TRANSACTIONS:

               

Decrease in derivative liabilities and increase in common stock and additional paid-in capital on exercise of warrants

  $ -     $ 1,975  

Issuance of other liability for purchase of treasury shares

    -       500  

Relief of stock subscription accrual through long-term debt

    (3,200 )     -  

Issuance of new long-term debt as payment of existing stock subscription accrual

    3,200       -  

Property and equipment acquired through the issuance of capital leases

    330       -  

Repayment of short-term debt

    -       (2,589 )

Issuance of long-term debt

    -       2,589  

 

The accompanying notes are an integral part of the condensed consolidated financial statements.

 

4

 

 

TWINLAB CONSOLIDATED HOLDINGS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

(AMOUNTS IN THOUSANDS, EXCEPT SHARE AND PER SHARE AMOUNTS)

 

NOTE 1 – NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization

Twinlab Consolidated Holdings, Inc. (the “Company”, “Twinlab,” “we,” “our” and “us”) was incorporated on October 24, 2013 under the laws of the State of Nevada as Mirror Me, Inc. On August 7, 2014, we amended our articles of incorporation and changed our name to Twinlab Consolidated Holdings, Inc.

 

Nature of Operations

We are an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty stores retailers, on-line retailers and websites. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers.

 

Our products include vitamins, minerals, specialty supplements and sports nutrition products sold under the Twinlab® brand name (including the Twinlab® Fuel brand of sports nutrition products); a market leader in the healthy aging and beauty from within categories sold under the Reserveage™ Nutrition and ResVitale® brand names; diet and energy products sold under the Metabolife® brand name; the Re-Body® brand name; and a full line of herbal teas sold under the Alvita® brand name. To accommodate consumer preferences, our products come in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, sprays and powders. These products are sold primarily through health and natural food stores and on-line retailers, supermarkets, and mass-market retailers.

 

We also perform contract manufacturing services for private label products.  Our contract manufacturing business involves the manufacture of custom products to the specifications of a customer who requires finished product under the customer’s own brand name.  We do not market these private label products as our business is to manufacture and sell the products to the customer, who then markets and sells the products to retailers or end consumers.

 

Principles of Consolidation

The condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

 

Basis of Presentation and Unaudited Information

The condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with United States generally accepted accounting principles, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures are adequate to make the information presented not misleading. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management, are necessary for fair presentation of the information contained herein. Financial results for any interim period are not necessarily indicative of financial results that may be expected for the fiscal year. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 filed with the SEC on March 31, 2017.

 

Use of Estimates

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant management estimates include those with respect to returns and allowances, allowance for doubtful accounts, reserves for inventory obsolescence, the recoverability of long-lived assets, intangibles and goodwill and the estimated value of warrants and derivative liabilities.

 

5

 

 

 

Revenue Recognition

Revenue from product sales, net of estimated returns and allowances, is recognized when evidence of an arrangement is in place, related prices are fixed and determinable, contractual obligations have been satisfied, title and risk of loss have been transferred to the customer and collection of the resulting receivable is reasonably assured. Shipping terms are generally freight on board shipping point. We sell predominately in the North American and European markets, with international sales transacted in U.S. dollars.

 

Fair Value of Financial Instruments

We apply the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

 

Level 1 – inputs are quoted prices in active markets for identical assets that the reporting entity has the ability to access at the measurement date.

 

Level 2 – inputs are other than quoted prices included within Level 1 that are observable for the asset, either directly or indirectly.

 

Level 3 – inputs are unobservable inputs for the asset that are supported by little or no market activity and that are significant to the fair value of the underlying asset or liability.

 

The following table summarizes our financial instruments that are measured at fair value on a recurring basis as of September 30, 2017 and December 31, 2016:

 

September 30, 2017

 

Total

   

Level 1

   

Level 2

   

Level 3

 
                                 

Derivative liabilities

  $ 8,143     $ -     $ -     $ 8,143  

 

December 31, 2016

 

Total

   

Level 1

   

Level 2

   

Level 3

 
                                 

Derivative liabilities

  $ 6,455     $ -     $ -     $ 6,455  

 

 

Accounts Receivable and Allowances

We grant credit to customers and generally do not require collateral or other security. We perform credit evaluations of our customers and provide for expected claims related to promotional items; customer discounts; shipping shortages; damages; and doubtful accounts based upon historical bad debt and claims experience. As of September 30, 2017, total allowances amounted to $2,777, of which $314 was related to doubtful accounts receivable. As of December 31, 2016, total allowances amounted to $2,365, of which $481 was related to doubtful accounts receivable.

 

Inventories

Inventories are stated at the lower of cost or net realizable value and are reduced by an estimated reserve for obsolete inventory.

 

Property and Equipment

Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation, including amounts amortized under capital leases, is calculated on the straight-line method over the estimated useful lives of the related assets, which are 7 to 10 years for machinery and equipment, 8 years for furniture and fixtures and 3 years for computers. Leasehold improvements are amortized over the shorter of the useful life of the asset or the term of the lease.

  

Normal repairs and maintenance are expensed as incurred. When assets are retired or otherwise disposed of, the related cost and accumulated depreciation or amortization is removed from the accounts and any gain or loss is included in the results of operations.

 

6

 

 

Intangible Assets

Intangible assets consist primarily of trademarks and customer relationships, which are amortized on a straight-line basis over their estimated useful lives ranging from 3 to 30 years. The valuation and classification of these assets and the assignment of amortizable lives involve significant judgment and the use of estimates.

 

We believe that our long-term growth strategy supports our fair value conclusions. For intangible assets, the recoverability of these amounts is dependent upon achievement of our projections and the execution of key initiatives related to revenue growth and improved profitability.

 

Goodwill

Goodwill is not subject to amortization, but is reviewed for impairment annually, or more frequently whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. An impairment charge would be recorded to the extent the carrying value of goodwill exceeds its estimated fair value. The testing of goodwill under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.

 

Impairment of Long-Lived Assets

Long-lived assets, including intangible assets subject to amortization, are reviewed for impairment when changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If the carrying amount of the asset exceeds the expected undiscounted cash flows of the asset, an impairment charge is recognized equal to the amount by which the carrying amount exceeds fair value. The testing of these intangibles under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.

 

Indefinite-Lived Intangible Assets

Indefinite-lived intangible assets relating to the asset acquisition of Organic Holdings, LLC (“Organic Holdings”), a market leader in the healthy aging and beauty from within categories and owner of the award-winning Reserveage™ Nutrition brand, are determined to have an indefinite useful economic life and as such are not amortized. Indefinite-lived intangible assets are tested for impairment annually which consists of a comparison of the fair value of the asset with its carrying value. The total indefinite-lived intangible assets as of September 30, 2017 and December 31, 2016 was $5,900.

 

Value of Warrants Issued with Debt

We estimate the grant date value of certain warrants issued with debt, using an outside professional valuation firm, which uses the Monte Carlo option lattice model. We record the amounts as interest expense or debt discount, depending on the terms of the agreement. These estimates involve multiple inputs and assumptions, including the market price of the Company’s common stock, stock price volatility and other assumptions to project earnings before interest, taxes, depreciation and amortization (“EBITDA”) and other reset events. These inputs and assumptions are subject to management’s judgment and can vary materially from period to period.

 

Derivative Liabilities

We have recorded certain warrants as derivative liabilities at estimated fair value, as determined based on our use of an outside professional valuation firm, due to the variable terms of the warrant agreements. The value of the derivative liabilities is generally estimated using the Monte Carlo option lattice model with multiple inputs and assumptions, including the market price of the Company’s common stock, stock price volatility and other assumptions to project EBITDA and other reset events. These inputs and assumptions are subject to management’s judgment and can vary materially from period to period.

 

Deferred gain on sale of assets

We entered into a sale-leaseback arrangement relating to our office facilities in 2013. Under the terms of the arrangement, we sold an office building and surrounding land and then leased the property back under a 15-year operating lease. We recorded a deferred gain for the amount of the gain on the sale of the asset, to be recognized as a reduction of rent expense over the life of the lease. Accordingly, we recorded amortization of deferred gain as a reduction of rental expense of $40 and $41 for the three months ended September 30, 2017 and 2016, respectively. For the nine months ended September 30, 2017 and 2016, we recorded amortization of $121 and $122, respectively. As of September 30, 2017 and December 31, 2016, unamortized deferred gain on sale of assets was $1,606 and $1,727, respectively.

 

7

 

 

Net Loss per Common Share

Basic net income or loss per common share (Basic EPS) is computed by dividing net income or loss by the weighted average number of common shares outstanding. Diluted net income or loss per common share (Diluted EPS) is computed by dividing net income or loss by the sum of the weighted average number of common shares outstanding and the dilutive potential common shares then outstanding. Potential dilutive common share equivalents consist of total shares issuable upon the exercise of outstanding stock options and warrants to acquire common stock using the treasury stock method and the average market price per share during the period.

The common shares used in the computation of our basic and diluted net loss per share are reconciled as follows:

 

   

Three Months Ended

 

Nine Months Ended

 
   

September 30,

 

September 30,

 
   

2017

   

2016

     

2017

   

2016

 
           

(as corrected)

             

(as corrected)

 

Numerator:

                                 

Net income (loss)

  $ (5,418 )   $ 10,968       $ (12,854 )   $ 8,584  

Effect of dilutive securities on net income (loss):

                                 

Common stock warrants

    -       (14,065 )       -       (28,128 )
                                   

Total net loss for purpose of calculating diluted net loss per common share

  $ (5,418 )   $ (3,097 )     $ (12,854 )   $ (19,544 )
                                   

Number of shares used in per common share calculations:

                                 

Total shares for purposes of calculating basic net loss per common share

    252,924,027       250,806,152         252,935,792       264,740,245  

Weighted-average effect of dilutive securities:

                                 

Common stock warrants

    -       13,418,629         -       12,481,487  
                                   

Total shares for purpose of calculating diluted net loss per common share

    252,924,027       264,224,781         252,935,792       277,221,732  
                                   

Net income (loss) per common share:

                                 

Basic

  $ (0.02 )   $ 0.04       $ (0.05 )   $ 0.03  

Diluted

  $ (0.02 )   $ (0.01 )     $ (0.05 )   $ (0.07 )

 

 

Correction of 2016 Diluted Net Loss Per Share

The diluted net loss per share for the period ended September 30, 2016 has been corrected. In accordance with U.S. generally accepted accounting principles, when calculating diluted earnings or loss per share, if the effects are dilutive, companies are required to add back to net income or loss the effects of the change in derivative liabilities related to warrants. Additionally, if the effects of the change in derivative liabilities are added back to net income or loss, companies are required to include the warrants outstanding related to the derivative liability in the calculation of the weighted average dilutive shares.

 

For the period ended September 30, 2016, as originally reported, we did not add back the effects of the change in the derivative liability in computing dilutive income or loss per share. The dilutive loss per share for the three and nine months ended September 30, 2016 in the table above has been revised to correct this error.

 

The table below reflects the diluted net loss per share as originally reported and net loss per share as corrected for the three and nine months ended September 30, 2016.

 

   

As originally reported

   

As corrected

 
                 

Diluted net income (loss) per common share (three months)

  $ 0.04     $ (0.01 )

Diluted net income (loss) per common share (nine months)

  $ 0.03     $ (0.07 )

Weighted average shares oustanding - diluted (three months)

    258,565,687       264,224,781  

Weighted average shares oustanding - diluted (nine months)

    275,633,914       277,221,732  

 

 

The errors were corrected as of December 31, 2016, but since the adjustments were not material to any of the quarters previously reported, the Form 10-Qs for those periods were not amended. Management has determined the effects to be neither quantitatively or qualitatively material to the financial statements included in any of the Form 10-Qs filed during 2016.

 

8

 

 

Significant Concentration of Credit Risk

Sales to our top three customers aggregated to approximately 33% and 25% of total sales for the three months ended September 30, 2017 and 2016, respectively, and 27% and 26% of total sales for the nine months ended September 30, 2017 and 2016, respectively. Sales to one of those customers were approximately 13% and 11% of total sales for the three months ended September 30, 2017 and 2016, respectively, and 12% and 11% of total sales for the nine months ended September 30, 2017 and 2016, respectively. Accounts receivable from these customers were approximately 55% and 29% of total accounts receivable as of September 30, 2017 and December 31, 2016, respectively.

 

Recent Accounting Pronouncements

In May 2017, FASB amended its guidance regarding the scope of modification accounting for share-based compensation arrangements. The amendments provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. For public entities, the amendments in this update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, with early adoption permitted. The amendments in this update should be applied prospectively to an award modified on or after the adoption date. We do not expect the new guidance to have a significant impact on our condensed consolidated financial statements or related disclosures.

 

In January 2017, FASB issued ASU No. 2017-04, “Simplifying the Test for Goodwill Impairment (Topic 350)” which removes Step 2 of the goodwill impairment test that requires a hypothetical purchase price allocation.  A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill.  The amendments in this ASU are effective for fiscal years beginning after December 15, 2019.  Early adoption is permitted after January 1, 2017.  We do not expect the new guidance to have a significant impact on our condensed consolidated financial statements or related disclosures.

 

In February 2016, FASB issued ASU No. 2016-02, “Leases (Topic 842)”. The amendments in this ASU revise the accounting related to lessee accounting. Under the new guidance, lessees will be required to recognize a lease liability and a right-of-use asset for all leases with terms greater than 12 months affecting the pattern of expense recognition in the income statement. Leases previously defined as operating leases will be defined as financing leases and capitalized if the term is greater than one year. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018 and are to be applied through a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Early adoption is permitted. We are performing an assessment of our leases and have begun preparations for implementation and retrospective application to the earliest reporting period. As a result, financing leases will be recorded as an asset and a corresponding liability at the present value of the total lease payments. The asset will be decremented over the life of the lease on a pro-rata basis resulting in lease expense while the liability will be decremented using the interest method (ie. principal and interest). As such, we expect the new guidance will materially impact the asset and liability balances of our consolidated financial statements and related disclosures at the time of adoption.

 

Although there are several other new accounting pronouncements issued or proposed by FASB, which we have adopted or will adopt, as applicable, we do not believe any of these accounting pronouncements has had or will have a material impact on our condensed consolidated financial position or results of operations.

 

NOTE 2 – GOING CONCERN

 

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which assumes continuity of operations and realization of assets and liabilities in the ordinary course of business. In most periods since our formation, we have generated losses from operations. At September 30, 2017, we had an accumulated deficit of $237,326. Historical losses are primarily attributable to lower than planned sales resulting from low fill rates on demand due to limitations of our working capital, delayed product introductions and postponed marketing activities, merger-related and other restructuring costs, and interest and refinancing charges associated with our debt refinancing. Losses have been funded primarily through issuance of common stock and third-party or related party debt.

 

Because of our history of operating losses, significant interest expense on our debt, and the recording of significant derivative liabilities, we have a working capital deficiency of $8,531 at September 30, 2017. We also have $17,091 of debt, net of discount, due within the next 12 months. These continuing conditions, among others, raise substantial doubt about our ability to continue as a going concern.

 

9

 

 

Management has addressed operating issues through the following actions: focusing on growing the core business and brands; continuing emphasis on major customers and key products; reducing manufacturing and operating costs and continuing to negotiate lower prices from major suppliers. We believe that we may need additional capital to execute our business plan. If additional funding is required, there can be no assurance that sources of funding will be available when needed on acceptable terms or at all.

 

NOTE 3 – INVENTORIES

 

Inventories consisted of the following at:

 

   

September 30,

   

December 31,

 
   

2017

   

2016

 
                 

Raw materials

  $ 6,348     $ 4,912  

Work in process

    2,013       1,189  

Finished goods

    12,411       13,438  
      20,772       19,539  

Reserve for obsolete inventory

    (2,404 )     (1,938 )
    $ 18,368     $ 17,601  

 

 

NOTE 4 – PROPERTY AND EQUIPMENT

 

Property and equipment consisted of the following at:

 

   

September 30,

   

December 31,

 
   

2017

   

2016

 
                 

Machinery and equipment

  $ 12,156     $ 10,885  

Computers and other

    9,500       9,119  

Aquifer

    482       482  

Leasehold improvements

    1,518       1,518  
      23,656       22,004  

Accumulated depreciation and amortization

    (20,416 )     (18,476 )
    $ 3,240     $ 3,528  

 

 

Assets held under capital leases are included in machinery and equipment and amounted to $1,082 and $1,142 as of September 30, 2017 and December 31, 2016, respectively.

 

Depreciation and amortization expense totaled $222 and $221 for the three months ended September 30, 2017 and 2016, respectively, and totaled $669 and $567 for the nine months ended September 30, 2017 and 2016, respectively.

 

10

 

 

NOTE 5 – INTANGIBLE ASSETS

 

Intangible assets consisted of the following at:

 

   

September 30,

   

December 31,

 
   

2017

   

2016

 
                 

Trademarks

  $ 12,166     $ 12,166  

Indefinite-lived intangible assets

    5,900       5,900  

Customer relationships

    19,110       19,110  

Other

    753       753  
      37,929       37,929  

Accumulated amortization

    (9,479 )     (7,732 )
    $ 28,450     $ 30,197  

 

 

Trademarks are amortized over periods ranging from 3 to 30 years, customer relationships are amortized over periods ranging from 15 to 16 years, and other intangible assets are amortized over 3 years. Amortization expense was $582 and $557 for the three months ended September 30, 2017 and 2016, respectively, and was $1,747 and $1,645 for the nine months ended September 30, 2017 and 2016, respectively.

 

11

 

 

NOTE 6 – DEBT

 

Debt consisted of the following at:

 

   

September 30,

   

December 31,

 
   

2017

   

2016

 
                 

Related-Party Debt:

               

July 2014 note payable to Little Harbor, LLC, net of unamortized discount of $0 and $206 as of September 30, 2017 and December 31, 2016, respectively

  $ 3,267     $ 3,061  

July 2016 note payable to Little Harbor, LLC

    4,770       4,770  

January 2016 note payable to Great Harbor Capital, LLC

    2,500       2,500  

March 2016 note payable to Great Harbor Capital, LLC

    7,000       7,000  

December 2016 note payable to Great Harbor Capital, LLC

    2,500       2,500  

August 2017 note payable to Great Harbor Capital, LLC

    3,000       -  

January 2016 note payable to Golisano Holdings LLC

    2,500       2,500  

March 2016 note payable to Golisano Holdings LLC

    7,000       7,000  

July 2016 note payable to Golisano Holdings LLC

    4,770       4,770  

December 2016 note payable to Golisano Holdings LLC

    2,500       2,500  

March 2017 note payable to Golisano Holdings LLC

    3,267       -  

November 2014 note payable to Golisano Holdings LLC (formerly payble to Penta

               

Mezzanine SBIC Fund I, L.P.), net of discount and unamortized loan fees in the aggregate of $1,694 and $2,304 as of September 30, 2017 and December 31, 2016, respectively

    6,306       5,696  

January 2015 note payable to Golisano Holdings LLC (formerly payable to JL-BBNC

               

Mezz Utah, LLC), net of discount and unamortized loan fees in the aggregate of $2,058 as of September 30, 2017

    2,942       -  

February 2015 note payable to Golisano Holdings LLC (formerly payable to Penta

               

Mezzanine SBIC Fund I, L.P.), net of discount and unamortized loan fees in the aggregate of $148 and $201 as of September 30, 2017 and December 31, 2016, respectively

    1,852       1,799  

Total related-party debt

    54,174       44,096  
                 

Senior Credit Facility with Midcap, net of unamortized loan fees of $73 and $293 as of September 30, 2017 and December 31, 2016, respectively

    14,901       13,035  
                 

Other Debt:

               

January 2015 note payable to JL-BBNC Mezz Utah, LLC, net of discount and unamortized loan fees in the aggregate of $2,744 as of December 31, 2016

    -       2,256  

April 2016 note payable to JL-Utah Sub, LLC

    396       500  

Capital lease obligations

    1,582       2,732  

Huntington Holdings

    3,200       -  

Total other debt

    5,178       5,488  
                 

Total debt

    74,253       62,619  

Less current portion

    (17,091 )     (11,631 )

Long-term debt

  $ 57,162     $ 50,988  

 

12

 

 

Related-Party Debt

 

July 2014 Note Payable to Little Harbor, LLC

Pursuant to a July 2014 Debt Repayment Agreement with Little Harbor, LLC (“Little Harbor”), an entity owned by certain stockholders of the Company, we are obligated to pay such party $4,900 per year in structured monthly payments for 3 years provided that such payment obligations will terminate at such earlier time as the trailing ninety day volume weighted average closing sales price of the Company’s common stock on all domestic securities exchanges on which such stock is listed equals or exceeds $5.06 per share. This note is unsecured and matured on July 25, 2017 however this note remains outstanding and principal payment has been deferred to 2018. This note was non-interest bearing, accordingly, using an imputed interest rate of 16.2%, we recorded a note discount in July 2014, which has been amortized into interest expense based on the effective interest rate method over the term of the note.

 

July 2016 Note Payable to Little Harbor, LLC

On July 21, 2016, we issued an Unsecured Delayed Draw Promissory Note in favor of Little Harbor, pursuant to which Little Harbor may, in its sole discretion and pursuant to draw requests made by the Company, loan us up to the maximum principal amount of $4,770. This note is unsecured and matures on January 28, 2019. This note bears interest at an annual rate of 8.5%, with the principal payable at maturity. If Little Harbor, in its discretion, accepts a draw request made by the Company under this note, Little Harbor shall not transfer cash to the Company, but rather Little Harbor shall irrevocably agree to accept the principal amount of any monthly delayed draw under this note in lieu and in complete satisfaction of the obligation to make an equivalent dollar amount of periodic cash payments otherwise due to Little Harbor under the July 2014 note payable. During the year ended December 31, 2016, we requested and Little Harbor LLC approved, draws totaling $4,770. We issued a warrant into escrow in connection with this loan (see Little Harbor Escrow Warrants in Note 7).

 

January 2016 Note Payable to Great Harbor Capital, LLC

Pursuant to a January 28, 2016 Unsecured Promissory Note with Great Harbor Capital, LLC (“GH”), an affiliate of a member of our Board of Directors, GH lent us $2,500. The note matures on January 28, 2019, bears interest at an annual rate of 8.5%, with the principal payable in 24 monthly installments of $104 which was to commence on February 28, 2017 but has been deferred to January 28, 2018. We issued a warrant into escrow in connection with this loan (see GH Escrow Warrants in Note 7).

 

March 2016 Note Payable to Great Harbor Capital, LLC

Pursuant to a March 21, 2016 Unsecured Promissory Note, GH lent us $7,000. The note matures on March 21, 2019, bears interest at an annual rate of 8.5%, with the principal payable in 24 monthly installments of $292 which was to commence on April 21, 2017 but has been deferred to January 21, 2018. We issued a warrant into escrow in connection with this loan (see GH Escrow Warrants in Note 7).

 

December 2016 Note Payable to Great Harbor Capital, LLC

Pursuant to a December 31, 2016 Unsecured Promissory Note, GH lent us $2,500. The note matures on December 30, 2019, bears interest at an annual rate of 8.5%, with the principal payable at maturity. We issued a warrant into escrow in connection with this loan (see GH Escrow Warrants in Note 7).

 

August 2017 Note Payable to Great Harbor Capital, LLC

Pursuant to an August 30, 2017 Secured Promissory Note, GH lent us $3,000.  The note matures on August 29, 2020, bears interest at an annual rate of 8.5%, with the principal payable at maturity.  We issued a warrant into escrow in connection with this loan (see GH Escrow Warrants in Note 7).

 

November 2014 Note Payable to Golisano Holdings LLC (formerly payable to Penta Mezzanine SBIC Fund I, L.P.)

On November 13, 2014, we raised proceeds of $8,000, less certain fees and expenses, from the issuance of a secured note to Penta Mezzanine SBIC Fund I, L.P. (“Penta”). The Managing Director of Penta, an institutional investor, is also a director of our Company. We granted Penta a security interest in our assets and pledged the shares of our subsidiaries as security for the note. On March 8, 2017, Golisano Holdings LLC (“Golisano LLC”) acquired this note payable from Penta. Interest on the outstanding principal accrued at a rate of 12% per year from date of issuance to March 8, 2017, and decreased to 8% per year thereafter, payable monthly. The note matures on November 13, 2019. On August 30, 2017, we entered into an amendment with Golisano LLC which extended payment of principal to maturity. We issued a warrant to Penta to purchase 4,960,740 shares of the Company’s common stock in connection with this loan (see Penta Warrants in Note 7). The estimated fair value of the warrant at the date of issuance was $3,770, which was recorded as a note discount and is being amortized into interest expense over the term of this loan. Additionally, we had incurred loan fees of $273, which is also being amortized into interest expense over the term of this loan.

 

13

 

 

January 2015 Note Payable to Golisano Holdings LLC (formerly payable to JL-Mezz Utah, LLC-f/k/a JL-BBNC Mezz Utah, LLC)

On January 22, 2015, we raised proceeds of $5,000, less certain fees and expenses, from the sale of a note to JL-Mezz Utah, LLC (f/k/a JL-BBNC Mezz Utah, LLC) (“JL-US”). The proceeds were restricted to pay a portion of the Nutricap Labs, LLC (“Nutricap”) asset acquisition. We granted JL a security interest in the Company’s assets, including real estate and pledged the shares of our subsidiaries as security for the note. On March 8, 2017, Golisano LLC acquired this note payable from JL.

Interest on the outstanding principal accrued at a rate of 12% per year from date of issuance to March 8, 2017, and decreased to 8% per year thereafter, payable monthly. The note matures on November 13, 2019. On August 30, 2017, we entered into an amendment with Golisano LLC which extended payment of principal to maturity. We issued a warrant to JL to purchase 2,329,400 shares of the Company’s common stock on January 22, 2015 and 434,809 shares of the Company’s common stock on February 4, 2015 (see JL Warrants in Note 7). The estimated fair value of these warrants at the date of issuances was $4,389, which was recorded as a note discount and is being amortized into interest expense over the term of these loans. Additionally, we had incurred loan fees of $152 relating to this loan, which is also being amortized into interest expense over the term of these loans.

 

February 2015 Note Payable to Golisano Holdings LLC (formerly payable to Penta Mezzanine SBIC Fund I, L.P.)

On February 6, 2015, we raised proceeds of $2,000, less certain fees and expenses, from the issuance of a secured note payable to Penta. The proceeds were restricted to pay a portion of the acquisition of the customer relationships of Nutricap. On March 8, 2017, Golisano LLC acquired this note payable from Penta. Interest on the outstanding principal accrued at a rate of 12% per year from date of issuance to March 8, 2017, and decreased to 8% per year thereafter, payable monthly. The note matures on November 13, 2019. On August 30, 2017, we entered into an amendment with Golisano LLC which extended payment of principal to maturity. We issued a warrant to Penta to purchase 869,618 shares of the Company’s common stock in connection with this loan (see Penta Warrants in Note 7). The estimated fair value of these warrants at the date of issuances totaled $250, which was recorded as a note discount and is being amortized into interest expense over the term of this loan. Additionally, we had incurred loan fees of $90, which is also being amortized into interest expense over the term of these loans.

 

January 2016 Note Payable to Golisano Holdings LLC

Pursuant to a January 28, 2016 Unsecured Promissory Note with Golisano LLC, an affiliate of a member of our Board of Directors, Golisano LLC lent us $2,500. The note matures on January 28, 2019, bears interest at an annual rate of 8.5%, with the principal payable in 24 monthly installments of $104 which was to commence on February 28, 2017 but has been deferred to January 28, 2018. We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note 7).

 

March 2016 Note Payable to Golisano Holdings LLC

Pursuant to a March 21, 2016 Unsecured Promissory Note, Golisano LLC lent us $7,000. The note matures on March 21, 2019, bears interest at an annual rate of 8.5%, with the principal payable in 24 monthly installments of $292 which was to commence on April 21, 2017 but has been deferred to January 21, 2018. We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note 7).

 

July 2016 Note Payable to Golisano Holdings LLC

On July 21, 2016, we issued an Unsecured Delayed Draw Promissory Note in favor of Golisano LLC pursuant to which Golisano LLC may, in its sole discretion and pursuant to draw requests made by the Company, loan the Company up to the maximum principal amount of $4,770 (the “Golisano LLC July 2016 Note”). The Golisano LLC July 2016 Note matures on January 28, 2019. Interest on the outstanding principal accrues at a rate of 8.5% per year. The principal of the Golisano LLC July 2016 Note is payable at maturity. We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note 7). During the year ended December 31, 2016, we requested and Golisano LLC approved, draws totaling $4,770.

 

December 2016 Note Payable to Golisano Holdings LLC

Pursuant to a December 31, 2016 Unsecured Promissory Note, Golisano LLC lent us $2,500. The note matures on December 30, 2019, bears interest at an annual rate of 8.5%, with the principal payable at maturity. We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note 7).

 

14

 

 

March 2017 Note Payable to Golisano Holdings LLC

Pursuant to a March 14, 2017 Unsecured Promissory Note, Golisano LLC lent us $3,267. The note matures on December 30, 2019, bears interest at an annual rate of 8.5%, with the principal payable at maturity. We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note 7).

 

Senior Credit Facility

 

On January 22, 2015, we entered into a three-year $15,000 revolving credit facility (the “Senior Credit Facility”) based on our accounts receivable and inventory, increasable to up to $20,000, with MidCap Financial Trust, which subsequently assigned the agreement to an affiliate, Midcap Funding X Trust (“MidCap”). On September 2, 2016, we entered into an amendment with Midcap to increase the Senior Credit Facility to $17,000 and extend our facility an additional 12 months. We granted MidCap a first priority security interest in certain of our assets and pledged the shares of our subsidiaries as security for amounts owed under the credit facility. We are required to pay Midcap an unused line fee of 0.50% per annum, a collateral management fee of 1.20% per month and interest of LIBOR plus 5% per annum, which was 6.24% per annum as of September 30, 2017. We issued a warrant to Midcap to purchase 500,000 shares of the Company’s common stock (see Midcap Warrant in Note 7). The estimated fair value of these warrants at the date of issuance was $130, which was recorded as a note discount and is being amortized into interest expense over the term of the Senior Credit Facility. Additionally, we have incurred loan fees totaling $540 relating to the Senior Credit Facility and any subsequent amendments, which is also being amortized into interest expense over the term of the Senior Credit Facility.

 

Other Debt 

 

April 2016 Note Payable to JL-Utah Sub, LLC

Pursuant to an April 5, 2016 Unsecured Promissory Note, JL-Utah Sub, LLC lent us $500. The note matures on March 21, 2019, bears interest at an annual rate of 8.5%, with the principal payable in 24 monthly installments of $21 commencing on April 21, 2017.

 

Capital Lease Obligations

Our capital lease obligations pertain to various leasing agreements with Essex Capital Corporation (“Essex”), a related party to the Company as Essex’s principal owner is a director of the Company.

 

Huntington Holdings, LLC

On August 6, 2016, the 18-month anniversary of the closing of a share purchase agreement, we were required to pay the purchaser of the common stock the difference between $2.29 per share and either a defined market price or a price per share determined by a valuation firm acceptable to both parties. Based on an outside professional valuation performed on the Company’s common stock, the Company estimated the stock price guarantee payment to be $3,210. Accordingly, the Company recorded a loss on the stock purchase price guarantee of $3,210 and a corresponding liability for the same amount in 2016, which was included in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheet as of December 31, 2016.  On June 2, 2017, the two parties came to an agreement in which we were required to issue an Unsecured Promissory Note (“Huntington Note”) in favor of Huntington Holdings, LLC (“Huntington”). The Huntington Note matures on June 2, 2019 with the principal amount of $3,200 payable at maturity. Interest on the outstanding principal accrues at a rate of 8.5% per year from August 6, 2016 to August 15, 2017, and increases to 10% per year thereafter. We paid $50 to Huntington related to accrued interest from August 6, 2016 through the date of issuance of the Huntington Note. Huntington was required to return 778,385 shares of the Company’s common stock which were issued into escrow. We were required to provide certain piggyback registration rights to Huntington in regards to the remaining 749,999 shares of the Company’s common stock held by Huntington. If the Huntington Note was paid off prior to August 14, 2017, the 778,385 shares held in escrow were to be released from escrow and transferred to the Company for no additional consideration. If the note remained outstanding on August 15, 2017, we had the right, but not the obligation, to pay $140 to Huntington to purchase 764,192 of the shares held in escrow (the “Subject Shares”). Upon the exercise of this purchase option, the Subject Shares were to be released from escrow and transferred to the Company. If the note remained outstanding on August 15, 2017 and we did not exercise the option to purchase the shares, the shares were to be returned from escrow to Huntington and we would no longer have repurchase rights. On August 15, 2017, the note was outstanding and we did not excerise the repurchase right. The 778,385 shares were returned from escrow to Huntington.

 

15

 

 

Financial Covenants

 

Certain of the foregoing debt agreements, as amended, require us to meet certain affirmative and negative covenants, including maintenance of specified ratios. We amended our debt agreements with MidCap, Penta and JL, effective July 29, 2016, to, among other things, reset the financial covenants of each debt agreement. As of September 30, 2017, management believes we are in compliance with our financial covenants for each debt agreement.

 

NOTE 7 WARRANTS AND REGISTRATION RIGHTS AGREEMENTS

 

The following table presents a summary of the status of our issued warrants as of September 30, 2017, and changes during the nine months then ended:

 

           

Weighted Average

 
   

Shares

   

Exercise Price

 
                 
                 

Outstanding, December 31, 2016

    15,855,017       0.18  
                 

Granted

    -       -  

Canceled / Expired

    -       -  

Exercised

    -       -  

Outstanding, September 30, 2017

    15,855,017       0.18  

 

 

Warrants Issued

 

Midcap Warrant

In connection with the line of credit agreement with MidCap described in Note 6, we issued MidCap a warrant, exercisable through January 22, 2018, for an aggregate of 500,000 shares of the Company’s common stock at an exercise price of $0.76 per share (the “MidCap Warrant”). We entered into a Registration Rights Agreement with Midcap, dated as of January 22, 2015, granting MidCap certain registration rights, commencing October 1, 2015, for the shares of common stock issuable on exercise of the MidCap Warrant.

 

Penta Warrants

Pursuant to a stock purchase agreement dated June 30, 2015, a warrant was issued to Penta to purchase an aggregate 807,018 shares of our common stock at a price of $0.01 per share at any time prior to the close of business on June 30, 2020. We granted Penta certain registration rights, commencing October 1, 2015, for the shares of common stock issuable upon exercise of the warrant.

 

JL Warrants

Pursuant to a June 30, 2015 stock purchase agreement, a warrant was issued to JL to purchase an aggregate 403,509 shares of the Company’s common stock at a price of $0.01 per share at any time prior to the close of business on June 30, 2020, subject to certain adjustments. We granted JL certain registration rights, commencing October 1, 2015, for the shares of common stock issuable upon exercise of the warrant. The warrant was subsequently assigned by JL to two individuals.

 

Essex Warrants

In connection with the guarantee of a note payable issued in the Nutricap asset acquisition and equipment financing by Essex discussed in Note 6, Essex was issued a warrant exercisable for an aggregate 1,428,571 shares of the Company’s common stock at a purchase price of $0.77 per share, at any time prior to the close of business on June 30, 2020. The number of shares issuable upon the exercise of the warrant is subject to adjustment on terms and conditions customary for a transaction of this nature in the event of (i) reorganization, recapitalization, stock split-up, combination of shares, mergers, consolidations and (ii) sale of all or substantially all of our assets or property. Essex subsequently assigned warrants for 350,649 shares to another company.

 

JL Properties, Inc. Warrants

In April 2015, we entered into an office lease agreement which requires a $1,000 security deposit, subject to reduction if we achieve certain market capitalization metrics at certain dates. On April 30, 2015, we entered into a reimbursement agreement with JL Properties, Inc. (“JL Properties”) pursuant to which JL Properties agreed to arrange for and provide an unconditional, irrevocable, transferable, and negotiable commercial letter of credit to serve as the security deposit. As partial consideration for the entry by JL Properties into the reimbursement agreement and the provision of the letter of credit, we issued JL Properties two warrants to purchase shares of the Company’s common stock.

 

16

 

 

The first warrant is exercisable for an aggregate of 465,880 shares of common stock, subject to certain adjustments, at an aggregate purchase price of $0.01, at any time prior to April 30, 2020. In addition to adjustments on terms and conditions customary for a transaction of this nature in the event of (i) reorganization, recapitalization, stock split-up, combination of shares, mergers, consolidations and (ii) sale of all or substantially all of our assets or property, the number of shares of common stock issuable pursuant to the warrant will be increased in the event our consolidated audited adjusted EBITDA (as defined in the warrant agreement) for the fiscal year ending December 31, 2018 does not equal or exceed $19,250. JL Properties subsequently assigned the warrant to two individuals.

 

The second warrant is exercisable for an aggregate of 86,962 shares of common stock, at a per share purchase price of $1.00, at any time prior to April 30, 2020. The number of shares issuable upon exercise of the second warrant is subject to adjustment on terms and conditions customary for a transaction of this nature in the event of (i) reorganization, recapitalization, stock split-up, combination of shares, mergers, consolidations and (ii) sale of all or substantially all of our assets or property.

 

We have granted JL Properties certain registration rights, commencing October 1, 2015, for the shares of common stock issuable on exercise of the two warrants.

 

Golisano LLC Warrants (formerly Penta Warrants)

In connection with the November 13, 2014 note for $8,000 (see Note 6), Penta was issued a warrant to acquire 4,960,740 shares of the Company’s common stock at an aggregate exercise price of $0.01, through November 13, 2019. In connection with Penta’s consent to the terms of additional debt obtained by us, we also granted Penta a warrant to acquire an additional 869,618 shares of common stock at a purchase price of $1.00 per share, through November 13, 2019. Both warrant agreements grant Penta certain registration rights, commencing October 1, 2015, for the shares of common stock issuable on exercise of the warrants. Penta has the right, under certain circumstances, to require us to purchase all or any portion of the equity interest in the Company issued or represented by the warrant to acquire 4,960,740 shares at a price based on the greater of (i) the product of (x) ten times our adjusted EBITDA with respect to the twelve months preceding the exercise of the put right multiplied by (y) the investor’s percentage ownership in the Company assuming full exercise of the warrant; or (ii) the fair market value of the investor’s equity interest underlying the warrant. In the event (i) we do not have the funds available to repurchase the equity interest under the warrant or (ii) such repurchase is not lawful, adjustments to the principal of the note purchased by Penta will be made or, under certain circumstances, interest will be charged on the amount otherwise due for such repurchase. We have the right, under certain circumstances, to require Penta to sell to us all or any portion of the equity interest issued or represented by the warrant to acquire 4,960,740 shares. The price for such repurchase will be the greater of (i) the product of (x) eleven times our adjusted EBITDA with respect to the twelve months preceding the exercise of the call right multiplied by (y) the investor’s percentage ownership in the company assuming full exercise of the warrant; or (ii) the fair market value of the equity interests underlying the warrant; or (iii) $3,750. In connection with Golisano LLC’s acquisition of the note payable from Penta on March 8, 2017 (see Note 6 above for additional information), these warrants were assigned to Golisano LLC.

 

Golisano LLC Warrants (formerly JL Warrants)

In connection with the January 22, 2015 note payable to JL, we issued JL warrants to purchase an aggregate of 2,329,400 shares of the Company’s common stock, at an aggregate exercise price of $0.01, through February 13, 2020. On February 4, 2015, we also granted to JL a warrant to acquire a total of 434,809 shares of common stock at a purchase price of $1.00 per share, through February 13, 2020. Both warrant agreements grant JL certain registration rights, commencing October 1, 2015, for the shares of common stock issuable upon exercise of the warrants. These warrants were subsequently assigned to two individuals. During the year ended December 31, 2016, these individuals exercised warrants for a total of 1,187,995 shares of the Company’s common stock for total proceeds to the Company of less than $1. In connection with Golisano LLC’s acquisition of the note payable from JL on March 8, 2017 (see Note 6 above for additional information), the remaining portions of these warrants were assigned to Golisano LLC.

 

17

 

 

Golisano LLC Warrants

Pursuant to an October 2015 Securities Purchase Agreement with Golisano LLC, we issued Golisano LLC a warrant (the “Golisano Warrant”), which Golisano Warrant is intended to maintain, following each future issuance of shares of common stock pursuant to the conversion, exercise or exchange of certain currently outstanding warrants to purchase shares of common stock held by third-parties (the “Outstanding Warrants”), Golisano LLC’s proportional ownership of our issued and outstanding common stock so that it is the same thereafter as on October 5, 2015. We have reserved 12,697,977 shares of common stock for issuance under the Golisano Warrant. The purchase price for any shares of common stock issuable upon exercise of the Golisano Warrant is $.001 per share. The Golisano Warrant is exercisable immediately and up to and including the date which is sixty days after the later to occur of the termination, expiration, conversion, exercise or exchange of all of the Outstanding Warrants and our delivery of notice thereof to Golisano LLC. The Golisano Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets. In addition, if any payments are made to a holder of an Outstanding Warrant in consideration for the termination of or agreement not to exercise such Outstanding Warrant, Golisano LLC will be entitled to equal treatment. We have entered into a registration rights agreement with Golisano LLC, dated as of October 5, 2015, granting Golisano LLC certain registration rights for the shares of common stock issuable on exercise of the Golisano Warrant. On February 6, 2016, Golisano LLC exercised the Golisano Warrant in part for 509,141 shares of the Company’s common stock for an aggregate purchase price of $1. During the year ended December 31, 2016, the Golisano Warrant was cancelled in part for 6,857,143 shares pursuant to the cancellation of a portion of the Outstanding Warrants. As of September 30, 2017, we have reserved 4,756,505 shares of its common stock for issuance under the Golisano Warrant.

 

Warrants Issued into Escrow

 

Golisano Escrow Warrants

In connection with a January 28, 2016 Unsecured Promissory Note, we issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of 1,136,363 shares of the Company’s common stock at an exercise price of $0.01 per share (the “January 2016 Golisano Warrant”). The January 2016 Golisano Warrant will not be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the related promissory note and any accrued and unpaid interest thereon as of January 28, 2019 or such earlier date as is required pursuant to an Acceleration Notice (as defined in the related note agreement). We have reserved 1,136,363 shares of the Company’s common stock for issuance under the January 2016 Golisano Warrant. The January 2016 Golisano Warrant, if exercisable, expires on February 28, 2022. The January 2016 Golisano Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.

 

In connection with a March 21, 2016 Unsecured Promissory Note, we issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of 3,181,816 shares of the Company’s common stock at an exercise price of $0.01 per share (the “March 2016 Golisano Warrant”). The March 2016 Golisano Warrant will not be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the related promissory note and any accrued and unpaid interest thereon as of March 21, 2019 or such earlier date as is required pursuant to an Acceleration Notice (as defined in the related note agreement). We have reserved 3,181,816 shares of the Company’s common stock for issuance under the March 2016 Golisano Warrant. The March 2016 Golisano Warrant, if exercisable, expires on March 21, 2022. The March 2016 Golisano Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.

In connection with the Golisano LLC July 2016 Note, we issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of 2,168,178 shares of the Company’s common stock, at an exercise price of $0.01 per share (the “Golisano July 2016 Warrant”). The Golisano July 2016 Warrant will not be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the Golisano July 2016 Note and any accrued and unpaid interest thereon as of January 28, 2019 or such earlier date as is required pursuant to an Acceleration Notice (as defined in the Golisano LLC July 2016 Note). We have reserved 2,168,178 shares of the Company’s common stock for issuance under the Golisano July 2016 Warrant. The Golisano July 2016 Warrant, if exercisable, expires on July 21, 2022. The Golisano July 2016 Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.

 

In connection with the Golisano LLC December 2016 Note, we issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of 1,136,363 shares of the Company’s common stock, at an exercise price of $0.01 per share (the “Golisano December 2016 Warrant”). The Golisano December 2016 Warrant will not be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the Golisano December 2016 Note and any accrued and unpaid interest thereon as of December 30, 2019 or such earlier date as is required pursuant to an Acceleration Notice (as defined in the Golisano LLC December 2016 Note). We have reserved 1,136,363 shares of the Company’s common stock for issuance under the Golisano December 2016 Warrant. The Golisano December 2016 Warrant, if exercisable, expires on December 30, 2022. The Golisano December 2016 Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.

 

18

 

 

In connection with the Golisano LLC March 2017 Note, we issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of 1,484,847 shares of the Company’s common stock, at an exercise price of $0.01 per share (the “Golisano March 2017 Warrant”). The Golisano March 2017 Warrant will not be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the Golisano March 2017 Note and any accrued and unpaid interest thereon as of December 30, 2019 or such earlier date as is required pursuant to an Acceleration Notice (as defined in the Golisano LLC March 2017 Note). We have reserved 1,484,847 shares of the Company’s common stock for issuance under the Golisano March 2017 Warrant. The Golisano March 2017 Warrant, if exercisable, expires on March 14, 2023. The Golisano March 2017 Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.

 

We previously entered into a registration rights agreement with Golisano LLC, dated as of October 5, 2015 (the “Registration Rights Agreement”), granting Golisano LLC certain registration rights for certain shares of the Company’s common stock. The shares of common stock issuable pursuant to the above warrants are also entitled to the benefits of the Registration Rights Agreement.

 

GH Escrow Warrants

In connection with a January 28, 2016 Unsecured Promissory Note, we issued into escrow in the name of GH a warrant to purchase an aggregate of 1,136,363 shares of the Company’s common stock at an exercise price of $0.01 per share (the “January 2016 GH Warrant”). The January 2016 GH Warrant will not be released from escrow or be exercisable unless and until we fail to pay GH the entire unamortized principal amount of the related promissory note and any accrued and unpaid interest thereon as of January 28, 2019 or such earlier date as is required pursuant to an Acceleration Notice (as defined in the related note agreement). We have reserved 1,136,363 shares of the Company’s common stock for issuance under the January 2016 GH warrant. The January 2016 GH Warrant, if exercisable, expires on February 28, 2022. The January 2016 GH Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.

 

In connection with a March 21, 2016 Unsecured Promissory Note, we issued into escrow in the name of GH a warrant to purchase an aggregate of 3,181,816 shares of the Company’s common stock at an exercise price of $0.01 per share (the “March 2016 GH Warrant”). The March 2016 GH Warrant will not be released from escrow or be exercisable unless and until we fail to pay GH the entire unamortized principal amount of the related promissory note and any accrued and unpaid interest thereon as of March 21, 2019 or such earlier date as is required pursuant to an Acceleration Notice (as defined in the related note agreement). We have reserved 3,181,816 shares of the Company’s common stock for issuance under the March 2016 GH Warrant. The March 2016 GH Warrant, if exercisable, expires on March 21, 2022. The March 2016 GH Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.

 

In connection with the GH December 2016 Note, we issued into escrow in the name of GH a warrant to purchase an aggregate of 1,136,363 shares of the Company’s common stock, at an exercise price of $0.01 per share (the “December 2016 GH Warrant”). The December 2016 GH Warrant will not be released from escrow or be exercisable unless and until we fail to pay GH the entire unamortized principal amount of the December 2016 GH Warrant and any accrued and unpaid interest thereon as of December 30, 2019 or such earlier date as is required pursuant to an Acceleration Notice (as defined in the December 2016 GH Warrant). We have reserved 1,136,363 shares of common stock for issuance under the December 2016 GH Warrant. The December 2016 GH Warrant, if exercisable, expires on December 30, 2022. The December 2016 GH Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.

 

In connection with the GH August 2017 Note, we issued into escrow in the name of GH a warrant to purchase an aggregate of 1,363,636 shares of the Company’s common stock, at an exercise price of $0.01 per share (the “August 2017 GH Warrant”). The August 2017 GH Warrant will not be released from escrow or be exercisable unless and until we fail to pay GH the entire unamortized principal amount of the August 2017 GH Warrant and any accrued and unpaid interest thereon as of August 29, 2020 or such earlier date as is required pursuant to an Acceleration Notice (as defined in the August 2017 GH Warrant). We have reserved 1,363,636 shares of common stock for issuance under the August 2017 GH Warrant. The August 2017 GH Warrant, if exercisable, expires on August 30, 2023. The August 2017 GH Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.

 

19

 

 

JL-US Escrow Warrant

In connection with an April 5, 2016 Unsecured Promissory Note, we issued into escrow in the name of JL-US a warrant to purchase an aggregate of 227,273 shares of the Company’s common stock at an exercise price of $0.01 per share (the “JL-US Warrant”). The JL-US Warrant will not be released from escrow or be exercisable unless and until we fail to pay JL-US the entire unamortized principal amount of the JL-US Note and any accrued and unpaid interest thereon as of March 21, 2019 or such earlier date as is required pursuant to an Acceleration Notice (as defined in the JL-US Note). We have reserved 227,273 shares of the Company’s common stock for issuance under the JL-US Warrant. The JL-US Warrant, if exercisable, expires on March 21, 2022. The JL-US Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.

 

Little Harbor Escrow Warrant

The Little Harbor July 2016 Note provides that we issue into escrow in the name of Little Harbor a warrant to purchase an aggregate of 2,168,178 shares of common stock at an exercise price of $0.01 per share (the “Little Harbor July 2016 Warrant”). The Little Harbor July 2016 Warrant will not be released from escrow or be exercisable unless and until we fail to pay Little Harbor the entire unamortized principal amount of the Little Harbor July 2016 Note and any accrued and unpaid interest thereon as of January 28, 2019 or such earlier date as is required pursuant to an Acceleration Notice (as defined in the Little Harbor July 2016 Note). We have reserved 2,168,178 shares of the Company’s common stock for issuance under the Little Harbor July 2016 Warrant. The Little Harbor July 2016 Warrant, if exercisable, expires on July 21, 2022. The Little Harbor July 2016 Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets. The Little Harbor July 2016 Warrant grants Little Harbor certain registration rights for the shares of the Company’s common stock issuable upon exercise of the Little Harbor July 2016 Warrant.

 

NOTE 8 – DERIVATIVE LIABILITIES

 

The number of shares of common stock issuable pursuant to certain warrants issued in 2015 will be increased if our adjusted EBITDA or the market price of the Company’s common stock does not meet certain defined amounts. We have recorded the estimated fair value of the warrants as of the date of issuance. Due to the variable terms of the warrant agreements, the warrants are recorded as derivative liabilities with a corresponding charge to our consolidated statements of comprehensive loss for changes in the estimated fair value of the warrants from the date of issuance to each balance sheet reporting date. As of September 30, 2017, we have estimated the total fair value of the derivative liabilities to be $8,143 as compared to $6,455 as of December 31, 2016. We had the following activity in our derivative liabilities account since December 31, 2016:

 

   

Nine Months Ended

 
   

September 30,

 
   

2017

 

Derivative liabilities at December 31, 2016

  $ 6,455  
         

Loss on change in fair value of derivative liabilities

    1,688  

Derivative liabilities at September 30, 2017

  $ 8,143  

 

The value of the derivative liabilities is generally estimated using an options lattice model with multiple inputs and assumptions, including the market price of the Company’s common stock, stock price volatility and other assumptions to project EBITDA and other reset events. These inputs and assumptions are subject to management’s judgment and can vary materially from period to period.

 

NOTE 9 STOCKHOLDERS’ EQUITY (DEFICIT)

 

Preferred Stock

The Company has authorized 500,000,000 shares of preferred stock with a par value of $0.001 per share. No shares of the preferred stock have been issued.

 

Twinlab Consolidation Corporation 2013 Stock Incentive Plan

The only equity compensation plan currently in effect is the Twinlab Consolidation Corporation 2013 Stock Incentive Plan (the “TCC Plan”), which was assumed by the Company on September 16, 2014. The TCC Plan originally established a pool of 20,000,000 shares of common stock for issuance as incentive awards to employees for the purposes of attracting and retaining qualified employees who will aid in the success of the Company. From January through December 2015, the Company granted restricted stock units to certain employees of the Company pursuant to the TCC Plan. Each restricted stock unit relates to one share of the Company’s common stock. The restricted stock unit awards vest 25% each annually on various dates through 2019. The Company estimated the grant date fair market value per share of the restricted stock units and is amortizing the total estimated grant date value over the vesting periods. During the nine months ended September 30, 2017, there were not any shares of common stock issued to employees pursuant to the vesting of restricted stock units. As of September 30, 2017, 6,060,943 shares remain available for use in the TCC Plan.

 

20

 

 

Common Stock Repurchase

On January 5, 2017, pursuant to a repurchase agreement, 642,366 shares of the Company’s common stock were repurchased for an aggregate repurchase price of less than $1.

 

Stock Subscription Receivable and Loss on Stock Price Guarantee

At September 30, 2017, the stock subscription receivable dated August 1, 2014 for the purchase of 1,528,384 shares of the Company’s common stock had a principal balance of $30 and bears interest at an annual rate of 5%.

 

On August 6, 2016, the 18-month anniversary of the closing of a share purchase agreement, we were required to pay the purchaser of the common stock the difference between $2.29 per share and either a defined market price or a price per share determined by a valuation firm acceptable to both parties. Based on an outside professional valuation performed on the Company’s common stock, the Company estimated the stock price guarantee payment to be $3,210. Accordingly, the Company recorded a loss on the stock purchase price guarantee of $3,210 and a corresponding liability for the same amount in 2016, which was included in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheet as of December 31, 2016. On June 2, 2017, the two parties came to an agreement in which we were required to issue the Huntington Note in favor of Huntington. The Huntington Note matures on June 2, 2019 with the principal amount of $3,200 payable at maturity. Interest on the outstanding principal accrues at a rate of 8.5% per year from August 6, 2016 to August 15, 2017, and increases to 10% per year thereafter. We paid $50 to Huntington related to accrued interest from August 6, 2016 through the date of issuance of the Huntington Note. Huntington was required to return 778,385 shares of the Company’s common stock which were issued into escrow. We were required to provide certain piggyback registration rights to Huntington in regards to the remaining 749,999 shares of the Company’s common stock held by Huntington. If the Huntington Note was paid off prior to August 14, 2017, the 778,385 shares held in escrow were to be released from escrow and transferred to the Company for no additional consideration. If the note remained outstanding on August 15, 2017, we had the right, but not the obligation, to pay $140 to Huntington to purchase 764,192 of the Subject Shares held in escrow. Upon the exercise of this purchase option, the Subject Shares were to be released from escrow and transferred to the Company. If the note remained outstanding on August 15, 2017 and we did not exercise the option to purchase the shares, the shares were to be returned from escrow to Huntington and we would no longer have repurchase rights. On August 15, 2017, the note was outstanding and we did not excerise the repurchase right. The 778,385 shares were returned from escrow to Huntington. Pursuant to the agreement, we were also required to enter into a four-year lease agreement with the purchaser related to our premises occupied by Nutricap.

 

21

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

(Amounts in thousands, except share and per share amounts and number of employees)

 

Overview

 

This Quarterly Report on Form 10-Q contains forward-looking statements. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). The words “believes,” “anticipates,” “plans,” “expects,” “intends” and similar expressions identify some of the forward-looking statements. Forward-looking statements are not guarantees of performance or future results and involve risks, uncertainties and assumptions. The factors discussed elsewhere in this Form 10-Q and in subsequent Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K, could also cause actual results to differ materially from those indicated by our forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements.

 

Our Operations

 

We are an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty stores retailers, on-line retailers and websites. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers.

 

Our products include vitamins, minerals, specialty supplements and sports nutrition products primarily under the Twinlab® (including the Twinlab® Fuel brand of sports nutrition products), Reserveage™ and ResVitale® brands. We also manufacture and sell diet and energy products under the Metabolife® and Re-Body® brands and a full line of herbal teas under the Alvita® brand. To accommodate consumer preferences, our products come in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, sprays, powders and whole herbs. These products are sold primarily through health and natural food stores and on-line retailers, supermarkets, and mass-market retailers.

 

We also perform contract manufacturing services for private label products.  Our contract manufacturing business involves the manufacture of custom products to the specifications of a customer who requires finished products under the customer’s own brand name.  We do not market these private label products as our business is to manufacture and sell the products to the customer, who then markets and sells the products to retailers or end consumers.

 

We manufacture and/or distribute one of the broadest branded product lines in the industry with approximately 260 stock keeping units, or SKUs. We believe that as a result of our emphasis on innovation, quality, loyalty, education and customer service, our brands are widely recognized in health and natural food stores and among their customers.

 

We have fully integrated our two 2015 acquisitions. The first was the acquisition of the customer relationships of Nutricap, a provider of dietary supplement contract manufacturing services, into our subsidiary, NutraScience, in February 2015, and the second was the acquisition of 100% of the equity interests of Organic Holdings, a market leader in the healthy aging and beauty from within categories and owner of the award-winning Reserveage™ Nutrition brand, in October 2015. Progress has been made in consolidating manufacturing operations and we continue to believe that these acquisitions significantly strengthened our product offerings, contract manufacturing services and our sales and marketing capabilities, providing us with opportunities to improve our market position in addition to adding to supply chain efficiencies.

 

Going Concern Uncertainty

 

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which assumes continuity of operations and realization of assets and liabilities in the ordinary course of business. In most periods since our formation, we have generated losses from operations. At September 30, 2017, we had an accumulated deficit of $237,326. Historical losses are primarily attributable to lower than planned sales resulting from low fill rates on demand due to limitations of our working capital, delayed product introductions and postponed marketing activities, merger-related and other restructuring costs, and interest and refinancing charges associated with our debt refinancing. Losses have been funded primarily through issuance of common stock and third-party or related party debt.

 

Because of this history of operating losses, significant interest expense on our debt, and the recording of significant derivative liabilities, we have a working capital deficiency of $8,531 at September 30, 2017. We also have $17,091 of debt, net of discount, due within the next 12 months. These continuing conditions, among others, raise substantial doubt about our ability to continue as a going concern.

 

22

 

 

Management has taken steps to address operating issues through the following actions: focusing on growing the core business and brands; continuing emphasis on major customers and key products; reducing manufacturing and operating costs and continuing to negotiate lower prices from major suppliers. During the nine months ended September 30, 2017, we obtained debt funding totaling $6,267 to execute the new supply chain initiatives and increase inventory levels. It is possible that we may need additional capital to execute our business plan. If additional funding is required, there can be no assurance that sources of funding will be available when needed on acceptable terms or at all.

 

Critical Accounting Policies and Estimates

 

This discussion and analysis of our financial condition and results of operations is based on our condensed consolidated financial statements, which we have prepared in accordance with the U.S. generally accepted accounting principles. The preparation of our financial statements required us to make estimates and assumptions that affected the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of net sales and expenses during the reported periods. Significant estimates include values and lives assigned to acquired intangible assets, reserves for customer returns and allowances, uncollectible accounts receivable, valuation adjustments for slow moving, obsolete and/or damaged inventory and valuation, recoverability of long-lived assets, intangibles and goodwill, estimated values of stock options and warrants, share-based compensation, and the identification and valuation of derivatives. Actual results may differ from these estimates.

 

Our critical accounting policies and estimates include the following:

 

Revenue Recognition

Revenue from product sales, net of estimated returns and allowances, is recognized when evidence of an arrangement is in place, related prices are fixed and determinable, contractual obligations have been satisfied, title and risk of loss have been transferred to the customer and collection of the resulting receivable is reasonably assured. Shipping terms are generally freight on board shipping point. We sell predominately in the North American and European markets, with international sales transacted in U.S. Dollars.

 

Accounts Receivable and Allowances

We grant credit to customers and generally do not require collateral or other security. We perform credit evaluations of our customers and provide for expected claims, related to promotional items; customer discounts; shipping shortages and damages; and doubtful accounts based upon historical bad debt and claims experience.

 

Inventories

Inventories are stated at the lower of cost or net realizable value and are reduced by an estimated reserve for obsolete inventory.

 

Intangible Assets

Intangible assets consist primarily of trademarks and customer relationships, which are amortized on a straight-line basis over their estimated useful lives ranging from 3 to 30 years. The valuation and classification of these assets and the assignment of amortizable lives involve significant judgment and the use of estimates.

 

We believe that our long-term growth strategy supports our fair value conclusions. For intangible assets, the recoverability of these amounts is dependent upon achievement of our projections and the execution of key initiatives related to revenue growth and improved profitability.

 

Goodwill

Goodwill is not subject to amortization, but is reviewed for impairment annually, or more frequently whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. An impairment charge would be recorded to the extent the carrying value of goodwill exceeds its estimated fair value. The testing of goodwill under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.

 

23

 

 

Impairment of Long-Lived Assets

Long-lived assets, including intangible assets subject to amortization, are reviewed for impairment when changes in circumstances indicate that the carrying amount of the asset may not be recoverable. If the carrying amount of the asset exceeds the expected undiscounted cash flows of the asset, an impairment charge is recognized equal to the amount by which the carrying amount exceeds fair value. The testing of these intangibles under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.

 

Indefinite-Lived Intangible Assets

Indefinite-lived intangible assets relating to the asset acquisition of Organic Holdings are determined to have an indefinite useful economic life and as such are not amortized. Indefinite-lived intangible assets are tested for impairment annually which consists of a comparison of the fair value of the asset with its carrying value.

 

Value of Warrants Issued with Debt

We estimate the grant date value of certain warrants issued with debt, using an outside professional valuation firm, which uses the Monte Carlo option lattice model. We record the amounts as interest expense or debt discount, depending on the terms of the agreement. These estimates involve multiple inputs and assumptions, including the market price of the Company’s common stock, stock price volatility and other assumptions to project earnings before interest, taxes, depreciation and amortization (“EBITDA”) and other reset events. These inputs and assumptions are subject to management’s judgment and can vary materially from period to period.

 

Derivative Liabilities

We have recorded certain warrants as derivative liabilities at estimated fair value, as determined based on the Company’s use of an outside professional valuation firm, due to the variable terms of the warrant agreements. The value of the derivative liabilities is generally estimated using Monte Carlo option lattice model with multiple inputs and assumptions, including the market price of the Company’s common stock, stock price volatility and other assumptions to project EBITDA and other reset events. These inputs and assumptions are subject to management’s judgment and can vary materially from period to period.

 

Share-Based Compensation

We record share-based compensation, including grants of restricted stock units, based on their grant date fair values and record compensation expense over the vesting period of the restricted stock awards.

 

Income Taxes

We account for income taxes using an asset and liability approach. Deferred income taxes are determined by applying currently enacted tax laws and rates to the cumulative temporary differences between the carrying values of assets and liabilities for financial statement and income tax purposes. Valuation allowances against deferred tax assets are recorded when we are unable to conclude that it is more likely than not that such deferred tax assets will be realized.

 

Results of Operations

 

Net Sales

Our net sales decreased $2,434, or 11%, to $20,612 for the three months ended September 30, 2017 from $23,046 for the three months ended September 30, 2016. On a year-to-date basis, our net sales increased $245, or 0%, to $66,130 for the nine months ended September 30, 2017 from $65,885 for the nine months ended September 30, 2016. The decrease in our net sales for the three months ended September 30, 2017 reflects the decision to exit certain lower margin contract manufacturing business at Twinlab and lower Twinlab branded sales due to lost distribution from out-of-stock conditions caused by order fulfillment shortfalls during 2016. Our net sales for the nine months ended September 30, 2017 increased due to organic growth in Nutrascience’s contract manufacturing business.

  

Gross Profit

Our gross profit decreased $3,574, or 50%, to $3,509 for the three months ended September 30, 2017 from $7,083 for the three months ended September 30, 2016.  On a year-to-date basis, our gross profit decreased $718, or 4%, to $15,762 for the nine months ended September 30, 2017 from $16,480 for the nine months ended September 30, 2016.  The decrease in our gross profit for the three months ended September 30, 2017 is derived from lower net sales as well as one-time inventory write-offs. The decrease in our gross profit for the nine months ended September 30, 2017 is derived from one-time inventory write-offs.

 

24

 

 

Selling, General and Administrative Expenses

Our selling, general and administrative expenses decreased $1,114, or 14%, to $6,646 for the three months ended September 30, 2017 from $7,760 for the three months ended September 30, 2016. On a year-to-date basis, our selling, general and administrative expenses decreased $5,675, or approximately 22%, to $20,574 for the nine months ended September 30, 2017 from $26,249 for the nine months ended September 30, 2016. The decreases in our selling, general and administrative expenses are primarily due to our reduction in force to right-size the number of employees which began in 2016.

 

Loss on Stock Purchase Price Guarantee

On August 6, 2016, the 18-month anniversary of the closing of a share purchase agreement, we were required to pay the purchaser of the common stock the difference between $2.29 per share and either a defined market price or a price per share determined by a valuation firm acceptable to both parties. Based on an outside professional valuation performed on the Company’s common stock, the Company estimated the stock price guarantee payment to be $3,210. Accordingly, the Company recorded a loss on the stock purchase price guarantee of $3,210 and a corresponding liability for the same amount in 2016, which was included in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheet as of December 31, 2016.  On June 2, 2017, the two parties came to an agreement in which we were required to issue an Unsecured Promissory Note (“Huntington Note”) in favor of Huntington Holdings, LLC (“Huntington”). The Huntington Note matures on June 2, 2019 with the principal amount of $3,200 payable at maturity. Interest on the outstanding principal accrued at a rate of 8.5% per year from August 6, 2016 to August 15, 2017, and increased to 10% per year thereafter. We paid $50 to Huntington related to accrued interest from August 6, 2016 through the date of issuance of the Huntington Note. Huntington was required to return 778,385 shares of the Company’s common stock which were issued into escrow. We were required to provide certain piggyback registration rights to Huntington in regards to the remaining 749,999 shares of the Company’s common stock held by Huntington. If the Huntington Note was paid off prior to August 14, 2017, the 778,385 shares held in escrow were to be released from escrow and transferred to the Company for no additional consideration. If the note remained outstanding on August 15, 2017, we had the right, but not the obligation, to pay $140 to Huntington to purchase 764,192 of the Subject Shares held in escrow. Upon the exercise of this purchase option, the Subject Shares were to be released from escrow and transferred to the Company.  If the Huntington Note remained outstanding on August 15, 2017 and we did not exercise the option to purchase the shares, the shares were to be returned from escrow to Huntington and we would no longer have repurchase rights. On August 15, 2017, the note was outstanding and we did not excerise the repurchase right. The 778,385 shares were returned from escrow to Huntington.

 

Interest Expense, Net

Our interest expense decreased $547, or 23%, to $1,876 for the three months ended September 30, 2017 from $2,423 for the three months ended September 30, 2016.  On a year-to-date basis, our interest expense decreased $212, or 3%, to $6,318 for the nine months ended September 30, 2017 from $6,530 for the nine months ended September 30, 2016. The decrease in our interest expense is primarily due to a decrease in our note discounts which are amortized into interest expense.

 

Gain (Loss) on Change in Derivative Liabilities

The number of shares of common stock issuable pursuant to certain warrants issued in 2015 will be increased if our audited adjusted earnings before interest, taxes, depreciation and amortization (“EBITDA”) or the market price of the Company’s common stock do not meet certain defined amounts. We have recorded the estimated fair value of the warrants as of the date of issuance and each subsequent balance sheet reporting date. Due to the variable terms of the warrant agreements, changes in the estimated fair value of the warrants from the date of issuance to each balance sheet reporting date are recorded as gain (loss) on change in derivative liabilities in our consolidated statements of comprehensive loss. During the three months and nine months ended September 30, 2017, we reported a loss on change in derivative liabilities of $393 and $1,688, respectively. During the three and nine months ended September 30, 2016, we reported a gain on change in derivative liabilities of $14,065 and $28,128, respectively.

 

Liquidity and Capital Resources

 

At September 30, 2017, we had an accumulated deficit of $237,326, primarily because of our history of operating losses and our recording of derivative liabilities and loss on a stock purchase price guarantee. We have a working capital deficiency of $8,531 at September 30, 2017. Losses have been funded primarily through issuance of common stock, borrowings from our stockholders and third-party or related party debt and proceeds from the exercise of warrants. As of September 30, 2017, we had cash of $2,233. On an ongoing basis, we also seek to improve operating cash through trade receivables and payables management as well as inventory stocking levels. We used net cash in operating activities of $9,143 for the nine months ended September 30, 2017. During the nine months ended September 30, 2017, we incurred new debt of $6,267, had a net increase in borrowings on our senior credit facility of $1,646 to fund our operations and debt repayment of $1,583.

 

25

 

 

Our total liabilities increased by $8,774 to $99,834 at September 30, 2017 from $91,060 at December 31, 2016. This increase in our total liabilities was primarily due to an increase in our non-cash derivative liabilities of $1,688, a non-cash increase in our debt of $3,530, a decrease in our liabilities related to operations of $4,548 and a net increase of $8,104 in debt. For discussion of our debt financings completed to date during 2017, see Notes 6 and 7 in the Notes to Condensed Consolidated Financial Statements included in this report.

 

Cash Flows from Operating, Investing and Financing Activities

Net cash used in operating activities was $9,143 for the nine months ended September 30, 2017 as a result of our net loss of $12,854, a non-cash loss on change in derivative liabilities of $1,688, as well as non-cash expenses totaling $5,088 and an increase in net operating assets and liabilities of $3,065. By comparison, for the nine months ended September 30, 2016, net cash used in operating activities was $20,535 as a result of our net income of $8,584, a non-cash gain on change in derivative liabilities of $28,128 as well as other non-cash expenses totaling $10,016 and a increase in net operating assets and liabilities of $11,007. See Condensed Consolidated Statements of Cash Flows included in this report for additional information.

 

Net cash used in investing activities for the nine months ended September 30, 2017 and 2016 was $51 and $119, respectively, consisting of the purchase of property and equipment.

 

Net cash provided by financing activities was $6,330 for the nine months ended September 30, 2017, primarily consisting of proceeds from the issuance of debt of $6,267, net borrowings of $1,646 under our revolving credit facilities, partially offset by repayment of debt of $1,583. Net cash provided by financing activities was $22,459 for the nine months ended September 30, 2016, consisting of proceeds from the issuance of debt of $22,089, net borrowings of $3,342 under our revolving credit facilities, partially offset by repayment of debt of $2,973.

 

Ongoing Funding Requirements

As set forth above, we have obtained additional debt financing to date in 2017 to support operations. It is possible that we may need additional funding to enable us to fund our operating expenses and capital expenditure requirements.

 

Until such time, if ever, as we can generate substantial product revenues, we intend to finance our cash needs through a combination of equity offerings, debt financings, collaborations, strategic alliances and licensing arrangements. There can be no assurance that any of those sources of funding will be available when needed on acceptable terms or at all. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interests of existing stockholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of existing stockholders. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we raise funds through collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product candidates or we may have to grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings or relationships with third parties when needed or on acceptable terms, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts; abandon our business strategy of growth through acquisitions; or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves.

 

Recent Accounting Pronouncements

 

In May 2017, FASB amended its guidance regarding the scope of modification accounting for share-based compensation arrangements. The amendments provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718. For public entities, the amendments in this update are effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years, with early adoption permitted. The amendments in this update should be applied prospectively to an award modified on or after the adoption date. We do not expect the new guidance to have a significant impact on our condensed consolidated financial statements or related disclosures.

 

In January 2017, FASB issued ASU No. 2017-04, “Simplifying the Test for Goodwill Impairment (Topic 350)” which removes Step 2 of the goodwill impairment test that requires a hypothetical purchase price allocation.  A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill.  The amendments in this ASU are effective for fiscal years beginning after December 15, 2019.  Early adoption is permitted after January 1, 2017.  We do not expect the new guidance to have a significant impact on our condensed consolidated financial statements or related disclosures.

 

26

 

 

In February 2016, FASB issued ASU No. 2016-02, “Leases (Topic 842)”. The amendments in this ASU revise the accounting related to lessee accounting. Under the new guidance, lessees will be required to recognize a lease liability and a right-of-use asset for all leases with terms greater than 12 months affecting the pattern of expense recognition in the income statement. Leases previously defined as operating leases will be defined as financing leases and capitalized if the term is greater than one year. The amendments in this ASU are effective for fiscal years beginning after December 15, 2018 and are to be applied through a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Early adoption is permitted. We are performing an assessment of our leases and have begun preparations for implementation and retrospective application to the earliest reporting period. As a result, financing leases will be recorded as an asset and a corresponding liability at the present value of the total lease payments. The asset will be decremented over the life of the lease on a pro-rata basis resulting in lease expense while the liability will be decremented using the interest method (ie. principal and interest). As such, we expect the new guidance will materially impact the asset and liability balances of our consolidated financial statements and related disclosures at the time of adoption.

 

Although there are several other new accounting pronouncements issued or proposed by FASB, which we have adopted or will adopt, as applicable, we do not believe any of these accounting pronouncements has had or will have a material impact on our condensed consolidated financial position or results of operations.

 

Material Contractual Obligations

 

On December 15, 2016, we entered into an operating lease agreement for approximately 13,000 square feet of office space in Boca Raton, Florida. The agreement expires 103 months after the commencement, which occured in August 2017, and has a monthly base rent of $17.

 

As of September 30, 2017, we have total debt of $74,253, of which $54,174 is considered to be related-party debt. For discussion of our debt financings, see Notes 6 and 7 in the Notes to Condensed Consolidated Financial Statements included in this report.

 

Effective February 6, 2013, we entered into an operating lease agreement for approximately 170,000 square feet of manufacturing, research and development, warehousing and shipping space, which includes roughly 30,000 square feet of office space, in American Fork, Utah. The agreement expires in February 2028 and has a monthly base rent of $60, provided that commencing on the five-year anniversary date thereafter, the base rent shall be increased by 10% over the base rent for the preceding five-year period.

 

Effective April 7, 2015, we entered into an operating lease agreement for approximately 31,000 square feet of office space in St. Petersburg, Florida. The agreement expires in April 2027 and has a monthly base rent of $59 for year 1 to $76 for year 12.

 

Off-Balance Sheet Arrangements

 

None.

 

Item 3.          Quantitative and Qualitative Disclosures About Market Risk.

 

This item is not applicable as we are currently considered a smaller reporting company.

 

 

Item 4.          Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of our chief executive officer and our chief financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2017, pursuant to Rule 13a-15(b) under the Exchange Act. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

 

27

 

 

Based on the evaluation of our disclosure controls and procedures as of September 30, 2017, our management concluded that, as a result of material weaknesses in our internal control over financial reporting discussed below, our disclosure controls and procedures were not effective as of September 30, 2017. 

 

Management’s Remediation Initiatives

 

Management plans and has initiated actions to implement a number of initiatives that address the ineffective design of the system of internal control over financial reporting and plans to initiate further actions to implement a number of initiatives, including but not limited to the following:

 

Work throughout the year with our independent Sarbanes-Oxley Act consultant to help improve the overall testing of our system of internal control over financial reporting, so we promptly identify and refine prior to year-end.

 

Continue to evaluate control procedures on an ongoing basis, and, where possible modify those control procedures to improve management oversight.

 

Implement and improve systems to automate certain financial reporting processes and to improve information accuracy.

 

We made various staff changes during 2017 in our finance and accounting department and we believe these changes have enabled us to broaden the scope and quality of our controls relating to the oversight and review of financial statements and to properly apply all relevant accounting. Furthermore, we plan to implement and improve systems to automate certain financial reporting processes and to improve information accuracy.

 

Management will continue the process of reviewing existing controls, procedures and responsibilities to more closely identify financial reporting risks and the required controls to address them. Key control and compensating control procedures have been developed to ensure that weaknesses are properly addressed and related financial reporting risks are mitigated. Periodic control validation and testing has been implemented to ensure that controls continue to operate consistently and as designed. The remediation steps we have taken, are taking and expect to take may not effectively remediate the material weaknesses, in which case our internal control over financial reporting would continue to be ineffective. Even if we are able to complete these actions successfully, these measures may not adequately address our material weaknesses and may take additional time to complete. In addition, it is possible that we will discover additional material weaknesses in our internal control over financial reporting or that our existing material weaknesses will result in additional errors in or restatements of our financial statements. 

 

Changes in Internal Control over Financial Reporting

 

Other than the items discussed above, there were no changes in our internal control over financial reporting during our most recent fiscal quarter that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on Effectiveness of Controls and Procedures

 

In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

 

28

 

 

PART II—OTHER INFORMATION

 

Item 1.          Legal Proceedings

 

In re: Herbal Supplements Marketing and Sales Practice Litigation, MDL No. 2619, Case No. 1:15-cv-5070, U.S. District Court for the Northern District of Illinois, filed on June 9, 2015. We are not a party to this matter, which joined in a multidistrict litigation a number of purported class actions arising from allegations raised by a state attorney general claiming that DNA barcoding testing conducted on behalf of the attorney general indicated that certain herbal supplement products did not contain the herbal ingredients stated on the label. We do, however, pursuant to contractual obligations, provide indemnity and defense with respect to certain of the claims in this litigation. The defendants in this litigation intend to take all necessary steps to vigorously defend this matter.

 

Amy Mathews v. Wal-Mart Stores, Inc. and Wal-Mart Stores Arkansas LLC, Case No. CV-2015-0294, in the Circuit Court of Independence County, Arkansas, Civil Division. This purported class action alleges a violation of the Arkansas Deceptive Trade Practices Act based on the same allegations of the state attorney general that serve as the basis for the claims in the Herbal Supplements multidistrict litigation referenced above, and seeks certification of a class of Arkansas residents purportedly impacted by the allegations. We are not a party to this litigation but provide indemnity and defense with respect to certain of the claims in this litigation.

 

Corr-Jensen Inc. v. Mark Walsh and Twinlab Corporation, Case No. 1:17-cv-01473-CBS, in the U.S. District Court for the District of Colorado, filed on June 16, 2017. The plaintiff, Corr-Jensen Inc., alleges Twinlab Corporation intentionally and improperly interfered with Mr. Walsh’s employment agreement and release with the plaintiff by allegedly engaging Mr. Walsh or continuing to engage him. On September 21, 2017, we entered into a confidential settlement of this matter with the plaintiff, which did not have a material adverse effect on our financial condition/results of operations or cash flows.

 

Winn-Dixie Stores, Inc., BI-LO, LLC and Sampson Merger Sub, LLC v. Twinlab Corporation, Case No.: 16-2017-CA-004367, in the Circuit Court of the Fourth Judicial District in and for Duval County, Florida, filed on July 11, 2017. The plaintiffs in this matter allege Twinlab Corporation is in breach of a contract agreement related to unpaid invoices. On September 25, 2017, we entered into a confidential settlement of this matter with the plaintiffs, which did not have a material adverse effect on our financial condition/results of operations or cash flows.

 

Item 1A.     Risk Factors.

 

Risks and uncertainties that, if they were to occur, could materially adversely affect our business or cause our actual results to differ materially from the results contemplated by the forward-looking statements contained in this report and other public statements were set forth in the “Item 1A Risk Factors” section of our Annual Report on Form 10-K filed with the SEC on March 31, 2017.

 

Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial conditions and/or operating cash flow.

 

29

 

 

Item 6.             Exhibits.

 

Exhibit

Number

Exhibit Description

   

10.1

Secured Promissory Note, dated August 30, 2017, issued by Twinlab Consolidated Holdings, Inc., Twinlab Consolidation Corporation, Twinlab Holdings, Inc., ISI Brands Inc., Twinlab Corporation, Nutrascience Labs, Inc., Nutrascience Labs IP Corporation, Organic Holdings LLC, Reserve Life Organics, LLC, Resvitale, LLC, Re-Body, LLC, Innovitamin Organics, LLC, Organics Management LLC, Cocoawell, LLC, Fembody, LLC, Reserve Life Nutrition, LLC, Innovita Specialty Distribution LLC, and Joie Essance, LLC in favor of Great Harbor Capital, LLC (incorporated by reference from Exhibit 10.171 to the Form 8-K filed with the Securities and Exchange Commission on September 6, 2017).

10.2

Warrant, dated August 30, 2017, by and between Twinlab Consolidated Holdings, Inc. and Great Harbor Capital, LLC (incorporated by reference from Exhibit 10.172 to the Form 8-K filed with the Securities and Exchange Commission on September 6, 2017).

10.3

Amendment No. 13 to Credit and Security Agreement and Limited Consent, dated as of August 30, 2017, by and among Twinlab Consolidated Holdings, Inc., Twinlab Consolidation Corporation, Twinlab Holdings, Inc., ISI Brands Inc., Twinlab Corporation, NutraScience Labs, Inc., NutraScience Labs IP Corporation, Organic Holdings LLC, Reserve Life Organics, LLC, Resvitale, LLC, Re-Body, LLC, Innovitamin Organics, LLC, Organics Management LLC, Cocoawell, LLC, Fembody, LLC, Reserve Life Nutrition, L.L.C., Innovita Specialty Distribution, LLC, Joie Essance, LLC and MidCap Funding X Trust (incorporated by reference from Exhibit 10.173 to the Form 8-K filed with the Securities and Exchange Commission on September 6, 2017).

31.1

Rule 13a-14(a)/15d-14(a) Certification.

31.2

Rule 13a-14(a)/15d-14(a) Certification.

32.1

Certification Pursuant to 18 U.S.C. Section 1350.

32.2

Certification Pursuant to 18 U.S.C. Section 1350.

101.INS

XBRL Instance

101.SCH

XBRL Taxonomy Extension Schema.

101.CA

XBRL Taxonomy Extension Calculation.

101.DEF

XBRL Taxonomy Extension Definition.

101.LAB

XBRL Taxonomy Extension Label.

101.PRE

XBRL Taxonomy Extension Presentation.

 

30

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

   

TWINLAB CONSOLIDATED HOLDINGS, INC.

       
       

Date: November 14, 2017

 

By:

/s/ Naomi L. Whittel

     

Naomi L. Whittel

     

Chief Executive Officer

       

Date: November 14, 2017

 

By:

/s/ Alan S. Gever

     

Alan S. Gever

     

Chief Financial Officer and Chief Operating Officer

 

 31

EX-31.1 2 ex_100143.htm EXHIBIT 31.1 ex_100143.htm

EXHIBIT 31.1

 

CERTIFICATION

 

I, Naomi L. Whittel, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Twinlab Consolidated Holdings, Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2017

   

/s/ Naomi L. Whittel

   

Naomi L. Whittel

   

Chief Executive Officer

 

EX-31.2 3 ex_100144.htm EXHIBIT 31.2 ex_100144.htm

EXHIBIT 31.2

 

CERTIFICATION

 

I, Alan S. Gever, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of Twinlab Consolidated Holdings, Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2017

   

/s/ Alan S. Gever

   

Alan S. Gever

   

Chief Financial Officer and Chief Operating Officer

 

EX-32.1 4 ex_100145.htm EXHIBIT 32.1 ex_100145.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Twinlab Consolidated Holdings, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Naomi L. Whittel, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. s.s. 1350, as adopted pursuant to s.s. 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: November 14, 2017

 

/s/ Naomi L. Whittel

   

Naomi L. Whittel

   

Chief Executive Officer

     

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Twinlab Consolidated Holdings, Inc. and will be retained by Twinlab Consolidated Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-32.2 5 ex_100146.htm EXHIBIT 32.2 ex_100146.htm

EXHIBIT 32.2 

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report of Twinlab Consolidated Holdings, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Alan S. Gever, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. s.s. 1350, as adopted pursuant to s.s. 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

Date: November 14, 2017

 

/s/ Alan S. Gever

   

Alan S. Gever

   

Chief Financial Officer and Chief Operating Officer

     

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to Twinlab Consolidated Holdings, Inc. and will be retained by Twinlab Consolidated Holdings, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

EX-101.INS 6 tlcc-20170930.xml XBRL INSTANCE DOCUMENT false --12-31 Q3 2017 2017-09-30 10-Q 0001590695 252924027 Yes Smaller Reporting Company Twinlab Consolidated Holdings, Inc. No No tlcc 19250000 314000 481000 40000 41000 121000 122000 807018 1187995 2023-03-14 2022-02-28 2022-03-21 2022-07-21 2022-12-30 2022-12-30 2022-03-21 2022-07-21 3750000 140000 140000 764192 764192 778385 778385 778385 2.29 5.06 1975000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Value of Warrants Issued with Debt</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We estimate the grant date value of certain warrants issued with debt, using an outside professional valuation firm, which uses the <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Monte Carlo option lattice model. We record </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">the amounts as interest expense or debt discount, depending on the terms of the agreement. These estimates involve multiple inputs and assumptions, including the market price of the Company&#x2019;s common stock, stock price volatility and other assumptions to project </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">earnings before interest, taxes, depreciation and amortization (&#x201c;EBITDA&#x201d;) and other reset events. These inputs and assumptions are subject to management&#x2019;s judgment and can vary materially from period to period.</div></div></div></div> 3200000 500000 20000000 2589000 3210000 3210000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Nature of Operations</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We are<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty stores retailers, on-line retailers and websites. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Our <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">products include vitamins, minerals, specialty supplements and sports nutrition products sold under the Twinlab&reg; brand name (including the Twinlab&reg; Fuel brand of sports nutrition products); a market leader in the healthy aging and beauty from within categories sold under the Reserveage&#x2122; Nutrition and ResVitale&reg; brand names; diet and energy products sold under the Metabolife&reg; brand name; the Re-Body&reg; brand name; and a full line of herbal teas sold under the Alvita&reg; brand name. To accommodate consumer preferences, our products come in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, sprays and&nbsp;powders. These products are sold primarily through health and natural food stores and on-line retailers, supermarkets, and mass-market retailers.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We also perform contract manufacturing services for private label products.<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp; Our contract manufacturing business involves the manufacture of custom products to the specifications of a customer who requires finished product under the customer&#x2019;s own brand name.&nbsp; We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> market these private label products as our business is to manufacture and sell the products to the customer, who then markets and sells the products to retailers or end consumers.</div></div></div></div> 1 3 1 3 6857143 509141 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Organization</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Twinlab Consolidated Holdings, Inc. (the &#x201c;Company&#x201d;<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">, &#x201c;Twinlab,&#x201d; &#x201c;we,&#x201d; &#x201c;our&#x201d; and &#x201c;us&#x201d;) was incorporated on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 24, 2013 </div>under the laws of the State of Nevada as Mirror Me, Inc. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 7, 2014, </div>we amended our articles of incorporation and changed our name to Twinlab Consolidated Holdings, Inc.</div></div></div></div> 0.012 0.005 3200000 642366 1 3210000 0.05 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div> </div><div style="display: inline; font-weight: bold;">&#x2013;</div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">WARRANTS</div><div style="display: inline; font-weight: bold;"> AND REGISTRATION RIGHTS AGREEMENT</div><div style="display: inline; font-weight: bold;">S</div><div style="display: inline; font-weight: bold;"> </div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The following table presents a summary of the status of our issued warrants <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>and changes during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months then ended:</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted Average</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise Price</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding, December 31, 2016</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,855,017</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.18</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Canceled / Expired</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding, September 30, 2017</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,855,017</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.18</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;text-indent:36pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Warrants Issued</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Midcap Warrant</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with the line of credit agreement<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> with MidCap described in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,</div> we issued MidCap a warrant, exercisable through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 22, 2018, </div>for an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500,000</div> shares of the Company&#x2019;s common stock at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.76</div> per share (the &#x201c;MidCap Warrant&#x201d;). We entered into a Registration Rights Agreement with Midcap, dated as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 22, 2015, </div>granting MidCap certain registration rights, commencing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 1, 2015, </div>for the shares of common stock issuable on exercise of the MidCap Warrant.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Penta Warrants</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to a stock purchase agreement dated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2015, </div>a warrant was issued to Penta to purchase an aggregate <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">807,018</div> shares of our common stock at a price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share at any time prior to the close of business on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2020. </div>We granted Penta certain registration rights, commencing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 1, 2015, </div>for the shares of common stock issuable upon exercise of the warrant.</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">JL Warrants</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2015 </div>stock purchase agreement, a warrant was issued to JL to purchase an aggregate <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">403,509</div> shares of the Company<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2019;s common stock at a price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share at any time prior to the close of business on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2020, </div>subject to certain adjustments. We granted JL certain registration rights, commencing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 1, 2015, </div>for the shares of common stock issuable upon exercise of the warrant. The warrant was subsequently assigned by JL to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> individuals.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Essex Warrants</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with the guarantee of a note payable issued in the Nutricap asset acquisition and equipment financing by Essex discussed in Note <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,</div> Essex was issued a warrant exercisable for an aggregate <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,428,571</div> shares of the Company&#x2019;s common stock at a purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.77</div> per share, at any time prior to the close of business on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 30, 2020. </div>The number of shares issuable upon the exercise of the warrant is subject to adjustment on terms and conditions customary for a transaction of this nature in the event of (i) reorganization, recapitalization, stock split-up, combination of shares, mergers, consolidations and (ii) sale of all or substantially all of our assets or property. Essex subsequently assigned warrants for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350,649</div> shares to another company.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">JL Properties, Inc. Warrants</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2015, </div>we entered into an office lease agreement which requires a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,000</div> security deposit, subject to reduction if we achieve certain market capitalization metrics at certain dates. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2015, </div>we entered into a reimbursement agreement with JL Properties, Inc. (&#x201c;JL Properties&#x201d;) pursuant to which JL Properties agreed to arrange for and provide an unconditional, irrevocable, transferable, and negotiable commercial letter of credit to serve as the security deposit. As partial consideration for the entry by JL Properties into the reimbursement agreement and the provision of the letter of credit, we issued JL Properties <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> warrants to purchase shares of the Company<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2019;s common stock.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> warrant is exercisable for an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">465,880</div> shares of <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">common stock, subject to certain adjustments, at an aggregate purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01,</div> at any time prior to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2020. </div>In addition to adjustments on terms and conditions customary for a transaction of this nature in the event of (i) reorganization, recapitalization, stock split-up, combination of shares, mergers, consolidations and (ii) sale of all or substantially all of our assets or property, the number of shares of common stock issuable pursuant to the warrant will be increased in the event our consolidated audited adjusted EBITDA (as defined in the warrant agreement) for the fiscal year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2018 </div>does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> equal or exceed <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$19,250.</div> JL Properties subsequently assigned the warrant to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> individuals.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> warrant is exercisable for an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">86,962</div> shares of <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">common stock, at a per share purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.00,</div> at any time prior to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 30, 2020. </div>The number of shares issuable upon exercise of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> warrant is subject to adjustment on terms and conditions customary for a transaction of this nature in the event of (i) reorganization, recapitalization, stock split-up, combination of shares, mergers, consolidations and (ii) sale of all or substantially all of our assets or property.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> have granted JL Properties certain registration rights, commencing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 1, 2015, </div>for the shares of common stock issuable on exercise of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> warrants.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Golisano</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; text-decoration: underline;"> LLC</div><div style="display: inline; text-decoration: underline;"> Warrants (formerly </div><div style="display: inline; text-decoration: underline;">Penta Warrants</div><div style="display: inline; text-decoration: underline;">)</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 13, 2014 </div>note for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8,000</div> (see Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div>), Penta was issued a warrant to acquire <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,960,740</div> shares of the Company&#x2019;s common stock at an aggregate exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01,</div> through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 13, 2019. </div>In connection with Penta&#x2019;s consent to the terms of additional debt obtained by us, we also granted Penta a warrant to acquire an additional <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">869,618</div> shares of common stock at a purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.00</div> per share, through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 13, 2019. </div>Both warrant agreements grant Penta certain registration rights, commencing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 1, 2015, </div>for the shares of common stock issuable on exercise of the warrants. Penta has the right, under certain circumstances, to require us to purchase all or any portion of the equity interest in the Company issued or represented by the warrant to acquire <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,960,740</div> shares at a price based on the greater of (i) the product of (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">x</div>) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> times our adjusted EBITDA with respect to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months preceding the exercise of the put right multiplied by (y) the investor&#x2019;s percentage ownership in the Company assuming full exercise of the warrant; or (ii) the fair market value of the investor&#x2019;s equity interest underlying the warrant. In the event (i) we do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> have the funds available to repurchase the equity interest under the warrant or (ii) such repurchase is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> lawful, adjustments to the principal of the note purchased by Penta will be made or, under certain circumstances, interest will be charged on the amount otherwise due for such repurchase. We have the right, under certain circumstances, to require Penta to sell to us all or any portion of the equity interest issued or represented by the warrant to acquire <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,960,740</div> shares. The price for such repurchase will be the greater of (i) the product of (<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">x</div>) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">eleven</div> times our adjusted EBITDA with respect to the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">twelve</div> months preceding the exercise of the call right multiplied by (y) the investor&#x2019;s percentage ownership in the company assuming full exercise of the warrant; or (ii) the fair market value of the equity interests underlying the warrant; or (iii) <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,750.</div> In connection with Golisano LLC&#x2019;s acquisition of the note payable from Penta on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 8, 2017 (</div>see Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div> above for additional information), these warrants were assigned to Golisano LLC. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Golisano</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; text-decoration: underline;"> LLC</div><div style="display: inline; text-decoration: underline;"> Warrants (formerly </div><div style="display: inline; text-decoration: underline;">JL Warrants</div><div style="display: inline; text-decoration: underline;">)</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 22, 2015 </div>note payable to JL, we<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> issued JL warrants to purchase an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,329,400</div> shares of the Company&#x2019;s common stock, at an aggregate exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01,</div> through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 13, 2020. </div>On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 4, 2015, </div>we also granted to JL a warrant to acquire a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">434,809</div> shares of common stock at a purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.00</div> per share, through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 13, 2020. </div>Both warrant agreements grant JL certain registration rights, commencing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 1, 2015, </div>for the shares of common stock issuable upon exercise of the warrants. These warrants were subsequently assigned to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> individuals. During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>these individuals exercised warrants for a total of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,187,995</div> shares of the Company&#x2019;s common stock for total proceeds to the Company of less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.</div> In connection with Golisano LLC&#x2019;s acquisition of the note payable from JL on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 8, 2017 (</div>see Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div> above for additional information), the remaining portions of these warrants were assigned to Golisano LLC. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Golisano </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; text-decoration: underline;">LLC </div><div style="display: inline; text-decoration: underline;">Warrants</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to an <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 2015 </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Securities Purchase Agreement with Golisano LLC, we issued Golisano LLC a warrant (the &#x201c;Golisano Warrant&#x201d;), which Golisano Warrant is intended to maintain, following each future issuance of shares of common stock pursuant to the conversion, exercise or exchange of certain currently outstanding warrants to purchase shares of common stock held by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div>-parties (the &#x201c;Outstanding Warrants&#x201d;), Golisano LLC&#x2019;s proportional ownership of our issued and outstanding common stock so that it is the same thereafter as on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 5, 2015. </div>We have reserved <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,697,977</div> shares of common stock for issuance under the Golisano Warrant. The purchase price for any shares of common stock issuable upon exercise of the Golisano Warrant is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$.001</div> per share. The Golisano Warrant is exercisable immediately and up to and including the date which is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">sixty</div> days after the later to occur of the termination, expiration, conversion, exercise or exchange of all of the Outstanding Warrants and our delivery of notice thereof to Golisano LLC. The Golisano Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets. In addition, if any payments are made to a holder of an Outstanding Warrant in consideration for the termination of or agreement <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> to exercise such Outstanding Warrant, Golisano LLC will be entitled to equal treatment. We have entered into a registration rights agreement with Golisano LLC, dated as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 5, 2015, </div>granting Golisano LLC certain registration rights for the shares of common stock issuable on exercise of the Golisano Warrant. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 6, 2016, </div>Golisano LLC exercised the Golisano Warrant in part for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">509,141</div> shares of the Company&#x2019;s common stock for an aggregate purchase price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.</div> During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>the Golisano Warrant was cancelled in part for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,857,143</div> shares pursuant to the cancellation of a portion of the Outstanding Warrants. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>we have reserved <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,756,505</div> shares of its common stock for issuance under the Golisano Warrant.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Warrants Issued into Escrow</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Golisano </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; text-decoration: underline;">Escrow </div><div style="display: inline; text-decoration: underline;">Warrants</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2016 </div>Unsecured Promissory Note, we<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,136,363</div> shares of the Company&#x2019;s common stock at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;January 2016 </div>Golisano Warrant&#x201d;). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2016 </div>Golisano Warrant will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the related promissory note and any accrued and unpaid interest thereon as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2019 </div>or such earlier date as is required pursuant to an Acceleration Notice (as defined in the related note agreement). We have reserved <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,136,363</div> shares of the Company&#x2019;s common stock for issuance under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2016 </div>Golisano Warrant. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2016 </div>Golisano Warrant, if exercisable, expires on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 28, 2022. </div>The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2016 </div>Golisano Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 21, 2016 </div>Unsecured Promissory Note, we<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,181,816</div> shares of the Company&#x2019;s common stock at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;March 2016 </div>Golisano Warrant&#x201d;). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016 </div>Golisano Warrant will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the related promissory note and any accrued and unpaid interest thereon as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 21, 2019 </div>or such earlier date as is required pursuant to an Acceleration Notice (as defined in the related note agreement). We have reserved <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,181,816</div> shares of the Company&#x2019;s common stock for issuance under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016 </div>Golisano Warrant. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016 </div>Golisano Warrant, if exercisable, expires on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 21, 2022. </div>The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016 </div>Golisano Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with t<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">he Golisano LLC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Note, we issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,168,178</div> shares of the Company&#x2019;s common stock, at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share (the &#x201c;Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Warrant&#x201d;). The Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Warrant will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Note and any accrued and unpaid interest thereon as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2019 </div>or such earlier date as is required pursuant to an Acceleration Notice (as defined in the Golisano LLC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Note). We have reserved <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,168,178</div> shares of the Company&#x2019;s common stock for issuance under the Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Warrant. The Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Warrant, if exercisable, expires on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 21, 2022. </div>The Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with t<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">he Golisano LLC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>Note, we issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,136,363</div> shares of the Company&#x2019;s common stock, at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share (the &#x201c;Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>Warrant&#x201d;). The Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>Warrant will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>Note and any accrued and unpaid interest thereon as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2019 </div>or such earlier date as is required pursuant to an Acceleration Notice (as defined in the Golisano LLC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>Note). We have reserved <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,136,363</div> shares of the Company&#x2019;s common stock for issuance under the Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>Warrant. The Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>Warrant, if exercisable, expires on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2022. </div>The Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with t<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">he Golisano LLC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2017 </div>Note, we issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,484,847</div> shares of the Company&#x2019;s common stock, at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share (the &#x201c;Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2017 </div>Warrant&#x201d;). The Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2017 </div>Warrant will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2017 </div>Note and any accrued and unpaid interest thereon as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2019 </div>or such earlier date as is required pursuant to an Acceleration Notice (as defined in the Golisano LLC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2017 </div>Note). We have reserved <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,484,847</div> shares of the Company&#x2019;s common stock for issuance under the Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2017 </div>Warrant. The Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2017 </div>Warrant, if exercisable, expires on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 14, 2023. </div>The Golisano <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2017 </div>Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> previously entered into a registration rights agreement with Golisano LLC, dated as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 5, 2015 (</div>the &#x201c;Registration Rights Agreement&#x201d;), granting Golisano LLC certain registration rights for certain shares of the Company&#x2019;s common stock. The shares of common stock issuable pursuant to the above warrants are also entitled to the benefits of the Registration Rights Agreement.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">GH Escrow Warrants</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2016 </div>Unsecured Promissory Note, we<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> issued into escrow in the name of GH a warrant to purchase an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,136,363</div> shares of the Company&#x2019;s common stock at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;January 2016 </div>GH Warrant&#x201d;). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2016 </div>GH Warrant will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be released from escrow or be exercisable unless and until we fail to pay GH the entire unamortized principal amount of the related promissory note and any accrued and unpaid interest thereon as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2019 </div>or such earlier date as is required pursuant to an Acceleration Notice (as defined in the related note agreement). We have reserved <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,136,363</div> shares of the Company&#x2019;s common stock for issuance under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2016 </div>GH warrant. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2016 </div>GH Warrant, if exercisable, expires on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 28, 2022. </div>The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2016 </div>GH Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 21, 2016 </div>Unsecured Promissory Note, we<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> issued into escrow in the name of GH a warrant to purchase an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,181,816</div> shares of the Company&#x2019;s common stock at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;March 2016 </div>GH Warrant&#x201d;). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016 </div>GH Warrant will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be released from escrow or be exercisable unless and until we fail to pay GH the entire unamortized principal amount of the related promissory note and any accrued and unpaid interest thereon as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 21, 2019 </div>or such earlier date as is required pursuant to an Acceleration Notice (as defined in the related note agreement). We have reserved <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,181,816</div> shares of the Company&#x2019;s common stock for issuance under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016 </div>GH Warrant. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016 </div>GH Warrant, if exercisable, expires on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 21, 2022. </div>The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016 </div>GH Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with t<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">he GH <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>Note, we issued into escrow in the name of GH a warrant to purchase an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,136,363</div> shares of the Company&#x2019;s common stock, at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;December 2016 </div>GH Warrant&#x201d;). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>GH Warrant will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be released from escrow or be exercisable unless and until we fail to pay GH the entire unamortized principal amount of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>GH Warrant and any accrued and unpaid interest thereon as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2019 </div>or such earlier date as is required pursuant to an Acceleration Notice (as defined in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>GH Warrant). We have reserved <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,136,363</div> shares of common stock for issuance under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>GH Warrant. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>GH Warrant, if exercisable, expires on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2022. </div>The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>GH Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with t<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">he GH <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2017 </div>Note, we issued into escrow in the name of GH a warrant to purchase an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,363,636</div> shares of the Company&#x2019;s common stock, at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share (the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> &#x201c;August 2017 </div>GH Warrant&#x201d;). The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2017 </div>GH Warrant will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be released from escrow or be exercisable unless and until we fail to pay GH the entire unamortized principal amount of the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2017 </div>GH Warrant and any accrued and unpaid interest thereon as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 29, 2020 </div>or such earlier date as is required pursuant to an Acceleration Notice (as defined in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2017 </div>GH Warrant). We have reserved <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,363,636</div> shares of common stock for issuance under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2017 </div>GH Warrant. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2017 </div>GH Warrant, if exercisable, expires on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 30, 2023. </div>The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2017 </div>GH Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"></div><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">JL-US Escrow Warrant</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In connection with an <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 5, 2016 </div>Unsecured Promissory Note, we issued into escrow in the name of JL-US a warrant to purchase an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">227,273</div> shares of the Company<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2019;s common stock at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share (the &#x201c;JL-US Warrant&#x201d;). The JL-US Warrant will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be released from escrow or be exercisable unless and until we fail to pay JL-US the entire unamortized principal amount of the JL-US Note and any accrued and unpaid interest thereon as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 21, 2019 </div>or such earlier date as is required pursuant to an Acceleration Notice (as defined in the JL-US Note). We have reserved <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">227,273</div> shares of the Company&#x2019;s common stock for issuance under the JL-US Warrant. The JL-US Warrant, if exercisable, expires on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 21, 2022. </div>The JL-US Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Little Harbor Escrow Warrant</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Little Harbor <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Note provides that we issue into escrow in the name of Little Harbor a warrant to purchase an aggregate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,168,178</div> shares of common stock at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.01</div> per share (the &#x201c;Little Harbor <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Warrant&#x201d;). The Little Harbor <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Warrant will <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be released from escrow or be exercisable unless and until we fail to pay Little Harbor the entire unamortized principal amount of the Little Harbor <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Note and any accrued and unpaid interest thereon as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2019 </div>or such earlier date as is required pursuant to an Acceleration Notice (as defined in the Little Harbor <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Note). We have reserved <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,168,178</div> shares of the Company&#x2019;s common stock for issuance under the Little Harbor <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Warrant. The Little Harbor <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Warrant, if exercisable, expires on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 21, 2022. </div>The Little Harbor <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets. The Little Harbor <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Warrant grants Little Harbor certain registration rights for the shares of the Company&#x2019;s common stock issuable upon exercise of the Little Harbor <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Warrant.</div></div></div> 8531000 10266000 11434000 4607000 7866000 8737000 7768000 20416000 18476000 226766000 226380000 2777000 2365000 1774000 2717000 582000 557000 1747000 1645000 89132000 92826000 31576000 33336000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Basis of Presentation and Unaudited Information</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with United States generally accepted accounting principles, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures are adequate to make the information presented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> misleading. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management, are necessary for fair presentation of the information contained herein. Financial results for any interim period are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of financial results that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be expected for the fiscal year. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>filed with the SEC on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2017.</div></div></div></div></div> 330000 1582000 2732000 1082000 1142000 5097000 1240000 2233000 3045000 -2864000 1805000 0.76 0.01 0.01 0.77 0.01 1 0.01 1 0.01 1 0.001 1 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.18 0.18 350649 1136363 3181816 1136363 1484847 1136363 1363636 227273 2168178 4960740 2329400 434809 869618 500000 500000 403509 1428571 465880 86962 4960740 869618 4960740 2329400 434809 2168178 15855017 15855017 12697977 4756505 1136363 3181816 2168178 1136363 1484847 1136363 1363636 227273 2168178 20000000 0.001 0.001 30000 30000 5000000000 5000000000 387730078 387730078 749999 1528384 388000 388000 -5418000 10968000 -12854000 8584000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Significant Concentration of Credit Risk</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Sales to our top <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div></div> customers a<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">ggregated to approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> of total sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26%</div> of total sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. Sales to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div></div> of those customers were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> of total sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> of total sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. Accounts receivable from these customers were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">55%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29%</div> of total accounts receivable as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>respectively.</div></div></div></div> 0.33 0.25 0.27 0.26 0.13 0.11 0.12 0.11 0.55 0.29 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Principles of Consolidation</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</div></div></div></div> 17103000 15963000 50368000 49405000 74253000 62619000 17091000 11631000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div> </div><div style="display: inline; font-weight: bold;">&#x2013; DEBT</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Debt <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">consisted of the following at:</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Related-Party Debt:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">July 2014 note payable to Little Harbor, LLC, net of unamortized discount of $0 and $206 as of September 30, 2017 and December 31, 2016, respectively</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,267</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,061</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">July 2016 note payable to Little Harbor, LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,770</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,770</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">January 2016 note payable to Great Harbor Capital, LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">March 2016 note payable to Great Harbor Capital, LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">December 2016 note payable to Great Harbor Capital, LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">August 2017 note payable to Great Harbor Capital, LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">January 2016 note payable to Golisano Holdings LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">March 2016 note payable to Golisano Holdings LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">July 2016 note payable to Golisano Holdings LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,770</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,770</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">December 2016 note payable to Golisano Holdings LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">March 2017 note payable to Golisano Holdings LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,267</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">November 2014 note payable to Golisano Holdings LLC (formerly payble to Penta</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">Mezzanine SBIC Fund I, L.P.), net of discount and unamortized loan fees in the aggregate of $1,694 and $2,304 as of September 30, 2017 and December 31, 2016, respectively</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,306</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,696</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">January 2015 note payable to Golisano Holdings LLC (formerly payable to JL-BBNC</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">Mezz Utah, LLC), net of discount and unamortized loan fees in the aggregate of $2,058 as of September 30, 2017</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,942</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">February 2015 note payable to Golisano Holdings LLC (formerly payable to Penta</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">Mezzanine SBIC Fund I, L.P.), net of discount and unamortized loan fees in the aggregate of $148 and $201 as of September 30, 2017 and December 31, 2016, respectively</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,852</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,799</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 63.9%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt;">Total related-party debt</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">54,174</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44,096</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left; text-indent: -9pt;">Senior Credit Facility with Midcap, net of unamortized loan fees of $73 and $293 as of September 30, 2017 and December 31, 2016, respectively</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,901</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,035</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Other Debt:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">January 2015 note payable to JL-BBNC Mezz Utah, LLC, net of discount and unamortized loan fees in the aggregate of $2,744 as of December 31, 2016</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,256</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">April 2016 note payable to JL-Utah Sub, LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">396</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">Capital lease obligations</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,582</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,732</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">Huntington Holdings</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,200</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt;">Total other debt</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,178</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,488</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">Total debt</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">74,253</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">62,619</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">Less current portion</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(17,091</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(11,631</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">Long-term debt</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57,162</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50,988</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Related-Party Debt</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2014 </div>Note Payable to Little Harbor, LLC</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2014 </div>Debt Repayment Agreement with Little Harbor, LLC (&#x201c;Little Harbor&#x201d;), an entity owned by certain stockholders of the Company, we are obligated to pay such party <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,900</div> per year in structured monthly payments for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> years provided that such payment obligations will terminate at such earlier time as the trailing <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ninety</div> day volume weighted average closing sales price of the Company<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2019;s common stock on all domestic securities exchanges on which such stock is listed equals or exceeds <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5.06</div> per share. This note is unsecured and matured on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 25, 2017 </div>however this note remains outstanding and principal payment has been deferred to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> This note was non-interest bearing, accordingly, using an imputed interest rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16.2%,</div> we recorded a note discount in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2014, </div>which has been amortized into interest expense based on the effective interest rate method over the term of the note. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Note Payable to Little Harbor, LLC</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 21, 2016, </div>we issued an Unsecured Delayed Draw Promissory Note in favor of Little Harbor, pursuant to which Little Harbor <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may, </div>in its sole discretion and pursuant to draw requests made by the Company, loan us up to the maximum principal amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,770.</div> This note is unsecured and matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2019. </div>This note bears interest at an annual rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.5%,</div> with the principal payable at maturity. If Little Harbor, in its discretion, accepts a draw request made by the Company under this note, Little Harbor shall <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> transfer cash to the Company, but rather Little Harbor shall irrevocably agree to accept the principal amount of any monthly delayed draw under this note in lieu and in complete satisfaction of the obligation to make an equivalent dollar amount of periodic cash payments otherwise due <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">to Little Harbor under the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2014 </div>note payable. During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>we requested and Little Harbor LLC approved, draws totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,770.</div> We issued a warrant into escrow in connection with this loan (see Little Harbor Escrow Warrants in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>). </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2016 </div>Note Payable to Great Harbor Capital, LLC</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2016 </div>Unsecured Promissory Note with Great Harbor Capital, LLC (&#x201c;GH&#x201d;), an affiliate of a member of our Board of Directors, GH lent us <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,500.</div> The note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2019, </div>bears interest at an annual rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.5%,</div> with the principal payable in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div> monthly installments of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$104</div> <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">which was to commence on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 28, 2017 </div>but has been deferred to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2018. </div>We issued a warrant into escrow in connection with this loan (see GH Escrow Warrants in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>).</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016 </div>Note Payable to Great Harbor Capital, LLC</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 21, 2016 </div>Unsecured Promissory Note, GH lent us <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7,000.</div> The note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 21, 2019, </div>bears interest at an annual rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.5%,</div> with the principal payable in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div> monthly installments of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$292</div> <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">which was to commence on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 21, 2017 </div>but has been deferred to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 21, 2018. </div>We issued a warrant into escrow in connection with this loan (see GH Escrow Warrants in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>).</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>Note Payable to Great Harbor Capital, LLC</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>Unsecured Promissory Note, GH lent us <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,500.</div> The note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 3</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019,</div> bears interest at an annual rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.5%,</div> with the principal payable at maturity. We issued a warrant into escrow in connection with this loan (see GH Escrow Warrants in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>).</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 2017 </div>Note Payable to Great Harbor Capital, LLC</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to a<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">n <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 30, 2017 </div>Unsecured Promissory Note, GH lent us <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,000.</div> The note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 29, 2020, </div>bears interest at an annual rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.5%,</div> with the principal payable at maturity. We issued a warrant into escrow in connection with this loan (see GH Escrow Warrants in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>).</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 2014 </div>Note Payable to Golisano Holdings LLC (formerly payable to Penta Mezzanine SBIC Fund I, L.P.)</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 13, 2014, </div>we raised proceeds of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8,000,</div> less certain fees and expenses, from the issuance of a secured note to Penta Mezzanine SBIC Fund I, L.P. (&#x201c;Penta&#x201d;). The Managing Director of Penta, an institutional investor, is also a director of our Company. We granted Penta a security interest in our assets and pledged the shares of our subsidiaries as security for the note. <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 8, 2017, </div>Golisano Holdings LLC (&#x201c;Golisano LLC&#x201d;) acquired this note payable from Penta. Interest on the outstanding principal accrued at a rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div> per year from date of issuance to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 8, 2017, </div>and decreased to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8%</div> per year thereafter, payable monthly</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">. The note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 13, 2019. </div>On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 30, 2017, </div>we entered into an amendment with Golisano LLC which extended payment of principal to maturity. We issued a warrant to Penta to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,960,740</div> shares of the Company&#x2019;s common stock in connection with this loan (see Penta Warrants in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>). The estimated fair value of the warrant at the date of issuance was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,770,</div> which was recorded as a note discount and is being amortized into interest expense over the term of this loan. Additionally, we had incurred loan fees of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$273,</div> which is also being amortized into interest expense over the term of this loan. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2015 </div>Note Payable to Golisano Holdings LLC (formerly payable to JL-Mezz Utah, LLC-f/k/a JL-BBNC Mezz Utah, LLC)</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 22, 2015, </div>we raised proceeds of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,000,</div> less certain fees and expenses, from the sale of a note to JL-Mezz Utah, LLC (f/k/a JL-BBNC Mezz Utah, LLC) (&#x201c;JL-US&#x201d;). The proceeds were restricted to pay a portion of the <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Nutricap Labs, LLC (&#x201c;Nutricap&#x201d;) asset acquisition. We granted JL a security interest in the Company&#x2019;s assets, including real estate and pledged the shares of our subsidiaries as security for the note. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 8, 2017, </div>Golisano LLC acquired this note payable from JL. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Interest on the outstanding principal accrued at a rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div> per year <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">from date of issuance to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 8, 2017, </div>and decreased to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8%</div> per year thereafter, payable monthly</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">. The note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 13, 2019. </div>On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 30, 2017, </div>we entered into an amendment with Golisano LLC which extended payment of principal to maturity. We issued a warrant to JL to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,329,400</div> shares of the Company&#x2019;s common stock on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 22, 2015 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">434,809</div> shares of the Company&#x2019;s common stock on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 4, 2015 (</div>see JL Warrants in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>). The estimated fair value of these warrants at the date of issuances was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,389,</div> which was recorded as a note discount and is being amortized into interest expense over the term of these loans. Additionally, we had incurred loan fees of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$152</div> relating to this loan, which is also being amortized into interest expense over the term of these loans. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2015 </div>Note Payable to Golisano Holdings LLC (formerly payable to Penta Mezzanine SBIC Fund I, L.P.)</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 6, 2015, </div>we raised proceeds of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,000,</div> less certain fees and expenses, from the issuance of a secured note payable to Penta. The proceeds were restricted to pay a portion of the acquisition of the customer r<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">elationships of Nutricap. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 8, 2017, </div>Golisano LLC acquired this note payable from Penta. Interest on the outstanding principal accrued at a rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div> per year from date of issuance to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 8, 2017, </div>and decreased to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8%</div> per year thereafter, payable monthly</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">. The note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> November 13, 2019. </div>On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 30, 2017, </div>we entered into an amendment with Golisano LLC which extended payment of principal to maturity. We issued a warrant to Penta to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">869,618</div> shares of the Company&#x2019;s common stock in connection with this loan (see Penta Warrants in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>). The estimated fair value of these warrants at the date of issuances totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$250,</div> which was recorded as a note discount and is being amortized into interest expense over the term of this loan. Additionally, we had incurred loan fees of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$90,</div> which is also being amortized into interest expense over the term of these loans. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2016 </div>Note Payable to Golisano Holdings LLC</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2016 </div>Unsecured Promissory Note with Golisano LLC, an affiliate of a member of our Board of Directors, Golisano LLC lent us <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,500.</div> The note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2019, </div>bears interest at an annual rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.5%,</div> with the principal payable in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div> monthly installments of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$104</div> <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">which was to commence on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 28, 2017 </div>but has been deferred to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2018. </div>We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>).</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 2016 </div>Note Payable to Golisano Holdings LLC</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 21, 2016 </div>Unsecured Promissory Note, Golisano LLC lent us <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7,000.</div> The note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 21, 2019, </div>bears interest at an annual rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.5%,</div> with the principal payable in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div> monthly installments of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$292</div> <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">which was to commence on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 21, 2017 </div>but has been deferred to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 21, 2018. </div>We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>).</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Note Payable to Golisano Holdings LLC</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 21, 2016, </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">we issued an Unsecured Delayed Draw Promissory Note in favor of Golisano LLC pursuant to which Golisano LLC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may, </div>in its sole discretion and pursuant to draw requests made by the Company, loan the Company up to the maximum principal amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,770</div> (the &#x201c;Golisano LLC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Note&#x201d;). The Golisano LLC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 28, 2019. </div>Interest on the outstanding principal accrues at a rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.5%</div> per year. The principal of the Golisano LLC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 2016 </div>Note is payable at maturity. We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>). During the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>we requested and Golisano LLC approved, draws totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,770.</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2016 </div>Note Payable to Golisano Holdings LLC</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>Unsecured Promissory Note, Golisano LLC lent <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">us <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,500.</div> The note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2019, </div>bears interest at an annual rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.5%,</div> with the principal payable at maturity. We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>).</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div></div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; text-decoration: underline;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">201</div></div><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div></div><div style="display: inline; text-decoration: underline;"> Note Payable to Golisano Holdings LLC</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to a <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 14, 2017 </div>Unsecured Promissory Note, Golisano LLC lent us <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,267.</div> The note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 30, 2019, </div>bears interest at an annual rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.5%,</div> with the principal payable at maturity. We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>).</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Senior Credit Facility</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 22, 2015, </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">we entered into a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-year <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$15,000</div> revolving credit facility (the &#x201c;Senior Credit Facility&#x201d;) based on our accounts receivable and inventory, increasable to up to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$20,000,</div> with MidCap Financial Trust, which subsequently assigned the agreement to an affiliate, Midcap Funding <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">X</div> Trust (&#x201c;MidCap&#x201d;). On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 2, 2016, </div>we entered into an amendment with Midcap to increase the Senior Credit Facility to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$17,000</div> and extend our facility an additional <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months. We granted MidCap a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> priority security interest in certain of our assets and pledged the shares of our subsidiaries as security for amounts owed under the credit facility. We are required to pay Midcap an unused line fee of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.50%</div> per annum, a collateral management fee of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.20%</div> per month and interest of LIBOR plus <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> per annum, which was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6.24%</div> per annum as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017. </div>We issued a warrant to Midcap to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500,000</div> shares of the Company&#x2019;s common stock (see Midcap Warrant in Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>). The estimated fair value of these warrants at the date of issuance was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$130,</div> which was recorded as a note discount and is being amortized into interest expense over the term of the Senior Credit Facility. Additionally, we have incurred loan fees totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$540</div> relating to the Senior Credit Facility and any subsequent amendments, which is also being amortized into interest expense over the term of the Senior Credit Facility.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Other Debt</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 2016 </div>Note Payable to </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; text-decoration: underline;">JL-Utah Sub, LLC</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Pursuant to an <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 5</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> Unsecured Promissory Note, JL-Utah Sub, LLC lent us <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$500.</div> The note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 21, 2019, </div>bears interest at an annual rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.5%,</div> with the principal payable in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24</div> monthly installments of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$21</div> commencing on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April 21, 2017.</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Capital Lease Obligations</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Our capital lease obligations pertain to various leasing agreements with Essex Capital Corporation (&#x201c;Essex&#x201d;), a related party to the Company as Essex<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2019;s principal owner is a director of the Company. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Huntington Holdings</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; text-decoration: underline;">, LLC</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 6, 2016, </div>the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div>-month anniversary of the closing of a share purchase agreement, we were required to pay the purchaser of the common stock the difference between <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.29</div> per share and either a defined market price or a price per share determined by a valuation firm acceptable to both parties. <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Based on an outside professional valuation performed on the Company&#x2019;s common stock, the Company estimated the stock price guarantee payment to be <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,210.</div> Accordingly, the Company recorded a loss on the stock purchase price guarantee of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,210</div> and a corresponding liability for the same amount in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> which was included in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheet as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016. </div>On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2, 2017, </div>the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> parties came to an agreement in which we were required to issue an Unsecured Promissory Note (&#x201c;Huntington Note&#x201d;) in favor of Huntington Holdings, LLC (&#x201c;Huntington&#x201d;). The Huntington Note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2, 2019 </div>with the principal amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,200</div> payable at maturity. Interest on the outstanding principal accrues at a rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.5%</div> per year from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 6, 2016 </div>to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 15, 2017, </div>and increases to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> per year thereafter. We paid <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$50</div> to Huntington related to accrued interest from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 6, 2016 </div>through the date of issuance of the Huntington Note. Huntington was required to return <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">778,385</div> shares of the Company&#x2019;s common stock which were issued into escrow. We were required to provide certain piggyback registration rights to Huntington in regards to the remaining <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">749,999</div> shares of the Company&#x2019;s common stock held by Huntington. If the Huntington Note was paid off prior to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 14, 2017, </div>the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">778,385</div> shares held in escrow were to be released from escrow and transferred to the Company for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> additional consideration. If the note remained outstanding on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 15, 2017, </div>we had the right, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> the obligation, to pay <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$140</div> to Huntington to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">764,192</div> of the shares held in escrow (the &#x201c;Subject Shares&#x201d;). Upon the exercise of this purchase option, the Subject Shares were to be released from escrow and transferred to the Company. If the note remained outstanding on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 15, 2017 </div>and we did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> exercise the option to purchase the shares, the shares were to be returned from escrow to Huntington and we would <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer have repurchase rights. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 15, 2017, </div>the note was outstanding and we did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> excerise the repurchase right. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">778,385</div> shares were returned from escrow to Huntington. Pursuant to the agreement, we were also required to enter into a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div>-year lease agreement with the purchaser related to our premises occupied by Nutricap.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Financial Covenants</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Certain of the foregoing debt agreements<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">, as amended, require us to meet certain affirmative and negative covenants, including maintenance of specified ratios. We amended our debt agreements with MidCap, Penta and JL, effective <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July 29, 2016, </div>to, among other things, reset the financial covenants of each debt agreement. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>management believes we are in compliance with our financial covenants for each debt agreement.</div></div></div> 0.05 0.0624 2017-02-28 2018-01-28 2017-04-21 2018-01-21 2017-03-08 2017-02-28 2018-01-28 2017-04-21 2018-01-21 2017-04-21 4770000 2500000 7000000 2500000 3000000 2000000 2500000 7000000 4770000 2500000 3267000 3200000 273000 152000 90000 540000 0.1 0.162 0.085 0.085 0.085 0.085 0.085 0.12 0.08 0.12 0.12 0.085 0.085 0.085 0.085 0.085 0.085 0.085 2019-01-28 2019-01-28 2019-01-28 2019-03-21 2019-12-30 2019-11-13 2019-11-13 2019-03-21 2019-01-28 2019-12-30 2019-12-30 2019-03-21 2019-06-02 4900000 104000 292000 104000 292000 21000 P3Y P3Y 0 206000 1694000 2304000 2058000 148000 201000 73000 293000 2744000 1871000 2297000 2102000 3451000 1606000 1727000 959000 959000 1000000 222000 221000 669000 567000 2416000 2212000 -1688000 28128000 -393000 14065000 8143000 6455000 8143000 0 0 8143000 6455000 0 0 6455000 8143000 6455000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div> </div><div style="display: inline; font-weight: bold;">&#x2013; DERIVATIVE LIABILIT</div><div style="display: inline; font-weight: bold;">IES</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The number of shares of common stock issuable pursuant to certain warrants issued in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> will be increased<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> if our adjusted EBITDA or the market price of the Company&#x2019;s common stock does <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> meet certain defined amounts. We have recorded the estimated fair value of the warrants as of the date of issuance. Due to the variable terms of the warrant agreements, the warrants are recorded as derivative liabilities with a corresponding charge to our consolidated statements of comprehensive loss for changes in the estimated fair value of the warrants from the date of issuance to each balance sheet reporting date. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>we have estimated the total fair value of the derivative liabilities to be <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8,143</div> as compared to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6,455</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016. </div>We had the following activity in our derivative liabilities account since <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016:</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 81%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Derivative liabilities at December 31, 2016</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,455</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Loss on change in fair value of derivative liabilities</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,688</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Derivative liabilities at September 30, 2017</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" background-color:#FFFFFF;font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div style=" background-color:#FFFFFF;font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The value of the derivative liabilities is generally estimated using an options lattice model with multiple inputs and assumptions, including the market price of the Company<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2019;s common stock, stock price volatility and other assumptions to project EBITDA and other reset events. These inputs and assumptions are subject to management&#x2019;s judgment and can vary materially from period to period.</div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Derivative Liabilities</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We have recorded certain warrants as derivative liabilities at estimated fair value, as determined based on our use of an outside professional valuation firm, due to the variable terms of the warrant agreements. <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">The value of the derivative liabilities is generally estimated using the Monte Carlo option lattice model with multiple inputs and assumptions, including the market price of the Company&#x2019;s common stock, stock price volatility and other assumptions to project EBITDA and other reset events. These inputs and assumptions are subject to management&#x2019;s judgment and can vary materially from period to period.</div></div></div></div> -14065000 -28128000 -0.02 0.04 -0.05 0.03 0.04 -0.01 0.03 -0.07 -0.02 -0.05 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Net Loss per Common Share</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Basic net income or loss per common share (Basic EPS) is computed by dividing net income or loss by the weighted average number of common shares outstanding. <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> Diluted net income or loss per common share (Diluted EPS) is computed by dividing net income or loss by the sum of the weighted average number of common shares outstanding and the dilutive potential common shares then outstanding. Potential dilutive common share equivalents consist of total shares issuable upon the exercise of outstanding stock options and warrants to acquire common stock using the treasury stock method and the average market price per share during the period.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The common shares used in the computation of our basic and diluted net loss per share are reconciled as follows:</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 3%; margin-left: 9pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="8" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="8" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;">September 30,</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">(as corrected)</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">(as corrected)</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Numerator:</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Net income (loss)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,418</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,968</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(12,854</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,584</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Effect of dilutive securities on net income (loss):</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Common stock warrants</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(14,065</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(28,128</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="width: 48%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Total net loss for purpose of calculating diluted net loss per common share</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,418</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,097</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(12,854</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(19,544</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="width: 48%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Number of shares used in per common share calculations:</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Total shares for purposes of calculating basic net loss per common share</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252,924,027</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250,806,152</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252,935,792</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">264,740,245</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Weighted-average effect of dilutive securities:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Common stock warrants</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,418,629</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,481,487</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 48%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Total shares for purpose of calculating diluted<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> net loss per common share</div></div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252,924,027</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">264,224,781</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252,935,792</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">277,221,732</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 48%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Net income (loss) per common share:</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Basic</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.05</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.03</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Diluted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.05</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.07</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Correction </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic;">of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> Diluted Net Loss Per Share</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The diluted net loss per share for the period ended <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2016 </div>has been corrected. In accordance with U.S. generally accepted accounting principles, when calculating diluted earnings or loss per share, if the effects are dilutive, companies are required to add back to net income or loss the effects of the change in derivative liabilities related to warrants. Additionally, if the effects of the change in derivative liabilities are added back to net income or loss, companies are required to include the warrants outstanding related to the derivative liability in the calculation of the weighted average dilutive shares.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">For the period ended <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2016, </div>as originally reported, we did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> add back the effects of the change in the derivative liability in computing dilutive income or loss per share. The dilutive loss per share for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2016 </div>in the table above has been revised to correct this error.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The table below reflects the diluted net <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">loss per share as originally reported and net loss per share as corrected for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2016.</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 27pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">As originally reported</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">As corrected</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 66%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Diluted net income (loss) per common share (three months)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Diluted net income (loss) per common share (nine months)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.03</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.07</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Weighted average shares oustanding - diluted (three months)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">258,565,687</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">264,224,781</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Weighted average shares oustanding - diluted (nine months)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">275,633,914</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">277,221,732</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The errors were corrected as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>but since the adjustments were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> material to any of the quarters<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> previously reported, the Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Qs for those periods were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> amended. Management has determined the effects to be neither quantitatively or qualitatively material to the financial statements included in any of the Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Qs filed during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">September 30, 2017</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 1</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 2</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 3</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 36%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Derivative liabilities</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">December 31, 2016</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 1</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 2</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 3</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 36%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Derivative liabilities</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,455</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,455</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Fair </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic;">V</div><div style="display: inline; font-style: italic;">alue of </div><div style="display: inline; font-style: italic;">F</div><div style="display: inline; font-style: italic;">inancial </div><div style="display: inline; font-style: italic;">I</div><div style="display: inline; font-style: italic;">nstruments</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We apply the following fair value hierarchy, which prioritizes the inputs used to measure fair value into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2013; inputs are quoted prices in active markets for identical assets that the reporting entity has the ability to access at the measurement date.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2013; inputs are other than quoted prices included within Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> that are observable for the asset, either directly or indirectly.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2013; inputs are unobservable inputs for the asset that are supported by little or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> market activity and that are significant to the fair value of the underlying asset or liability.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The following table summarizes our financial instruments that are measured at fair value on a recurring basis as of<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016:</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">September 30, 2017</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 1</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 2</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 3</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 36%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Derivative liabilities</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">December 31, 2016</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 1</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 2</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 3</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 36%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Derivative liabilities</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,455</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,455</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div></div></div> P3Y P30Y P3Y P30Y P15Y P16Y P3Y 9479000 7732000 12166000 12166000 19110000 19110000 753000 753000 121000 124000 24098000 24098000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Goodwill</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Goodwill is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> subject to amortization, but is reviewed for impairment annually, or more frequently whenever events or changes in circumstances indicate the carrying value of goodwill <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. An impairment charge would be recorded to the extent the carrying value of goodwill exceeds its estimated fair value. The testing of goodwill under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.</div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Indefinite-Lived Intangible Assets</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Indefinite-lived intangible assets relating to the asset acquisition of Organic Holdings<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">, LLC (&#x201c;Organic Holdings&#x201d;), a market leader in the healthy aging and beauty from within categories and owner of the award-winning Reserveage</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2122; Nutrition brand, are determined to have an indefinite useful economic life and as such are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> amortized. Indefinite-lived intangible assets are tested for impairment annually which consists of a comparison of the fair value of the asset with its carrying value. The total indefinite-lived intangible assets as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,900</div>.</div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Intangible Assets</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Intangible assets consist primarily of trademarks and customer relationships, which are amortized on a straight-line basis over their estimated useful lives ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30</div> years. The valuation and classification of these assets and the assignment of amortizable lives involve significant judgment and the use of estimates.</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We believe that our long-term growth strategy supports our fair value conclusions. For intangible assets, the recoverability of these amounts is dependent upon achievement of our projections and the execution of key initiatives related to revenue growth and improved profitability.</div></div></div> 3509000 7083000 15762000 16480000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Impairment of Long-Lived Assets</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Long-lived assets, including intangible assets subject to amortization, are reviewed for impairment when changes in circumstances indicate that the carrying amount of the asset <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. If the carrying amount of the asset exceeds the expected undiscounted cash flows of the asset, an impairment charge is recognized equal to the amount by which the carrying amount exceeds fair value. The testing of these intangibles under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.</div></div></div> -5418000 10968000 -12854000 8601000 17000 27000 -3259000 -5241000 1136000 2293000 2032000 1621000 1233000 4044000 101000 -63000 -632000 1113000 13418629 12481487 5900000 5900000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div> </div><div style="display: inline; font-weight: bold;">&#x2013; INTANGIBLE ASSETS</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Intangible assets<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> consisted of the following at:</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Trademarks</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,166</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,166</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Indefinite-lived intangible assets</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,900</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,900</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Customer relationships</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,110</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,110</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Other</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">753</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">753</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37,929</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37,929</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Accumulated amortization</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,479</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7,732</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28,450</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,197</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Trademarks are amortized over period<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">s ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30</div> years, customer relationships are amortized over periods ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div> years, and other intangible assets are amortized over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> years. Amortization expense was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$582</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$557</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively, and was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,747</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,645</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively.</div></div></div> 37929000 37929000 28450000 30197000 1876000 2423000 6318000 6530000 50000 50000 982000 3818000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> </div><div style="display: inline; font-weight: bold;">&#x2013; INVENTORIES</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Inventories<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> consisted of the following at:</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Raw materials</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,348</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,912</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Work in process</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,013</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,189</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Finished goods</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,411</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,438</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,772</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,539</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Reserve for obsolete inventory</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,404</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,938</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,368</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,601</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div></div> 12411000 13438000 20772000 19539000 18368000 17601000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Inventories</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Inventories are stated at the <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">lower of cost or net realizable value and are reduced by an estimated reserve for obsolete inventory.</div></div></div></div> 6348000 4912000 2404000 1938000 2013000 1189000 466000 1194000 P4Y P4Y P15Y 99834000 91060000 89132000 92826000 40107000 37386000 59727000 53674000 15000000 17000000 3267000 3061000 4770000 4770000 2500000 2500000 7000000 7000000 2500000 2500000 3000000 2500000 2500000 7000000 7000000 4770000 4770000 2500000 2500000 3267000 6306000 5696000 2942000 1852000 1799000 54174000 44096000 14901000 13035000 3200000 57162000 50988000 17091000 11631000 6330000 22459000 -9143000 -20535000 -12854000 8584000 -5418000 10968000 -5418000 -3097000 -12854000 -19544000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Recent Accounting Pronouncements</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> FASB amended its guidance regarding the scope of modification accounting for share-based compensation arrangements. The amendments provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718.</div> For public entities, the amendments in this update are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> including interim periods within those fiscal years, with early adoption permitted. The amendments in this update should be applied prospectively to an award modified on or after the adoption date. </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect the new guidance to have a significant impact on our condensed consolidated financial statements or related disclosures.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2017, </div>FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">04,</div> &#x201c;Simplifying the Test for Goodwill Impairment (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div>)&#x201d; which removes Step <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> of the goodwill impairment test that requires a hypothetical purchase price allocation.&nbsp;&nbsp;A goodwill impairment will now be the amount by which a reporting unit&#x2019;s carrying value exceeds its fair value, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> to exceed the carrying amount of goodwill.&nbsp;&nbsp;The amendments in this ASU are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2019.&nbsp;&nbsp;</div>Early adoption is permitted after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2017.&nbsp;&nbsp;</div></div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect the new guidance to have a significant impact on our condensed consolidated financial statements or related disclosures.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>)&#x201d;. The amendments in this ASU revise the accounting related to lessee accounting. Under the new guidance, lessees will be required to recognize a lease liability and a right-of-use asset for all leases with terms greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months affecting the pattern of expense recognition in the income statement. Leases previously defined as operating leases will be defined as financing leases and capitalized if the term is greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year. The amendments in this ASU are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018 </div>and are to be applied through a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Early adoption is permitted. We are performing an assessment of our leases and have begun preparations for implementation and retrospective application to the earliest reporting period. As a result, financing leases will be recorded as an asset and a corresponding liability at the present value of the total lease payments. The asset will be decremented over the life of the lease on a pro-rata basis resulting in lease expense while the liability will be decremented using the interest method (ie. principal and interest). As such, we expect the new guidance will materially impact the asset and liability balances of our consolidated financial statements and related disclosures at the time of adoption.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Although there are several other new accounting pronouncements issued or proposed by FASB, which we have adopted or will adopt, as applicable, we do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe any of these accounting pronouncements has had or will have a material impact on our <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">condensed consolidated financial position or results of operations.</div></div></div></div> -2281000 11645000 -8042000 18370000 500000 2589000 -3137000 -677000 -4812000 -9769000 1768000 1667000 2256000 396000 500000 5178000 5488000 -12000 3000 -36000 -18000 51000 119000 0.001 0.001 500000000 500000000 0 0 0 0 0 0 2238000 2870000 6267000 22089000 8000000 5000000 8000000 4770000 4770000 1646000 3342000 1 1000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div> </div><div style="display: inline; font-weight: bold;">&#x2013; PROPERTY AND EQUIPMENT</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Property and equipment consisted of the following at:</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Machinery and equipment</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,156</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,885</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Computers and other</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,119</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Aquifer</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">482</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">482</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Leasehold improvements</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,518</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,518</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23,656</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,004</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Accumulated depreciation and amortization</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(20,416</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(18,476</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,240</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,528</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:36pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:36pt;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Assets held under capital leases are included in <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">machinery and equipment and amounted to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,082</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,142</div> as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>respectively. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Depreciation and amortization expense totale<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">d <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$222</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$221</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively,&nbsp;and totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$669</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$567</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">.</div></div></div> 12156000 10885000 9500000 9119000 482000 482000 1518000 1518000 23656000 22004000 3240000 3528000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Property and Equipment</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation, including amounts amortized under capital leases, is calculated on the straight-line method over the estimated useful lives of the related assets, which are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> years for machinery and equipment, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div> years for furniture and fixtures and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> years for computers. Leasehold improvements are amortized over the shorter of the useful life of the asset or the term of the lease.</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Normal repairs and maintenance are expensed as incurred. When assets are retired or otherwise disposed of, the related cost and accumulated depreciation or amortization is removed from the accounts and any gain or loss is included in the results of operations.</div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Machinery and equipment</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,156</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,885</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Computers and other</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,119</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Aquifer</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">482</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">482</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Leasehold improvements</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,518</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,518</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23,656</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">22,004</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Accumulated depreciation and amortization</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(20,416</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(18,476</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,240</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,528</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> P7Y P10Y P8Y P3Y 167000 267000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Accounts Receivable and Allowances</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> grant credit to customers and generally do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require collateral or other security. We perform credit evaluations of our customers and provide for expected claims related to promotional items; customer discounts; shipping shortages; damages; and doubtful accounts based upon historical bad debt and claims experience. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>total allowances amounted to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,777,</div> of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$314</div> was related to doubtful accounts receivable. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>total allowances amounted to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,365,</div> of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$481</div> was related to doubtful accounts receivable. </div></div></div></div> 1583000 2973000 -237326000 -224472000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Revenue Recognition</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Revenue from product sales, net of estimated returns and allowances, is recognized when evidence of an arrangement is in place, related prices are fixed and determinable, contractual obligations have been satisfied, title and risk of loss have been transferred to the customer and collection of the resulting receivable is reasonably assured. Shipping terms are generally<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> freight on board shipping point. We sell predominately in the North American and European markets, with international sales transacted in U.S. dollars.</div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Deferred gain on sale of assets</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> entered into a sale-leaseback arrangement relating to our office facilities in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2013.</div> Under the terms of the arrangement, we sold an office building and surrounding land and then leased the property back under a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div>-year operating lease. We recorded a deferred gain for the amount of the gain on the sale of the asset, to be recognized as a reduction of rent expense over the life of the lease. Accordingly, we recorded amortization of deferred gain as a reduction of rental expense of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$40</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$41</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> we recorded&nbsp;amortization of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$121</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$122,</div> respectively. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>unamortized deferred gain on sale of assets was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,606</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,727,</div> respectively.</div></div></div></div> 20612000 23046000 66130000 65885000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Related-Party Debt:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">July 2014 note payable to Little Harbor, LLC, net of unamortized discount of $0 and $206 as of September 30, 2017 and December 31, 2016, respectively</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,267</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,061</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">July 2016 note payable to Little Harbor, LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,770</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,770</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">January 2016 note payable to Great Harbor Capital, LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">March 2016 note payable to Great Harbor Capital, LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">December 2016 note payable to Great Harbor Capital, LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">August 2017 note payable to Great Harbor Capital, LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">January 2016 note payable to Golisano Holdings LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">March 2016 note payable to Golisano Holdings LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">July 2016 note payable to Golisano Holdings LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,770</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,770</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">December 2016 note payable to Golisano Holdings LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">March 2017 note payable to Golisano Holdings LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,267</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">November 2014 note payable to Golisano Holdings LLC (formerly payble to Penta</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">Mezzanine SBIC Fund I, L.P.), net of discount and unamortized loan fees in the aggregate of $1,694 and $2,304 as of September 30, 2017 and December 31, 2016, respectively</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,306</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,696</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">January 2015 note payable to Golisano Holdings LLC (formerly payable to JL-BBNC</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">Mezz Utah, LLC), net of discount and unamortized loan fees in the aggregate of $2,058 as of September 30, 2017</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,942</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">February 2015 note payable to Golisano Holdings LLC (formerly payable to Penta</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">Mezzanine SBIC Fund I, L.P.), net of discount and unamortized loan fees in the aggregate of $148 and $201 as of September 30, 2017 and December 31, 2016, respectively</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,852</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,799</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 63.9%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt;">Total related-party debt</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">54,174</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">44,096</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left; text-indent: -9pt;">Senior Credit Facility with Midcap, net of unamortized loan fees of $73 and $293 as of September 30, 2017 and December 31, 2016, respectively</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,901</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,035</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Other Debt:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 18pt; text-align: left; text-indent: -9pt;">January 2015 note payable to JL-BBNC Mezz Utah, LLC, net of discount and unamortized loan fees in the aggregate of $2,744 as of December 31, 2016</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,256</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">April 2016 note payable to JL-Utah Sub, LLC</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">396</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">Capital lease obligations</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,582</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,732</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">Huntington Holdings</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,200</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 27pt;">Total other debt</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,178</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,488</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">Total debt</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">74,253</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">62,619</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">Less current portion</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(17,091</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(11,631</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">Long-term debt</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">57,162</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50,988</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 81%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Derivative liabilities at December 31, 2016</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,455</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Loss on change in fair value of derivative liabilities</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,688</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Derivative liabilities at September 30, 2017</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 3%; margin-left: 9pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="8" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="8" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;">September 30,</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">(as corrected)</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">(as corrected)</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Numerator:</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Net income (loss)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,418</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,968</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(12,854</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,584</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Effect of dilutive securities on net income (loss):</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Common stock warrants</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(14,065</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(28,128</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="width: 48%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Total net loss for purpose of calculating diluted net loss per common share</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,418</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,097</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(12,854</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(19,544</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="width: 48%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Number of shares used in per common share calculations:</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Total shares for purposes of calculating basic net loss per common share</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252,924,027</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250,806,152</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252,935,792</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">264,740,245</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Weighted-average effect of dilutive securities:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Common stock warrants</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,418,629</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,481,487</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 48%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Total shares for purpose of calculating diluted<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> net loss per common share</div></div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252,924,027</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">264,224,781</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252,935,792</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">277,221,732</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 48%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Net income (loss) per common share:</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Basic</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.05</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.03</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Diluted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.05</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.07</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 27pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">As originally reported</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">As corrected</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 66%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Diluted net income (loss) per common share (three months)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Diluted net income (loss) per common share (nine months)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.03</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.07</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Weighted average shares oustanding - diluted (three months)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">258,565,687</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">264,224,781</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Weighted average shares oustanding - diluted (nine months)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">275,633,914</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">277,221,732</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Trademarks</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,166</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,166</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Indefinite-lived intangible assets</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,900</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,900</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Customer relationships</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,110</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,110</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Other</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">753</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">753</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37,929</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">37,929</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Accumulated amortization</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,479</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7,732</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28,450</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,197</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 62%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Raw materials</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,348</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,912</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Work in process</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,013</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,189</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Finished goods</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,411</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,438</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,772</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,539</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Reserve for obsolete inventory</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,404</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,938</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18,368</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">17,601</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted Average</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise Price</div></div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 62%;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding, December 31, 2016</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,855,017</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.18</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Canceled / Expired</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding, September 30, 2017</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,855,017</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 16%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.18</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> 6646000 7760000 20574000 26249000 386000 540000 6060943 0.25 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2013; NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Organization</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Twinlab Consolidated Holdings, Inc. (the &#x201c;Company&#x201d;<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">, &#x201c;Twinlab,&#x201d; &#x201c;we,&#x201d; &#x201c;our&#x201d; and &#x201c;us&#x201d;) was incorporated on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October 24, 2013 </div>under the laws of the State of Nevada as Mirror Me, Inc. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 7, 2014, </div>we amended our articles of incorporation and changed our name to Twinlab Consolidated Holdings, Inc.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Nature of Operations</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We are<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty stores retailers, on-line retailers and websites. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Our <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">products include vitamins, minerals, specialty supplements and sports nutrition products sold under the Twinlab&reg; brand name (including the Twinlab&reg; Fuel brand of sports nutrition products); a market leader in the healthy aging and beauty from within categories sold under the Reserveage&#x2122; Nutrition and ResVitale&reg; brand names; diet and energy products sold under the Metabolife&reg; brand name; the Re-Body&reg; brand name; and a full line of herbal teas sold under the Alvita&reg; brand name. To accommodate consumer preferences, our products come in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, sprays and&nbsp;powders. These products are sold primarily through health and natural food stores and on-line retailers, supermarkets, and mass-market retailers.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We also perform contract manufacturing services for private label products.<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp; Our contract manufacturing business involves the manufacture of custom products to the specifications of a customer who requires finished product under the customer&#x2019;s own brand name.&nbsp; We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> market these private label products as our business is to manufacture and sell the products to the customer, who then markets and sells the products to retailers or end consumers.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Principles of Consolidation</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Basis of Presentation and Unaudited Information</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with United States generally accepted accounting principles, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures are adequate to make the information presented <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> misleading. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management, are necessary for fair presentation of the information contained herein. Financial results for any interim period are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> necessarily indicative of financial results that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>be expected for the fiscal year. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company&#x2019;s Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>filed with the SEC on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March 31, 2017.</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant management estimates include those with respect to returns and allowances, allowance for doubtful accounts, reserves for inventory obsolescence, the recoverability of long-lived assets, intangibles and goodwill and the estimated value of warrants and derivative liabilities.</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Revenue Recognition</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Revenue from product sales, net of estimated returns and allowances, is recognized when evidence of an arrangement is in place, related prices are fixed and determinable, contractual obligations have been satisfied, title and risk of loss have been transferred to the customer and collection of the resulting receivable is reasonably assured. Shipping terms are generally<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> freight on board shipping point. We sell predominately in the North American and European markets, with international sales transacted in U.S. dollars.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Fair </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic;">V</div><div style="display: inline; font-style: italic;">alue of </div><div style="display: inline; font-style: italic;">F</div><div style="display: inline; font-style: italic;">inancial </div><div style="display: inline; font-style: italic;">I</div><div style="display: inline; font-style: italic;">nstruments</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We apply the following fair value hierarchy, which prioritizes the inputs used to measure fair value into <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2013; inputs are quoted prices in active markets for identical assets that the reporting entity has the ability to access at the measurement date.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2013; inputs are other than quoted prices included within Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> that are observable for the asset, either directly or indirectly.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:36pt;margin-right:0pt;margin-top:0pt;text-align:left;">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2013; inputs are unobservable inputs for the asset that are supported by little or <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> market activity and that are significant to the fair value of the underlying asset or liability.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The following table summarizes our financial instruments that are measured at fair value on a recurring basis as of<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016:</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">September 30, 2017</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 1</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 2</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 3</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 36%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Derivative liabilities</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">December 31, 2016</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Total</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 1</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 2</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Level 3</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="width: 36%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 36%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Derivative liabilities</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,455</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,455</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Accounts Receivable and Allowances</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> grant credit to customers and generally do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> require collateral or other security. We perform credit evaluations of our customers and provide for expected claims related to promotional items; customer discounts; shipping shortages; damages; and doubtful accounts based upon historical bad debt and claims experience. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>total allowances amounted to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,777,</div> of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$314</div> was related to doubtful accounts receivable. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>total allowances amounted to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2,365,</div> of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$481</div> was related to doubtful accounts receivable. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Inventories</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Inventories are stated at the <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">lower of cost or net realizable value and are reduced by an estimated reserve for obsolete inventory.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Property and Equipment</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation, including amounts amortized under capital leases, is calculated on the straight-line method over the estimated useful lives of the related assets, which are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div> years for machinery and equipment, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div> years for furniture and fixtures and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> years for computers. Leasehold improvements are amortized over the shorter of the useful life of the asset or the term of the lease.</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Normal repairs and maintenance are expensed as incurred. When assets are retired or otherwise disposed of, the related cost and accumulated depreciation or amortization is removed from the accounts and any gain or loss is included in the results of operations.</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Intangible Assets</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Intangible assets consist primarily of trademarks and customer relationships, which are amortized on a straight-line basis over their estimated useful lives ranging from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30</div> years. The valuation and classification of these assets and the assignment of amortizable lives involve significant judgment and the use of estimates.</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We believe that our long-term growth strategy supports our fair value conclusions. For intangible assets, the recoverability of these amounts is dependent upon achievement of our projections and the execution of key initiatives related to revenue growth and improved profitability.</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Goodwill</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Goodwill is <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> subject to amortization, but is reviewed for impairment annually, or more frequently whenever events or changes in circumstances indicate the carrying value of goodwill <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. An impairment charge would be recorded to the extent the carrying value of goodwill exceeds its estimated fair value. The testing of goodwill under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Impairment of Long-Lived Assets</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Long-lived assets, including intangible assets subject to amortization, are reviewed for impairment when changes in circumstances indicate that the carrying amount of the asset <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> be recoverable. If the carrying amount of the asset exceeds the expected undiscounted cash flows of the asset, an impairment charge is recognized equal to the amount by which the carrying amount exceeds fair value. The testing of these intangibles under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Indefinite-Lived Intangible Assets</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Indefinite-lived intangible assets relating to the asset acquisition of Organic Holdings<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">, LLC (&#x201c;Organic Holdings&#x201d;), a market leader in the healthy aging and beauty from within categories and owner of the award-winning Reserveage</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2122; Nutrition brand, are determined to have an indefinite useful economic life and as such are <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> amortized. Indefinite-lived intangible assets are tested for impairment annually which consists of a comparison of the fair value of the asset with its carrying value. The total indefinite-lived intangible assets as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016 </div>was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,900</div>.</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Value of Warrants Issued with Debt</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We estimate the grant date value of certain warrants issued with debt, using an outside professional valuation firm, which uses the <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Monte Carlo option lattice model. We record </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">the amounts as interest expense or debt discount, depending on the terms of the agreement. These estimates involve multiple inputs and assumptions, including the market price of the Company&#x2019;s common stock, stock price volatility and other assumptions to project </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">earnings before interest, taxes, depreciation and amortization (&#x201c;EBITDA&#x201d;) and other reset events. These inputs and assumptions are subject to management&#x2019;s judgment and can vary materially from period to period.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Derivative Liabilities</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We have recorded certain warrants as derivative liabilities at estimated fair value, as determined based on our use of an outside professional valuation firm, due to the variable terms of the warrant agreements. <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">The value of the derivative liabilities is generally estimated using the Monte Carlo option lattice model with multiple inputs and assumptions, including the market price of the Company&#x2019;s common stock, stock price volatility and other assumptions to project EBITDA and other reset events. These inputs and assumptions are subject to management&#x2019;s judgment and can vary materially from period to period.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Deferred gain on sale of assets</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">We<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> entered into a sale-leaseback arrangement relating to our office facilities in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2013.</div> Under the terms of the arrangement, we sold an office building and surrounding land and then leased the property back under a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div>-year operating lease. We recorded a deferred gain for the amount of the gain on the sale of the asset, to be recognized as a reduction of rent expense over the life of the lease. Accordingly, we recorded amortization of deferred gain as a reduction of rental expense of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$40</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$41</div> for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. For the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> we recorded&nbsp;amortization of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$121</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$122,</div> respectively. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>unamortized deferred gain on sale of assets was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,606</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,727,</div> respectively.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Net Loss per Common Share</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Basic net income or loss per common share (Basic EPS) is computed by dividing net income or loss by the weighted average number of common shares outstanding. <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> Diluted net income or loss per common share (Diluted EPS) is computed by dividing net income or loss by the sum of the weighted average number of common shares outstanding and the dilutive potential common shares then outstanding. Potential dilutive common share equivalents consist of total shares issuable upon the exercise of outstanding stock options and warrants to acquire common stock using the treasury stock method and the average market price per share during the period.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The common shares used in the computation of our basic and diluted net loss per share are reconciled as follows:</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 3%; margin-left: 9pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="8" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;">Three Months Ended</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Nine Months Ended</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="8" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;">September 30,</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">September 30,</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2017</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="1" style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; width: 48%;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">(as corrected)</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">(as corrected)</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Numerator:</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Net income (loss)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,418</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,968</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(12,854</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,584</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Effect of dilutive securities on net income (loss):</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Common stock warrants</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(14,065</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(28,128</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="width: 48%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Total net loss for purpose of calculating diluted net loss per common share</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,418</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,097</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(12,854</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(19,544</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="width: 48%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Number of shares used in per common share calculations:</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Total shares for purposes of calculating basic net loss per common share</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252,924,027</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">250,806,152</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252,935,792</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">264,740,245</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Weighted-average effect of dilutive securities:</div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Common stock warrants</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,418,629</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,481,487</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 48%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Total shares for purpose of calculating diluted<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> net loss per common share</div></div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252,924,027</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">264,224,781</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">252,935,792</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">277,221,732</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="width: 48%;">&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">Net income (loss) per common share:</div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Basic</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.05</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.03</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="1" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 48%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:10pt;">Diluted</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.02</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.05</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.07</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> </table> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:18pt;margin-right:0pt;margin-top:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Correction </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic;">of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> Diluted Net Loss Per Share</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The diluted net loss per share for the period ended <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2016 </div>has been corrected. In accordance with U.S. generally accepted accounting principles, when calculating diluted earnings or loss per share, if the effects are dilutive, companies are required to add back to net income or loss the effects of the change in derivative liabilities related to warrants. Additionally, if the effects of the change in derivative liabilities are added back to net income or loss, companies are required to include the warrants outstanding related to the derivative liability in the calculation of the weighted average dilutive shares.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">For the period ended <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2016, </div>as originally reported, we did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> add back the effects of the change in the derivative liability in computing dilutive income or loss per share. The dilutive loss per share for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2016 </div>in the table above has been revised to correct this error.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The table below reflects the diluted net <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">loss per share as originally reported and net loss per share as corrected for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2016.</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; margin-left: 27pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">As originally reported</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">As corrected</div></div></div> </td> <td style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt; width: 66%;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Diluted net income (loss) per common share (three months)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.04</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Diluted net income (loss) per common share (nine months)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.03</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(0.07</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Weighted average shares oustanding - diluted (three months)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">258,565,687</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">264,224,781</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-align: left; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Weighted average shares oustanding - diluted (nine months)</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">275,633,914</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">277,221,732</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:center;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The errors were corrected as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>but since the adjustments were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> material to any of the quarters<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> previously reported, the Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Qs for those periods were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> amended. Management has determined the effects to be neither quantitatively or qualitatively material to the financial statements included in any of the Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-Qs filed during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Significant Concentration of Credit Risk</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Sales to our top <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div></div> customers a<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">ggregated to approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> of total sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">26%</div> of total sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. Sales to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div></div> of those customers were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> of total sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively, and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> of total sales for the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> respectively. Accounts receivable from these customers were approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">55%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29%</div> of total accounts receivable as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017 </div>and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016, </div>respectively.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Recent Accounting Pronouncements</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> FASB amended its guidance regarding the scope of modification accounting for share-based compensation arrangements. The amendments provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718.</div> For public entities, the amendments in this update are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December&nbsp;</div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> including interim periods within those fiscal years, with early adoption permitted. The amendments in this update should be applied prospectively to an award modified on or after the adoption date. </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect the new guidance to have a significant impact on our condensed consolidated financial statements or related disclosures.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 2017, </div>FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No.</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">04,</div> &#x201c;Simplifying the Test for Goodwill Impairment (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350</div>)&#x201d; which removes Step <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> of the goodwill impairment test that requires a hypothetical purchase price allocation.&nbsp;&nbsp;A goodwill impairment will now be the amount by which a reporting unit&#x2019;s carrying value exceeds its fair value, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> to exceed the carrying amount of goodwill.&nbsp;&nbsp;The amendments in this ASU are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2019.&nbsp;&nbsp;</div>Early adoption is permitted after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 1, 2017.&nbsp;&nbsp;</div></div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">We do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> expect the new guidance to have a significant impact on our condensed consolidated financial statements or related disclosures.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February 2016, </div>FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">02,</div> &#x201c;Leases (Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">842</div>)&#x201d;. The amendments in this ASU revise the accounting related to lessee accounting. Under the new guidance, lessees will be required to recognize a lease liability and a right-of-use asset for all leases with terms greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months affecting the pattern of expense recognition in the income statement. Leases previously defined as operating leases will be defined as financing leases and capitalized if the term is greater than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year. The amendments in this ASU are effective for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 15, 2018 </div>and are to be applied through a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Early adoption is permitted. We are performing an assessment of our leases and have begun preparations for implementation and retrospective application to the earliest reporting period. As a result, financing leases will be recorded as an asset and a corresponding liability at the present value of the total lease payments. The asset will be decremented over the life of the lease on a pro-rata basis resulting in lease expense while the liability will be decremented using the interest method (ie. principal and interest). As such, we expect the new guidance will materially impact the asset and liability balances of our consolidated financial statements and related disclosures at the time of adoption.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Although there are several other new accounting pronouncements issued or proposed by FASB, which we have adopted or will adopt, as applicable, we do <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> believe any of these accounting pronouncements has had or will have a material impact on our <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">condensed consolidated financial position or results of operations.</div></div></div> 0 -10702000 1766000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div></div><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">&#x2013; </div><div style="display: inline; font-weight: bold;">STOCKHOLDERS&#x2019; </div><div style="display: inline; font-weight: bold;">EQUITY </div><div style="display: inline; font-weight: bold;">(</div><div style="display: inline; font-weight: bold;">DEFICIT</div><div style="display: inline; font-weight: bold;">)</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Preferred Stock</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The Company has <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">authorized <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">500,000,000</div> shares of preferred stock with a par value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.001</div> per share. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">No</div> shares of the preferred stock have been issued. </div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">&nbsp;</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Twinlab Consolidation Corporation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2013</div> Stock Incentive Plan</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The only equity compensation plan currently in effect is the Twinlab Consolidation Corporation <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2013</div> Stock Incentive Plan (the &#x201c;TCC Plan&#x201d;), which was assumed by the Company on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 16, 2014. </div>The TCC Plan originally established a pool of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,000,000</div> shares of common stock for issuance as incentive awards to employees for the purposes of attracting and retaining qualified employees who will aid in the success of the Company. <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">From <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January </div>through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 2015, </div>the Company granted restricted stock units to certain employees of the Company pursuant to the TCC Plan. Each restricted stock unit relates to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> share of the Company&#x2019;s common stock. The restricted stock unit awards vest <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> each annually on various dates through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> The Company estimated the grant date fair market value per share of the restricted stock units and is amortizing the total estimated grant date value over the vesting periods. During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">nine</div> months ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> any shares of common stock issued to employees pursuant to the vesting of restricted stock units. </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,060,943</div> shares remain available for use in the TCC Plan.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Common Stock Repurchase</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January 5, 2017, </div>pursuant to a repurchase agreement, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">642,366</div> shares of the Company<div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2019;s common stock were repurchased for an aggregate repurchase price of less than <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Stock Subscription Receivable </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic;">and Loss on Stock Price Guarantee</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">At <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>the stock subscription receivable dated <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 1, 2014 </div>for the purchase of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,528,384</div> shares of the Company&#x2019;s common stock had a principal balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$30</div> and bears interest at an annual rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%.</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 6, 2016, </div>the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">18</div>-month anniversary of the closing of a share purchase agreement, we were required to pay the purchaser of the common stock the difference between <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$2.29</div> per share and either a defined market price or a price per share determined by a valuation firm acceptable to both parties. <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Based on an outside professional valuation performed on the Company&#x2019;s common stock, the Company estimated the stock price guarantee payment to be <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,210.</div> Accordingly, the Company recorded a loss on the stock purchase price guarantee of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,210</div> and a corresponding liability for the same amount in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> which was included in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheet as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December 31, 2016. </div></div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2, 2017, </div>the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> parties came to an agreement in which we were required to issue the Huntington Note in favor of Huntington. The Huntington Note matures on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June 2, 2019 </div>with the principal amount of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,200</div> payable at maturity. Interest on the outstanding principal accrues at a rate of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.5%</div> per year from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 6, 2016 </div>to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 15, 2017, </div>and increases to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10%</div> per year thereafter. We paid <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$50</div> to Huntington related to accrued interest from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 6, 2016 </div>through the date of issuance of the Huntington Note. </div><div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">Huntington was required to return <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">778,385</div> shares of the Company&#x2019;s common stock which were issued into escrow. We were required to provide certain piggyback registration rights to Huntington in regards to the remaining <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">749,999</div> shares of the Company&#x2019;s common stock held by Huntington. If the Huntington Note was paid off prior to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 14, 2017, </div>the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">778,385</div> shares held in escrow were to be released from escrow and transferred to the Company for <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> additional consideration. If the note remained outstanding on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 15, 2017, </div>we had the right, but <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> the obligation, to pay <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$140</div> to Huntington to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">764,192</div> of the Subject Shares held in escrow. Upon the exercise of this purchase option, the Subject Shares were to be released from escrow and transferred to the Company. If the note remained outstanding on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 15, 2017 </div>and we did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> exercise the option to purchase the shares, the shares were to be returned from escrow to Huntington and we would <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> longer have repurchase rights. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August 15, 2017, </div>the note was outstanding and we did <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> excerise the repurchase right. The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">778,385</div> shares were returned from escrow to Huntington. Pursuant to the agreement, we were also required to enter into a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div>-year lease agreement with the purchaser related to our premises occupied by Nutricap.</div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">&#x2013; GOING CONCERN</div></div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The accompanying <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">condensed consolidated financial statements have been prepared on a going concern basis, which assumes continuity of operations and realization of assets and liabilities in the ordinary course of business. In most periods since our formation, we have generated losses from operations. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017, </div>we had an accumulated deficit of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$237,326.</div> Historical losses are primarily attributable to lower than planned sales resulting from low fill rates on demand due to limitations of our working capital, delayed product introductions and postponed marketing activities, merger-related and other restructuring costs, and interest and refinancing charges associated with our debt refinancing. Losses have been funded primarily through issuance of common stock and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div>-party or related party debt.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Because of <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;">our history of operating losses, significant interest expense on our debt, and the recording of significant derivative liabilities, we have a working capital deficiency of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$8,531</div> at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September 30, 2017. </div>We also have <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$17,091</div> of debt, net of discount, due within the next <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div> months. These continuing conditions, among others, raise substantial doubt about our ability to continue as a going concern.</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">Management has addressed operating issues through the following actions: focusing on growing the core business and brands; continuing emphasis on major customers and key products; reducing manufacturing and operating costs and continuing to negotiate lower prices from major suppliers. <div style="display: inline; font-family:Times New Roman, Times, serif;font-size:10pt;"> We believe that we <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>need additional capital to execute our business plan. If additional funding is required, there can be <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div> assurance that sources of funding will be available when needed on acceptable terms or at all.</div></div></div> 134806051 134163685 500000 500000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Use of Estimates</div></div> <div style=" font-family:Times New Roman, Times, serif;font-size:10pt;margin:0pt;text-align:left;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant management estimates include those with respect to returns and allowances, allowance for doubtful accounts, reserves for inventory obsolescence, the recoverability of long-lived assets, intangibles and goodwill and the estimated value of warrants and derivative liabilities.</div></div></div> 3770000 4389000 250000 130000 258565687 264224781 275633914 277221732 252924027 252935792 252924027 250806152 252935792 264740245 xbrli:shares xbrli:pure iso4217:USD iso4217:USD xbrli:shares 0001590695 tlcc:GolisanoHoldingsLLCMember 2014-11-13 2014-11-13 0001590695 tlcc:PentaMezzanineSBICFundILPMember 2014-11-13 2014-11-13 0001590695 tlcc:GolisanoHoldingsLLCMember 2015-01-22 2015-01-22 0001590695 tlcc:JlMember 2015-01-22 2015-01-22 0001590695 us-gaap:RevolvingCreditFacilityMember tlcc:MidcapFundingXTrustMember 2015-01-22 2015-01-22 0001590695 tlcc:GolisanoHoldingsLLCMember 2015-02-06 2015-02-06 0001590695 tlcc:FirstWarrantMember tlcc:JLPropertiesIncMember 2015-04-01 2015-04-30 0001590695 2016-01-01 2016-09-30 0001590695 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tlcc:OneOfTopThreeCustomersMember 2016-01-01 2016-09-30 0001590695 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tlcc:TopThreeCustomersMember 2016-01-01 2016-09-30 0001590695 us-gaap:ScenarioPreviouslyReportedMember 2016-01-01 2016-09-30 0001590695 2016-01-01 2016-12-31 0001590695 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-12-31 0001590695 tlcc:GolisanoHoldingsLLCMember tlcc:UnsecuredDelayedDrawPromissoryNoteMember 2016-01-01 2016-12-31 0001590695 tlcc:JLBBNCMezzUtahLLCMember 2016-01-01 2016-12-31 0001590695 tlcc:RelatedPartyDebtJuly2016NotePayableToLittleHarborLLCMember 2016-01-01 2016-12-31 0001590695 tlcc:GolisanoHoldingsLLCMember 2016-01-01 2016-12-31 0001590695 tlcc:January2016GolisanoWarrantMember 2016-01-28 2016-01-28 0001590695 tlcc:GolisanoHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2016-01-28 2016-01-28 0001590695 tlcc:GreatHarborCapitalLLCMember us-gaap:NotesPayableOtherPayablesMember 2016-01-28 2016-01-28 0001590695 tlcc:GolisanoHoldingsLLCMember 2016-02-06 2016-02-06 0001590695 tlcc:March2016GolisanoWarrantMember 2016-03-21 2016-03-21 0001590695 tlcc:GolisanoHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2016-03-21 2016-03-21 0001590695 tlcc:GreatHarborCapitalLLCMember us-gaap:NotesPayableOtherPayablesMember 2016-03-21 2016-03-21 0001590695 2016-04-01 2016-09-30 0001590695 tlcc:JlWarrantsMember 2016-04-05 2016-04-05 0001590695 tlcc:JlMember tlcc:NotesPayableMaturingInMarch2019Member 2016-04-05 2016-04-05 0001590695 2016-07-01 2016-09-30 0001590695 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tlcc:OneOfTopThreeCustomersMember 2016-07-01 2016-09-30 0001590695 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tlcc:TopThreeCustomersMember 2016-07-01 2016-09-30 0001590695 us-gaap:ScenarioPreviouslyReportedMember 2016-07-01 2016-09-30 0001590695 tlcc:GolisanoHoldingsLLCMember tlcc:UnsecuredDelayedDrawPromissoryNoteMember 2016-07-21 2016-07-21 0001590695 tlcc:RelatedPartyDebtJuly2016NotePayableToLittleHarborLLCMember 2016-07-21 2016-07-21 0001590695 tlcc:GolisanoWarrantsMember 2016-07-31 2016-07-31 0001590695 tlcc:LittleHarborJuly2016WarrantMember 2016-07-31 2016-07-31 0001590695 tlcc:HuntingtonHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2016-08-06 2016-08-06 0001590695 tlcc:HuntingtonHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2016-08-06 2017-06-02 0001590695 us-gaap:RevolvingCreditFacilityMember tlcc:MidcapFundingXTrustMember 2016-09-02 2016-09-02 0001590695 tlcc:December2016GhWarrantMember 2016-12-31 2016-12-31 0001590695 tlcc:GolisanoLLCDecember2016WarrantMember 2016-12-31 2016-12-31 0001590695 tlcc:GolisanoHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2016-12-31 2016-12-31 0001590695 tlcc:GreatHarborCapitalLLCMember us-gaap:NotesPayableOtherPayablesMember 2016-12-31 2016-12-31 0001590695 tlcc:GolisanoLlcMarch2017WarrantMember 2017-01-01 2017-03-31 0001590695 tlcc:HuntingtonHoldingsLLCMember 2017-01-01 2017-08-15 0001590695 tlcc:GolisanoHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2017-01-01 2017-09-29 0001590695 tlcc:GreatHarborCapitalLLCMember us-gaap:NotesPayableOtherPayablesMember 2017-01-01 2017-09-29 0001590695 2017-01-01 2017-09-30 0001590695 us-gaap:RestrictedStockUnitsRSUMember tlcc:TCCPlanMember 2017-01-01 2017-09-30 0001590695 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2017-01-01 2017-09-30 0001590695 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tlcc:OneOfTopThreeCustomersMember 2017-01-01 2017-09-30 0001590695 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tlcc:TopThreeCustomersMember 2017-01-01 2017-09-30 0001590695 tlcc:GolisanoHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2017-01-01 2017-09-30 0001590695 tlcc:GreatHarborCapitalLLCMember us-gaap:NotesPayableOtherPayablesMember 2017-01-01 2017-09-30 0001590695 tlcc:HuntingtonHoldingsLLCMember 2017-01-01 2017-09-30 0001590695 tlcc:LittleHarborMember 2017-01-01 2017-09-30 0001590695 us-gaap:RevolvingCreditFacilityMember tlcc:MidcapFundingXTrustMember 2017-01-01 2017-09-30 0001590695 us-gaap:CustomerRelationshipsMember us-gaap:MaximumMember 2017-01-01 2017-09-30 0001590695 us-gaap:CustomerRelationshipsMember us-gaap:MinimumMember 2017-01-01 2017-09-30 0001590695 us-gaap:OtherIntangibleAssetsMember 2017-01-01 2017-09-30 0001590695 tlcc:TrademarksAndCustomerRelationshipsMember us-gaap:MaximumMember 2017-01-01 2017-09-30 0001590695 tlcc:TrademarksAndCustomerRelationshipsMember us-gaap:MinimumMember 2017-01-01 2017-09-30 0001590695 us-gaap:TrademarksMember us-gaap:MaximumMember 2017-01-01 2017-09-30 0001590695 us-gaap:TrademarksMember us-gaap:MinimumMember 2017-01-01 2017-09-30 0001590695 us-gaap:ComputerEquipmentMember 2017-01-01 2017-09-30 0001590695 us-gaap:FurnitureAndFixturesMember 2017-01-01 2017-09-30 0001590695 us-gaap:MachineryAndEquipmentMember us-gaap:MaximumMember 2017-01-01 2017-09-30 0001590695 us-gaap:MachineryAndEquipmentMember us-gaap:MinimumMember 2017-01-01 2017-09-30 0001590695 2017-01-05 2017-01-05 0001590695 tlcc:GolisanoHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2017-03-14 2017-03-14 0001590695 2017-04-01 2017-09-30 0001590695 tlcc:HuntingtonHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2017-06-02 2017-06-02 0001590695 2017-07-01 2017-09-30 0001590695 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tlcc:OneOfTopThreeCustomersMember 2017-07-01 2017-09-30 0001590695 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember tlcc:TopThreeCustomersMember 2017-07-01 2017-09-30 0001590695 tlcc:HuntingtonHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember us-gaap:ScenarioForecastMember 2019-06-02 2019-06-02 0001590695 tlcc:GolisanoHoldingsLLCMember 2014-11-13 0001590695 tlcc:WarrantsIssuedOnJanuary222015Member tlcc:JLBBNCMezzUtahLLCMember 2015-01-22 0001590695 tlcc:WarrantsIssuedOnJanuary222015Member tlcc:PentaMezzanineSBICFundILPMember 2015-01-22 0001590695 tlcc:GolisanoHoldingsLLCMember 2015-01-22 0001590695 tlcc:MidcapFundingXTrustMember 2015-01-22 0001590695 us-gaap:RevolvingCreditFacilityMember tlcc:MidcapFundingXTrustMember 2015-01-22 0001590695 tlcc:WarrantsIssuedOnFebruary42015Member tlcc:JLBBNCMezzUtahLLCMember 2015-02-04 0001590695 tlcc:GolisanoHoldingsLLCMember 2015-02-04 0001590695 tlcc:WarrantsIssuedOnJanuary222015Member tlcc:GolisanoHoldingsLLCMember 2015-02-06 0001590695 tlcc:GolisanoHoldingsLLCMember 2015-02-06 0001590695 tlcc:PentaMezzanineSBICFundILPMember 2015-02-06 0001590695 tlcc:FirstWarrantMember tlcc:JLPropertiesIncMember 2015-04-30 0001590695 tlcc:SecondWarrantMember tlcc:JLPropertiesIncMember 2015-04-30 0001590695 tlcc:JLPropertiesIncMember 2015-04-30 0001590695 tlcc:WarrantsIssuedOnJune302015Member tlcc:JLBBNCMezzUtahLLCMember 2015-06-30 0001590695 tlcc:WarrantsIssuedOnJune302015Member tlcc:PentaMezzanineSBICFundILPMember 2015-06-30 0001590695 tlcc:EssexCapitalCorporationMember 2015-06-30 0001590695 tlcc:GolisanoHoldingsLLCMember 2015-10-31 0001590695 2015-12-31 0001590695 tlcc:January2016GolisanoWarrantMember 2016-01-28 0001590695 tlcc:GolisanoHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2016-01-28 0001590695 tlcc:GreatHarborCapitalLLCMember us-gaap:NotesPayableOtherPayablesMember 2016-01-28 0001590695 tlcc:GolisanoHoldingsLLCMember 2016-02-06 0001590695 tlcc:March2016GolisanoWarrantMember 2016-03-21 0001590695 tlcc:GolisanoHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2016-03-21 0001590695 tlcc:GreatHarborCapitalLLCMember us-gaap:NotesPayableOtherPayablesMember 2016-03-21 0001590695 tlcc:JlWarrantsMember 2016-04-05 0001590695 tlcc:JlMember tlcc:NotesPayableMaturingInMarch2019Member 2016-04-05 0001590695 tlcc:GolisanoHoldingsLLCMember tlcc:UnsecuredDelayedDrawPromissoryNoteMember 2016-07-21 0001590695 tlcc:RelatedPartyDebtJuly2016NotePayableToLittleHarborLLCMember 2016-07-21 0001590695 tlcc:GolisanoWarrantsMember 2016-07-31 0001590695 tlcc:LittleHarborJuly2016WarrantMember 2016-07-31 0001590695 tlcc:HuntingtonHoldingsLLCMember 2016-08-06 0001590695 us-gaap:RevolvingCreditFacilityMember tlcc:MidcapFundingXTrustMember 2016-09-02 0001590695 2016-09-30 0001590695 2016-12-31 0001590695 tlcc:December2016GhWarrantMember 2016-12-31 0001590695 tlcc:GolisanoLLCDecember2016WarrantMember 2016-12-31 0001590695 tlcc:GolisanoHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2016-12-31 0001590695 tlcc:GreatHarborCapitalLLCMember us-gaap:NotesPayableOtherPayablesMember 2016-12-31 0001590695 tlcc:SeniorCreditFacilityWithMidcapMember 2016-12-31 0001590695 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001590695 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001590695 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001590695 us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0001590695 us-gaap:CustomerRelationshipsMember 2016-12-31 0001590695 us-gaap:OtherIntangibleAssetsMember 2016-12-31 0001590695 us-gaap:TrademarksMember 2016-12-31 0001590695 tlcc:February2015NotePayableToGolisanoHoldingsLlcFormerlyPayableToPentaMezzanineSbicFundILpMember 2016-12-31 0001590695 tlcc:RelatedPartDebtDecember2016NotePayableToGolisanoHoldingsLLCMember 2016-12-31 0001590695 tlcc:RelatedPartDebtJuly2016NotePayableToGolisanoHoldingsLLCMember 2016-12-31 0001590695 tlcc:RelatedPartyAugust2017NotePayableToGreatHarborLlcMember 2016-12-31 0001590695 tlcc:RelatedPartyDebtJanuary2015NotePayableToGolisanoHoldingsLLCFormerlyPayableToJLBBNCMezzUtahLLCMember 2016-12-31 0001590695 tlcc:RelatedPartyDebtJuly2016NotePayableToLittleHarborLLCMember 2016-12-31 0001590695 tlcc:RelatedPartyDebtMarch2017NotePayableToGolisanoHoldingsLLCMember 2016-12-31 0001590695 tlcc:RelatedPartyDebtNovember2014NotePayableToGolisanoHoldingsLLCFormerlyPentaMezzanineSBICFundILPMember 2016-12-31 0001590695 tlcc:RelatedPartyJuly2014NotePayableToLittleHarborLlcMember 2016-12-31 0001590695 tlcc:RelatedpartyDebtDecember2016NotePayableToGreatHarborCapitalLLCMember 2016-12-31 0001590695 tlcc:RelatedpartyDebtJanuary2016NotePayableToGolisanoHoldingsLlcMember 2016-12-31 0001590695 tlcc:RelatedpartyDebtJanuary2016NotePayableToGreatHarborCapitalLLCMember 2016-12-31 0001590695 tlcc:RelatedpartyDebtMarch2016NotePayableToGolisanoHoldingsLLCMember 2016-12-31 0001590695 tlcc:RelatedpartyDebtMarch2016NotePayableToGreatHarborCapitalLLCMember 2016-12-31 0001590695 tlcc:UnsecuriedPromissoryNoteWithHuntigtonHoldingsLLCMember 2016-12-31 0001590695 tlcc:AquiferMember 2016-12-31 0001590695 tlcc:ComputersAndOtherMember 2016-12-31 0001590695 us-gaap:LeaseholdImprovementsMember 2016-12-31 0001590695 us-gaap:MachineryAndEquipmentMember 2016-12-31 0001590695 tlcc:April2016NotePayableToJlutahSubLLCMember 2016-12-31 0001590695 tlcc:January2015NotePayableToJLBBNCMezzUtahLLCMember 2016-12-31 0001590695 tlcc:GolisanoHoldingsLLCMember 2017-03-09 0001590695 tlcc:GolisanoHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2017-03-14 0001590695 tlcc:GolisanoLlcMarch2017WarrantMember 2017-03-31 0001590695 tlcc:HuntingtonHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2017-06-02 0001590695 2017-08-15 0001590695 tlcc:HuntingtonHoldingsLLCMember 2017-08-15 0001590695 tlcc:HuntingtonHoldingsLLCMember tlcc:UnsecuredPromissoryNoteMember 2017-08-15 0001590695 tlcc:August2017GhWarrantMember 2017-08-30 0001590695 tlcc:GreatHarborCapitalLLCMember us-gaap:NotesPayableOtherPayablesMember 2017-08-30 0001590695 2017-09-30 0001590695 tlcc:HuntingtonHoldingsLLCMember 2017-09-30 0001590695 tlcc:LittleHarborMember 2017-09-30 0001590695 tlcc:PentaMezzanineSBICFundILPMember 2017-09-30 0001590695 tlcc:SeniorCreditFacilityWithMidcapMember 2017-09-30 0001590695 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001590695 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001590695 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001590695 us-gaap:FairValueMeasurementsRecurringMember 2017-09-30 0001590695 us-gaap:CustomerRelationshipsMember 2017-09-30 0001590695 us-gaap:OtherIntangibleAssetsMember 2017-09-30 0001590695 us-gaap:TrademarksMember 2017-09-30 0001590695 tlcc:February2015NotePayableToGolisanoHoldingsLlcFormerlyPayableToPentaMezzanineSbicFundILpMember 2017-09-30 0001590695 tlcc:RelatedPartDebtDecember2016NotePayableToGolisanoHoldingsLLCMember 2017-09-30 0001590695 tlcc:RelatedPartDebtJuly2016NotePayableToGolisanoHoldingsLLCMember 2017-09-30 0001590695 tlcc:RelatedPartyAugust2017NotePayableToGreatHarborLlcMember 2017-09-30 0001590695 tlcc:RelatedPartyDebtJanuary2015NotePayableToGolisanoHoldingsLLCFormerlyPayableToJLBBNCMezzUtahLLCMember 2017-09-30 0001590695 tlcc:RelatedPartyDebtJuly2016NotePayableToLittleHarborLLCMember 2017-09-30 0001590695 tlcc:RelatedPartyDebtMarch2017NotePayableToGolisanoHoldingsLLCMember 2017-09-30 0001590695 tlcc:RelatedPartyDebtNovember2014NotePayableToGolisanoHoldingsLLCFormerlyPentaMezzanineSBICFundILPMember 2017-09-30 0001590695 tlcc:RelatedPartyJuly2014NotePayableToLittleHarborLlcMember 2017-09-30 0001590695 tlcc:RelatedpartyDebtDecember2016NotePayableToGreatHarborCapitalLLCMember 2017-09-30 0001590695 tlcc:RelatedpartyDebtJanuary2016NotePayableToGolisanoHoldingsLlcMember 2017-09-30 0001590695 tlcc:RelatedpartyDebtJanuary2016NotePayableToGreatHarborCapitalLLCMember 2017-09-30 0001590695 tlcc:RelatedpartyDebtMarch2016NotePayableToGolisanoHoldingsLLCMember 2017-09-30 0001590695 tlcc:RelatedpartyDebtMarch2016NotePayableToGreatHarborCapitalLLCMember 2017-09-30 0001590695 tlcc:UnsecuriedPromissoryNoteWithHuntigtonHoldingsLLCMember 2017-09-30 0001590695 tlcc:TCCPlanMember 2017-09-30 0001590695 tlcc:AquiferMember 2017-09-30 0001590695 tlcc:ComputersAndOtherMember 2017-09-30 0001590695 us-gaap:LeaseholdImprovementsMember 2017-09-30 0001590695 us-gaap:MachineryAndEquipmentMember 2017-09-30 0001590695 tlcc:EssexCapitalCorporationMember 2017-09-30 0001590695 tlcc:GolisanoHoldingsLLCMember 2017-09-30 0001590695 tlcc:April2016NotePayableToJlutahSubLLCMember 2017-09-30 0001590695 tlcc:January2015NotePayableToJLBBNCMezzUtahLLCMember 2017-09-30 0001590695 2017-11-14 EX-101.SCH 7 tlcc-20170930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 2 - Going Concern link:calculationLink link:definitionLink link:presentationLink 007 - Document - Note 3 - Inventories link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 4 - Property and Equipment link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 5 - Intangible Assets link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 6 - Debt link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 7 - Warrants and Registration Rights Agreements link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 8 - Derivative Liabilities link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 9 - Stockholders' Equity (Deficit) link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 3 - Inventories (Tables) link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 4 - Property and Equipment (Tables) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 5 - Intangible Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 6 - Debt (Tables) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 7 - Warrants and Registration Rights Agreements (Tables) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 8 - Derivative Liabilities (Tables) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Financial Instruments Measured at Fair Value on a Recurring Basis (Details) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Basic and Diluted Net Loss Per Common Share (Details) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Restatement of 2016 Diluted Net Loss Per Share (Details) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 2 - Going Concern (Details Textual) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 3 - Inventories - Summary of Inventories (Details) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 4 - Property and Equipment (Details Textual) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 4 - Property and Equipment - Summary of Property and Equipment (Details) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 5 - Intangible Assets (Details Textual) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 5 - Intangible Assets - Summary of Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 6 - Debt (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 6 - Debt - Summary of Debt (Details) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 6 - Debt - Summary of Debt (Details) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 7 - Warrants and Registration Rights Agreements (Details Textual) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 7 - Warrants and Registration Rights Agreements - Summary of the Warrants Issued and Changes (Details) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 8 - Derivative Liabilities (Details Textual) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 8 - Derivative Liabilities - Activity in Derivative Liabilities Account (Details) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 9 - Stockholders' Equity (Deficit) (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 tlcc-20170930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 tlcc-20170930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 tlcc-20170930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Deferred gain on sale of assets Deferred Gain on Sale of Property Note To Financial Statement Details Textual statementsignificantaccountingpoliciespolicies Notes Payable Maturing in March 2019 [Member] Represents notes payable maturing in March 2019. statementnote1natureofoperationsandsummaryofsignificantaccountingpoliciestables statementnote3inventoriestables Related-Party Debt January 2016 Note Payable to Great Harbor Hospital, LLC [Member] Debt instrument to related-party, Great Harbor Capital, LLC. statementnote4propertyandequipmenttables Related-Party Debt March 2016 Note Payable to Great Harbor Capital, LLC [Member] Debt instrument to related-party, Harbor Capital, LLC issued March, 2016. statementnote5intangibleassetstables statementnote6debttables statementnote7warrantsandregistrationrightsagreementstables us-gaap_DebtAndCapitalLeaseObligations Total debt statementnote8derivativeliabilitiestables Related-Party Debt March 2016 note payable to Golisano Holdings LLC [Member] Debt instrument with related party, Golisano Holdings, LLC, issued in March, 2016. statementnote1natureofoperationsandsummaryofsignificantaccountingpoliciesfinancialinstrumentsmeasuredatfairvalueonarecurringbasisdetails Related-Party Debt December 2016 Note Payable to Great Harbor Hospital, LLC [Member] Debt instrument from related-party, Great Harbor, LLC, issued in December, 2016. Related-Party Debt January 2016 Note payable to Golisano Holdings LLC [Member] Debt instrument with related party, Golisano Holdings, LLC, issued January, 2016. statementnote1natureofoperationsandsummaryofsignificantaccountingpoliciesbasicanddilutednetlosspercommonsharedetails statementnote1natureofoperationsandsummaryofsignificantaccountingpoliciesrestatementof2016dilutednetlosspersharedetails Long-term debt, net statementnote3inventoriessummaryofinventoriesdetails Other debt April 2016 Note Payable To JL-Utah Sub, LLC [Member] Debt instrument payable to JL-Utah Sub, LLC issued April, 2016. statementnote4propertyandequipmentsummaryofpropertyandequipmentdetails Related Part Debt July 2016 Note Payable To Golisano Holdings LLC [Member] Debt instrument with related party, Golisano Holdings, LLC, issued in July, 2016. statementnote5intangibleassetssummaryofintangibleassetsdetails Related Part Debt December 2016 Note Payable To Golisano Holdings LLC [Member] Debt instrument with related party, Golisano Holdings, LLC, issued in December, 2016. Capital lease obligations statementnote6debtsummaryofdebtdetails statementnote6debtsummaryofdebtdetailsparentheticals statementnote7warrantsandregistrationrightsagreementssummaryofthewarrantsissuedandchangesdetails tlcc_AllowanceForAccountsReceivableCurrentDoubtfulAccounts Allowance for Accounts Receivable, Current, Doubtful Accounts A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible due to doubtful accounts. statementnote8derivativeliabilitiesactivityinderivativeliabilitiesaccountdetails tlcc_NumberOfWarrantsExpired Number of Warrants Expired Number of warrants expired. Notes To Financial Statements Notes To Financial Statements [Abstract] Derivatives, Policy [Policy Text Block] tlcc_NumberOfWarrantsCancelled Number of Warrants Cancelled Number of warrants cancelled during the period. Nature of Operations [Policy Text Block] Disclosure of accounting policy for nature of operations. December 2016 GH Warrant [Member] Warrants issued in December of 2016 to GH. Organization [Policy Text Block] Disclosure of accounting policy for organization. Little Harbor July 2016 Warrant [Member] Warrants issued in July 2016 to Little Harbor. Golisano LLC December 2016 Warrant [Member] Warrants issued to Golisano, LLC in December 2016. Fair Value, Inputs, Level 2 [Member] August 2017 GH Warrant [Member] Warrants issued in August of 2017 to GH. Fair Value, Inputs, Level 1 [Member] Proceeds from the exercise of warrants Proceeds from Warrant Exercises Fair Value, Inputs, Level 3 [Member] Related Party August 2017 Note Payable to Great Harbor LLC [Member] Information related to the August 2017 note payable to Great Harbor LLC. Top Three Customers [Member] Represent the information pertaining to the top three customers of the company. Trademarks and Customer Relationships [Member] Represent the information pertaining to Trademarks and Customer Relationships. Fair Value Hierarchy [Domain] Fair Value, Hierarchy [Axis] Cash flows from investing activities: tlcc_WorkingCapitalDeficiency Working Capital Deficiency It represents working capital deficiency. One of Top Three Customers [Member] Represents the information pertaining to one of the top three customers of the company. Equity Component [Domain] Concentration Risk, Credit Risk, Policy [Policy Text Block] Equity Components [Axis] tlcc_SubscriptionReceivableAnnualInterestRate Subscription Receivable Annual Interest Rate This element represents the interest rate on subscription receivable. Computers and Other [Member] Represent the information pertaining to computers and other equipment. tlcc_CommonStockSubscriptionPricePerShare Common Stock Subscription Price Per Share This element represents the subscription price per share of common stock. Aquifer [Member] Represents information pertaining to Aquifer. Debt instrument, unamortized discount us-gaap_ComprehensiveIncomeNetOfTax Total comprehensive income (loss) Notes payable and long-term debt, net of current portion, unamortized discount Notes payable and current portion of long-term debt, unamortized discount Little Harbor [Member] Related to the entity Little Harbor. Preferred stock, shares outstanding (in shares) Use of Estimates, Policy [Policy Text Block] us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity New Accounting Pronouncements, Policy [Policy Text Block] JL [Member] Related to the entity JL. tlcc_PercentageOfUnusedLineFeePerMonth Percentage of Unused Line Fee Per Month The percentage fee for an unused line of credit, applied monthly. tlcc_PercentageOfManagementFeePerMonth Percentage of Management Fee Per Month The percentage of collateral applied to the line of credit as a management fee, per month. Weighted average shares oustanding - diluted (three months) (in shares) Weighted average number of common shares outstanding – diluted (2016 corrected - see Note 1) (in shares) Total shares for purpose of calculating diluted net loss per common share (in shares) Long-term debt Notes payable and long-term debt, net of current portion and discount of $2,102 and $3,451, respectively Accounts payable us-gaap_IncreaseDecreaseInAccountsPayable Gain (loss) on change in derivative liabilities (Gain) loss on change in derivative liabilities Loss on change in fair value of derivative liabilities Substantial Doubt about Going Concern [Text Block] Consolidation, Policy [Policy Text Block] Line of Credit Facility, Lender [Domain] Related Party [Axis] Senior Credit Facility With Midcap [Member] Related to the senior credit facility operated by Midcap. Diluted (in dollars per share) Net loss per common share – diluted (2016 corrected - see Note 1) (in dollars per share) Diluted net income (loss) per common share (three months) (in dollars per share) Lender Name [Axis] Related Party Debt November 2014 Note Payable to Golisano Holdings LLC (Formerly Penta Mezzanine SBIC Fund I, L.P.) [Member] Related to the note payable due to Golisano Holdings LLC (formerly Penta Mezzanine SBIC Fund I, L.P.) issued November 2014. Related Party [Domain] Related Party July 2014 Note Payable to Little Harbor, LLC, [Member] Related to the note payable held by Little Harbor issued July 2014. Computer Equipment [Member] Cash Cash at the beginning of the period Cash at the end of the period Related-Party Debt January 2015 Note Payable to Golisano Holdings LLC (Formerly Payable to JL-BBNC Mezz Utah, LLC) [Member] Related to the note payable held by Golisano Holdings LLC (formerly payable to JL-BBNC Mezz Utah, LLC) issued in January 2015. Scenario, Previously Reported [Member] Machinery and Equipment [Member] Total shares for purposes of calculating basic net loss per common share (in shares) Weighted average number of common shares outstanding – basic (in shares) Basic (in dollars per share) Net income (loss) per common share – basic (in dollars per share) Scenario, Unspecified [Domain] Scenario, Forecast [Member] Scenario [Axis] Schedule of Error Corrections and Prior Period Adjustments [Table Text Block] Debt Disclosure [Text Block] tlcc_ClassOfWarrantOrRightExpirationDate Class of Warrant or Right, Expiration Date Date the warrant or right expires, in CCYY-MM-DD format. us-gaap_ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt tlcc_ClassOfWarrantOrRightCancelledNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Cancelled, Number of Securities Called by Warrants or Rights Number of securities into which the class of warrant or right might be converted but have been cancelled. us-gaap_ConcentrationRiskPercentage1 Concentration Risk, Percentage Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block] Maximum [Member] Customer Concentration Risk [Member] Basis of Accounting, Policy [Policy Text Block] Range [Domain] Penta Mezzanine SBIC Fund I, L.P. [Member] Represents the entity of Penta Mezzanine SBIC Fund I, L.P., an institutional investor. Accrued expenses and other current liabilities us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Minimum [Member] us-gaap_TreasuryStockValue Treasury stock, 134,806,051 and 134,163,685 shares at cost, respectively Customer [Axis] Concentration Risk Type [Domain] Warrants Issued on January 22, 2015[Member] Represent the warrants issued on January 22, 2015. us-gaap_IncreaseDecreaseInOtherOperatingAssets Other assets Significant Accounting Policies [Text Block] Range [Axis] Customer [Domain] Accounting Policies [Abstract] tlcc_ClassOfWarrantOrRightMinimumRepurchasePriceUnderAgreement Class of Warrant or Right, Minimum Repurchase Price, Under Agreement The minimum repurchase price of warrants required by the agreement. Under the agreement, the Company has the right, under certain circumstances, to require Penta to sell to the Company all or any portion of the equity interest issued or represented by the warrant to acquire 4,960,740 shares. The price for such repurchase will be the greater of (i) the product of (x) eleven times the Company’s adjusted EBITDA with respect to the twelve months preceding the exercise of the call right times (y) the investor’s percentage ownership in the Company assuming full exercise of the warrant; or (ii) the fair market value of the equity interests underlying the warrant; or (iii) $3,750. Statement of Financial Position [Abstract] Concentration Risk Type [Axis] Golisano Warrants [Member] Related to warrants issued to Golisano. us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Prepaid expenses and other current assets Warrants Issued on June 30, 2015 [Member] Represent the warrants issued on June 30, 2015. Stockholders' Equity Note Disclosure [Text Block] Sales Revenue, Net [Member] Statement of Cash Flows [Abstract] Accounts Receivable [Member] us-gaap_LessorLeasingArrangementsOperatingLeasesTermOfContract Lessor, Operating Lease, Term of Contract Huntington Holdings, LLC [Member] Represents the entity of Huntington Holdings, LLC. Midcap Funding X Trust [Member] Represents the entity of Midcap Funding X Trust. Derivatives and Fair Value [Text Block] March 2016 Golisano Warrant [Member] Related to warrants issued to Golisano in March 2016. us-gaap_ProceedsFromNotesPayable Proceeds from Notes Payable Warrants Issued on February 4, 2015 [Member] Represent the warrants issued on February 4, 2015. Concentration Risk Benchmark [Domain] JL-BBNC Mezz Utah, LLC [Member] Represents the entity of JL-BBNC Mezz Utah, LLC. Concentration Risk Benchmark [Axis] January 2016 Golisano Warrant [Member] Related to the warrants issued to Golisano in January 2016. Golisano Holdings LLC [Member] Represents the entity of Golisano Holdings LLC, a related party of the company. Great Harbor Capital, LLC [Member] Represents the entity of Great Harbor Capital, LLC, an entity owned by certain stockholders of the company. JL Properties, Inc. [Member] Represents the entity of JL Properties, Inc. First Warrant [Member] Represents the first of the warrants granted to a counterparty at the same days. JL Warrants [Member] Related to the JL warrants. SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING TRANSACTIONS: tlcc_CommonStockSharesSubscribedButUnissuedReturn Common Stock, Shares Subscribed but Unissued, Return Represents the return of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. tlcc_AdjustmentsOnWarrantsTriggerEventMaximumAdjustedEBITDA Adjustments on Warrants Trigger Event, Minimum Adjusted EBITDA The minimum adjusted EBITDA required by the agreement otherwise would trigger the adjustments of warrants term. us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross Essex Capital Corporation [Member] Represents the entity of Essex Capital Corporation, a California corporation and a related party of the company. Second Warrant [Member] Represents the second of the warrants granted to a counterparty at the same day. Net borrowings from revolving credit facility Unsecured Promissory Note with Huntington Holdings, LLC [Member] Represents information about the unsecured promissory note with Huntington Holdings, LLC. us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable tlcc_ReliefOfStockSubscriptionAccrualThroughLongTermDebt Relief of stock subscription accrual through long-term debt The amount represents the relief of stock subscription accrual through long-term debt. Warrants Disclosure [Text Block] The entire disclosure for information about warrants. Issuance of new long-term debt as payment of existing stock subscription accrual Amount represents the issuance of new long-term debt as a payment of existing prepaid stock subscription. us-gaap_LiabilitiesNoncurrent Total long-term liabilities tlcc_CommonStockSharesSubscribedButUnissuedOptionToPurchaseShares Common Stock, Shares Subscribed but Unissued, Option to Purchase Shares Represents the number of options to purchase shares subscribed but unissued. tlcc_CommonStockSharesSubscribedButUnissuedOptionToPurchaseSharePrice Common Stock, Shares Subscribed but Unissued, Option to Purchase Shares Price Represents the amount of option to purchase shares subscribed but unissued. Proceeds from the issuance of debt Fair Value, Assets Measured on Recurring Basis [Table Text Block] us-gaap_RepaymentsOfDebt Repayment of debt us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (loss) before income taxes Deferred tax liability us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and stockholders' equity (deficit) Trademarks [Member] us-gaap_IncomeTaxExpenseBenefit Provision for income taxes Accumulated deficit Retained Earnings (Accumulated Deficit) Other Intangible Assets [Member] Net sales Granted (in shares) The number of securities called by warrants or rights that are granted during the period. us-gaap_PolicyTextBlockAbstract Accounting Policies tlcc_ClassOfWarrantOrRightExercisedDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Exercised During Period, Number of Securities Called by Warrants or Rights Exercised (in shares) The number of securities called by warrants or rights which exercised during the period. us-gaap_IncreaseDecreaseInInventories Inventories Granted, , weighted average exercise price (in dollars per share) Exercise price per share or per unit of warrants or rights granted during the period. tlcc_ClassOfWarrantOrRightCancelledDuringPeriodNumberOfSecuritiesCalledByWarrantsOrRights Canceled / Expired (in shares) The number of securities called by warrants or rights which are cancelled during during the period. Canceled / expired, , weighted average exercise price (in dollars per share) Exercise price per share or per unit of warrants or rights canceled during the period. Exercised, weighted average exercise price (in dollars per share) Exercise price per share or per unit of warrants or rights exercised during the period. TCC Plan [Member] Represents the Twinlab Consolidation Corporation 2013 Stock Incentive Plan, a plan was assumed by the company on September 16, 2014. Credit Facility [Domain] Statement [Table] Revolving Credit Facility [Member] Credit Facility [Axis] Cash flows from financing activities: Income Statement [Abstract] Class of Stock [Axis] Award Type [Axis] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Equity Award [Domain] Customer Relationships [Member] Schedule of Derivative Liabilities at Fair Value [Table Text Block] us-gaap_NotesPayableToBankNoncurrent Notes Payable to Bank, Noncurrent February 2015 Note Payable to Golisano Holdings LLC (Formerly Payable to Penta Mezzanine SBIC Fund I, L.P.) [Member] Related to the note payable held by Golisano Holdings LLC (formerly payable to JL-BBNC Mezz Utah, LLC) issued in February 2015. Finite-Lived Intangible Assets, Major Class Name [Domain] Fair Value of Financial Instruments, Policy [Policy Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Sale Leaseback Transactions, Policy [Policy Text Block] Decrease in derivative liabilities and increase in common stock and additional paid-in capital on exercise of warrants Amount of decrease in derivative liabilities and increase in additional paid-in capital on exercise of warrants in a non cash activities. Issuance of other liability for purchase of treasury shares Amount represents issuance of other liability purchase of treasury shares in non cash activities. Loss on stock purchase price guarantee tlcc_LossOnStockPurchaseGuarantees Loss on Stock Purchase Guarantees Loss on stock purchase guarantee The loss recognized on stock purchase guarantees. Prepaid expenses and other current assets us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Issuance of long-term debt The fair value of long term debt issued in noncash investing and financing activities. Long-term liabilities: us-gaap_LiabilitiesCurrent Total current liabilities tlcc_NumberOfMajorCustomers Number of Major Customers Represents the number of major customers. Schedule of Debt [Table Text Block] us-gaap_NonoperatingIncomeExpense Total other income (expense) Earnings Per Share, Policy [Policy Text Block] Fair Value, Measurements, Recurring [Member] Other income (expense), net Fair Value, Measurement Frequency [Domain] Measurement Frequency [Axis] Changes in operating assets and liabilities: Property, Plant and Equipment [Table Text Block] tlcc_AmortizationOfDeferredGainOnSaleOfAssets Amortization of Deferred Gain on Sale of Assets The amount of amortization of deferred gain on the sale of assets recorded against rental expense. Property, Plant and Equipment Disclosure [Text Block] Derivative liabilities us-gaap_WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure Other income (expense): us-gaap_OperatingIncomeLoss Loss from operations Schedule of Inventory, Current [Table Text Block] Inventory Disclosure [Text Block] Fair Value of Warrants Issued, Policy [Policy Text Block] Disclosure of accounting policy for fair value of warrants issued with debt. us-gaap_GrossProfit Gross profit Treasury stock, shares (in shares) us-gaap_DebtCurrent Less current portion Amendment Flag Provision for obsolete inventory Notes payable and current portion of long-term debt, net of discount of $1,871 and $2,297, respectively Long-term Debt, Current Maturities Common stock, $0.001 par value, 5,000,000,000 shares authorized, 387,730,078 shares issued Common stock, shares authorized (in shares) us-gaap_LesseeLeasingArrangementsOperatingLeasesTermOfContract Lessee, Operating Lease, Term of Contract Common stock, shares issued (in shares) Other assets Common stock, par value (in dollars per share) us-gaap_CommonStockSharesSubscribedButUnissued Common Stock, Shares Subscribed but Unissued Stock-based compensation us-gaap_GainLossOnSaleOfPropertyPlantEquipment Other non-cash items Short-term Debt, Type [Domain] us-gaap_CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance Current Fiscal Year End Date Notes Payable, Other Payables [Member] Short-term Debt, Type [Axis] us-gaap_CommonStockShareSubscribedButUnissuedSubscriptionsReceivable Common Stock, Share Subscribed but Unissued, Subscriptions Receivable Stock subscriptions receivable Document Fiscal Period Focus Amortization of debt discount Document Fiscal Year Focus Document Period End Date Preferred stock, $0.001 par value, 500,000,000 shares authorized, no shares issued and outstanding us-gaap_FiniteLivedIntangibleAssetUsefulLife Finite-Lived Intangible Asset, Useful Life Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Document Type Accrued expenses and other current liabilities Depreciation and amortization Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Accounts payable Document Information [Line Items] Document Information [Table] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share us-gaap_Depreciation Depreciation us-gaap_AssetsCurrent Total current assets Long-term Debt, Type [Axis] Entity Filer Category Entity Current Reporting Status Counterparty Name [Domain] Schedule of Finite-Lived Intangible Assets [Table Text Block] Entity Voluntary Filers Counterparty Name [Axis] Long-term Debt, Type [Domain] Entity Well-known Seasoned Issuer Related-party Debt March 2017 Note payable to Golisano Holdings LLC [Member] Debt instrument with related party, Golisano Holdings, LLC, issued March 31, 2017. Common stock warrants (in shares) Related Party Debt July 2016 Note Payable to Little Harbor LLC [Member] Notes payable to related party issued in July 2016. Intangible Assets Disclosure [Text Block] us-gaap_AmortizationOfIntangibleAssets Amortization of Intangible Assets Golisano LLC March 2017 Warrant [Member] Warrants issued to Golisano LLC in March 2017. Adjustments to reconcile net income (loss) to net cash used in operating activities: Entity Central Index Key Entity Registrant Name Entity [Domain] Legal Entity [Axis] Class of Warrant or Right [Domain] Class of Warrant or Right [Axis] us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights Outstanding, weighted average exercise price (in dollars per share) Outstanding, weighted average exercise price (in dollars per share) us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights Outstanding, beginning balance (in shares) Outstanding, ending balance (in shares) Current liabilities: Entity Common Stock, Shares Outstanding (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Cash paid for income taxes Cash paid for interest Interest Paid us-gaap_DepositsAssets Deposits Assets Additional paid-in capital us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted Total net loss for purpose of calculating diluted net loss per common share us-gaap_Assets Total assets tlcc_StockPriceGuaranteePayment Stock Price Guarantee Payment Represents the amount of stock price guarantee payment. Common stock warrants Inventories, net Stockholders’ equity (deficit): Revenue Recognition, Policy [Policy Text Block] Work in process Unsecured Promissory Note [Member] Represents information about unsecured promissory note. Trading Symbol us-gaap_InventoryValuationReserves Reserve for obsolete inventory Finished goods us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchase of property and equipment us-gaap_InventoryGross Net income (loss) us-gaap_StockholdersEquity Total stockholders’ equity (deficit) Plan Name [Axis] Provision for losses on accounts receivable Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Selling, general and administrative expenses us-gaap_DebtInstrumentTerm Debt Instrument, Term Plan Name [Domain] Goodwill and Intangible Assets, Policy [Policy Text Block] Raw materials Commitments and contingencies us-gaap_Liabilities Total liabilities Property and equipment acquired through the issuance of capital leases Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Restricted Stock Units (RSUs) [Member] Cost of sales Intangible assets, net Cash flows from operating activities: us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization Accumulated amortization us-gaap_NotesReduction Repayment of short-term debt Intangible assets Accounts receivable, allowance Allowance for Doubtful Accounts Receivable, Current Accounts receivable, net of allowance of $2,777 and $2,365, respectively Statement [Line Items] Derivative liabilities us-gaap_DerivativeLiabilities Derivative Liability Derivative liabilities Derivative liabilities us-gaap_InterestExpense Interest expense, net SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) us-gaap_PropertyPlantAndEquipmentUsefulLife Property, Plant and Equipment, Useful Life us-gaap_DebtInstrumentMaturityDate Debt Instrument, Maturity Date us-gaap_DebtInstrumentDateOfFirstRequiredPayment1 Debt Instrument, Date of First Required Payment Goodwill us-gaap_DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment Property and equipment, net Current assets: us-gaap_DebtInstrumentPeriodicPaymentPrincipal Debt Instrument, Periodic Payment, Principal us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated depreciation and amortization Property and equipment Furniture and Fixtures [Member] us-gaap_CapitalLeasedAssetsGross Capital Leased Assets, Gross us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by financing activities us-gaap_DebtInstrumentBasisSpreadOnVariableRate1 Debt Instrument, Basis Spread on Variable Rate us-gaap_DebtInstrumentInterestRateIncreaseDecrease Debt Instrument, Interest Rate, Increase (Decrease) us-gaap_DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage Unsecured Delayed Draw Promissory Note [Member] Unsecured delayed draw promissory notes. us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Net increase (decrease) in cash Leasehold Improvements [Member] us-gaap_TableTextBlock Notes Tables Property, Plant and Equipment, Type [Domain] Property, Plant and Equipment, Type [Axis] tlcc_StockIssuedDuringPeriodValueWarrantsExercised Stock Issued During Period Value Warrants Exercised Value of stock issued as a result of the exercise of warrants. us-gaap_DebtInstrumentFeeAmount Debt Instrument, Fee Amount Property, Plant and Equipment, Policy [Policy Text Block] us-gaap_DebtInstrumentFaceAmount Debt Instrument, Face Amount tlcc_StockIssuedDuringPeriodSharesWarrantsExercised Stock Issued During Period Shares Warrants Exercised Total number of shares issued as a result of the warrant exercised. tlcc_LineOfCreditFacilityPotentialMaximumBorrowingCapacity Line of Credit Facility, Potential Maximum Borrowing Capacity The potential maximum borrowing capacity under a line of credit facility. Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] January, 2015 Note Payable to JL-BBNC Mezz Utah, LLC [Member] Represents the note payable to JL-BBNC Mezz Utah, LLC issued in January, 2015. tlcc_DebtInstrumentObligationTerminationStockPriceTrigger Debt Instrument, Obligation Termination, Stock Price Trigger The trailing ninety day volume weighted average closing price of the entity's common stock which would be required to be attained in order to terminate payment obligations Inventory, Policy [Policy Text Block] EX-101.PRE 11 tlcc-20170930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.8.0.1
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2017
Nov. 14, 2017
Document Information [Line Items]    
Entity Registrant Name Twinlab Consolidated Holdings, Inc.  
Entity Central Index Key 0001590695  
Trading Symbol tlcc  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Entity Current Reporting Status Yes  
Entity Voluntary Filers No  
Entity Well-known Seasoned Issuer No  
Entity Common Stock, Shares Outstanding (in shares)   252,924,027
Document Type 10-Q  
Document Period End Date Sep. 30, 2017  
Document Fiscal Year Focus 2017  
Document Fiscal Period Focus Q3  
Amendment Flag false  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2017
Dec. 31, 2016
Current assets:    
Cash $ 2,233,000 $ 5,097,000
Accounts receivable, net of allowance of $2,777 and $2,365, respectively 8,737,000 7,768,000
Inventories, net 18,368,000 17,601,000
Prepaid expenses and other current assets 2,238,000 2,870,000
Total current assets 31,576,000 33,336,000
Property and equipment, net 3,240,000 3,528,000
Intangible assets, net 28,450,000 30,197,000
Goodwill 24,098,000 24,098,000
Other assets 1,768,000 1,667,000
Total assets 89,132,000 92,826,000
Current liabilities:    
Accounts payable 4,607,000 7,866,000
Accrued expenses and other current liabilities 10,266,000 11,434,000
Derivative liabilities 8,143,000 6,455,000
Notes payable and current portion of long-term debt, net of discount of $1,871 and $2,297, respectively 17,091,000 11,631,000
Total current liabilities 40,107,000 37,386,000
Long-term liabilities:    
Deferred gain on sale of assets 1,606,000 1,727,000
Deferred tax liability 959,000 959,000
Notes payable and long-term debt, net of current portion and discount of $2,102 and $3,451, respectively 57,162,000 50,988,000
Total long-term liabilities 59,727,000 53,674,000
Total liabilities 99,834,000 91,060,000
Commitments and contingencies
Stockholders’ equity (deficit):    
Preferred stock, $0.001 par value, 500,000,000 shares authorized, no shares issued and outstanding 0 0
Common stock, $0.001 par value, 5,000,000,000 shares authorized, 387,730,078 shares issued 388,000 388,000
Additional paid-in capital 226,766,000 226,380,000
Stock subscriptions receivable (30,000) (30,000)
Treasury stock, 134,806,051 and 134,163,685 shares at cost, respectively (500,000) (500,000)
Accumulated deficit (237,326,000) (224,472,000)
Total stockholders’ equity (deficit) (10,702,000) 1,766,000
Total liabilities and stockholders' equity (deficit) $ 89,132,000 $ 92,826,000
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Accounts receivable, allowance $ 2,777 $ 2,365
Notes payable and current portion of long-term debt, unamortized discount 1,871 2,297
Notes payable and long-term debt, net of current portion, unamortized discount $ 2,102 $ 3,451
Preferred stock, par value (in dollars per share) $ 0.001 $ 0.001
Preferred stock, shares authorized (in shares) 500,000,000 500,000,000
Preferred stock, shares issued (in shares) 0 0
Preferred stock, shares outstanding (in shares) 0 0
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 5,000,000,000 5,000,000,000
Common stock, shares issued (in shares) 387,730,078 387,730,078
Treasury stock, shares (in shares) 134,806,051 134,163,685
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Net sales $ 20,612 $ 23,046 $ 66,130 $ 65,885
Cost of sales 17,103 15,963 50,368 49,405
Gross profit 3,509 7,083 15,762 16,480
Selling, general and administrative expenses 6,646 7,760 20,574 26,249
Loss from operations (3,137) (677) (4,812) (9,769)
Other income (expense):        
Interest expense, net (1,876) (2,423) (6,318) (6,530)
Loss on stock purchase guarantee (3,210)
Gain (loss) on change in derivative liabilities (393) 14,065 (1,688) 28,128
Other income (expense), net (12) 3 (36) (18)
Total other income (expense) (2,281) 11,645 (8,042) 18,370
Income (loss) before income taxes (5,418) 10,968 (12,854) 8,601
Provision for income taxes (17)
Total comprehensive income (loss) $ (5,418) $ 10,968 $ (12,854) $ 8,584
Weighted average number of common shares outstanding – basic (in shares) 252,924,027 250,806,152 252,935,792 264,740,245
Net income (loss) per common share – basic (in dollars per share) $ (0.02) $ 0.04 $ (0.05) $ 0.03
Weighted average number of common shares outstanding – diluted (2016 corrected - see Note 1) (in shares) 252,924,027 264,224,781 252,935,792 277,221,732
Net loss per common share – diluted (2016 corrected - see Note 1) (in dollars per share) $ (0.02) $ (0.01) $ (0.05) $ (0.07)
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net income (loss) $ (12,854) $ 8,584
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 2,416 2,212
Amortization of debt discount 1,774 2,717
Stock-based compensation 386 540
Provision for obsolete inventory 466 1,194
Provision for losses on accounts receivable 167 267
Loss on stock purchase price guarantee 3,210
(Gain) loss on change in derivative liabilities 1,688 (28,128)
Other non-cash items (121) (124)
Changes in operating assets and liabilities:    
Accounts receivable (1,136) (2,293)
Inventories (1,233) (4,044)
Prepaid expenses and other current assets 632 (1,113)
Other assets (101) 63
Accounts payable (3,259) (5,241)
Accrued expenses and other current liabilities 2,032 1,621
Net cash used in operating activities (9,143) (20,535)
Cash flows from investing activities:    
Purchase of property and equipment (51) (119)
Cash flows from financing activities:    
Proceeds from the exercise of warrants 1
Proceeds from the issuance of debt 6,267 22,089
Repayment of debt (1,583) (2,973)
Net borrowings from revolving credit facility 1,646 3,342
Net cash provided by financing activities 6,330 22,459
Net increase (decrease) in cash (2,864) 1,805
Cash at the beginning of the period 5,097 1,240
Cash at the end of the period 2,233 3,045
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid for interest 982 3,818
Cash paid for income taxes 27
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING TRANSACTIONS:    
Decrease in derivative liabilities and increase in common stock and additional paid-in capital on exercise of warrants 1,975
Issuance of other liability for purchase of treasury shares 500
Relief of stock subscription accrual through long-term debt (3,200)
Issuance of new long-term debt as payment of existing stock subscription accrual 3,200
Property and equipment acquired through the issuance of capital leases 330
Repayment of short-term debt (2,589)
Issuance of long-term debt $ 2,589
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 1 - Nature of Operations and Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Significant Accounting Policies [Text Block]
NOTE
1
– NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Organization
Twinlab Consolidated Holdings, Inc. (the “Company”
, “Twinlab,” “we,” “our” and “us”) was incorporated on
October 24, 2013
under the laws of the State of Nevada as Mirror Me, Inc. On
August 7, 2014,
we amended our articles of incorporation and changed our name to Twinlab Consolidated Holdings, Inc.
 
Nature of Operations
We are
an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty stores retailers, on-line retailers and websites. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers.
 
Our
products include vitamins, minerals, specialty supplements and sports nutrition products sold under the Twinlab® brand name (including the Twinlab® Fuel brand of sports nutrition products); a market leader in the healthy aging and beauty from within categories sold under the Reserveage™ Nutrition and ResVitale® brand names; diet and energy products sold under the Metabolife® brand name; the Re-Body® brand name; and a full line of herbal teas sold under the Alvita® brand name. To accommodate consumer preferences, our products come in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, sprays and powders. These products are sold primarily through health and natural food stores and on-line retailers, supermarkets, and mass-market retailers.
 
We also perform contract manufacturing services for private label products.
  Our contract manufacturing business involves the manufacture of custom products to the specifications of a customer who requires finished product under the customer’s own brand name.  We do
not
market these private label products as our business is to manufacture and sell the products to the customer, who then markets and sells the products to retailers or end consumers.
 
Principles of Consolidation
The
condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
 
Basis of Presentation and Unaudited Information
The condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with United States generally accepted accounting principles, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).
Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures are adequate to make the information presented
not
misleading. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management, are necessary for fair presentation of the information contained herein. Financial results for any interim period are
not
necessarily indicative of financial results that
may
be expected for the fiscal year. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form
10
-K for the year ended
December 31, 2016
filed with the SEC on
March 31, 2017.
 
Use of Estimates
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant management estimates include those with respect to returns and allowances, allowance for doubtful accounts, reserves for inventory obsolescence, the recoverability of long-lived assets, intangibles and goodwill and the estimated value of warrants and derivative liabilities.
 
Revenue Recognition
Revenue from product sales, net of estimated returns and allowances, is recognized when evidence of an arrangement is in place, related prices are fixed and determinable, contractual obligations have been satisfied, title and risk of loss have been transferred to the customer and collection of the resulting receivable is reasonably assured. Shipping terms are generally
freight on board shipping point. We sell predominately in the North American and European markets, with international sales transacted in U.S. dollars.
 
Fair
V
alue of
F
inancial
I
nstruments
We apply the following fair value hierarchy, which prioritizes the inputs used to measure fair value into
three
levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
 
Level
1
– inputs are quoted prices in active markets for identical assets that the reporting entity has the ability to access at the measurement date.
 
Level
2
– inputs are other than quoted prices included within Level
1
that are observable for the asset, either directly or indirectly.
 
Level
3
– inputs are unobservable inputs for the asset that are supported by little or
no
market activity and that are significant to the fair value of the underlying asset or liability.
 
The following table summarizes our financial instruments that are measured at fair value on a recurring basis as of
September 30, 2017
and
December 31, 2016:
 
September 30, 2017
 
Total
   
Level 1
   
Level 2
   
Level 3
 
                                 
Derivative liabilities
  $
8,143
    $
-
    $
-
    $
8,143
 
 
December 31, 2016
 
Total
   
Level 1
   
Level 2
   
Level 3
 
                                 
Derivative liabilities
  $
6,455
    $
-
    $
-
    $
6,455
 
 
 
Accounts Receivable and Allowances
We
grant credit to customers and generally do
not
require collateral or other security. We perform credit evaluations of our customers and provide for expected claims related to promotional items; customer discounts; shipping shortages; damages; and doubtful accounts based upon historical bad debt and claims experience. As of
September 30, 2017,
total allowances amounted to
$2,777,
of which
$314
was related to doubtful accounts receivable. As of
December 31, 2016,
total allowances amounted to
$2,365,
of which
$481
was related to doubtful accounts receivable.
 
Inventories
Inventories are stated at the
lower of cost or net realizable value and are reduced by an estimated reserve for obsolete inventory.
 
Property and Equipment
Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation, including amounts amortized under capital leases, is calculated on the straight-line method over the estimated useful lives of the related assets, which are
7
to
10
years for machinery and equipment,
8
years for furniture and fixtures and
3
years for computers. Leasehold improvements are amortized over the shorter of the useful life of the asset or the term of the lease.
 
 
Normal repairs and maintenance are expensed as incurred. When assets are retired or otherwise disposed of, the related cost and accumulated depreciation or amortization is removed from the accounts and any gain or loss is included in the results of operations.
 
Intangible Assets
Intangible assets consist primarily of trademarks and customer relationships, which are amortized on a straight-line basis over their estimated useful lives ranging from
3
to
30
years. The valuation and classification of these assets and the assignment of amortizable lives involve significant judgment and the use of estimates.
 
We believe that our long-term growth strategy supports our fair value conclusions. For intangible assets, the recoverability of these amounts is dependent upon achievement of our projections and the execution of key initiatives related to revenue growth and improved profitability.
 
Goodwill
Goodwill is
not
subject to amortization, but is reviewed for impairment annually, or more frequently whenever events or changes in circumstances indicate the carrying value of goodwill
may
not
be recoverable. An impairment charge would be recorded to the extent the carrying value of goodwill exceeds its estimated fair value. The testing of goodwill under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.
 
Impairment of Long-Lived Assets
Long-lived assets, including intangible assets subject to amortization, are reviewed for impairment when changes in circumstances indicate that the carrying amount of the asset
may
not
be recoverable. If the carrying amount of the asset exceeds the expected undiscounted cash flows of the asset, an impairment charge is recognized equal to the amount by which the carrying amount exceeds fair value. The testing of these intangibles under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.
 
Indefinite-Lived Intangible Assets
Indefinite-lived intangible assets relating to the asset acquisition of Organic Holdings
, LLC (“Organic Holdings”), a market leader in the healthy aging and beauty from within categories and owner of the award-winning Reserveage
™ Nutrition brand, are determined to have an indefinite useful economic life and as such are
not
amortized. Indefinite-lived intangible assets are tested for impairment annually which consists of a comparison of the fair value of the asset with its carrying value. The total indefinite-lived intangible assets as of
September 30, 2017
and
December 31, 2016
was
$5,900
.
 
Value of Warrants Issued with Debt
We estimate the grant date value of certain warrants issued with debt, using an outside professional valuation firm, which uses the
Monte Carlo option lattice model. We record
the amounts as interest expense or debt discount, depending on the terms of the agreement. These estimates involve multiple inputs and assumptions, including the market price of the Company’s common stock, stock price volatility and other assumptions to project
earnings before interest, taxes, depreciation and amortization (“EBITDA”) and other reset events. These inputs and assumptions are subject to management’s judgment and can vary materially from period to period.
 
Derivative Liabilities
We have recorded certain warrants as derivative liabilities at estimated fair value, as determined based on our use of an outside professional valuation firm, due to the variable terms of the warrant agreements.
The value of the derivative liabilities is generally estimated using the Monte Carlo option lattice model with multiple inputs and assumptions, including the market price of the Company’s common stock, stock price volatility and other assumptions to project EBITDA and other reset events. These inputs and assumptions are subject to management’s judgment and can vary materially from period to period.
 
Deferred gain on sale of assets
We
entered into a sale-leaseback arrangement relating to our office facilities in
2013.
Under the terms of the arrangement, we sold an office building and surrounding land and then leased the property back under a
15
-year operating lease. We recorded a deferred gain for the amount of the gain on the sale of the asset, to be recognized as a reduction of rent expense over the life of the lease. Accordingly, we recorded amortization of deferred gain as a reduction of rental expense of
$40
and
$41
for the
three
months ended
September 30, 2017
and
2016,
respectively. For the
nine
months ended
September 30, 2017
and
2016,
we recorded amortization of
$121
and
$122,
respectively. As of
September 30, 2017
and
December 31, 2016,
unamortized deferred gain on sale of assets was
$1,606
and
$1,727,
respectively.
 
Net Loss per Common Share
Basic net income or loss per common share (Basic EPS) is computed by dividing net income or loss by the weighted average number of common shares outstanding.
Diluted net income or loss per common share (Diluted EPS) is computed by dividing net income or loss by the sum of the weighted average number of common shares outstanding and the dilutive potential common shares then outstanding. Potential dilutive common share equivalents consist of total shares issuable upon the exercise of outstanding stock options and warrants to acquire common stock using the treasury stock method and the average market price per share during the period.
The common shares used in the computation of our basic and diluted net loss per share are reconciled as follows:
 
   
Three Months Ended
 
Nine Months Ended
 
   
September 30,
 
September 30,
 
   
2017
   
2016
     
2017
   
2016
 
           
(as corrected)
             
(as corrected)
 
Numerator:
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
Net income (loss)
  $
(5,418
)   $
10,968
      $
(12,854
)   $
8,584
 
Effect of dilutive securities on net income (loss):
                                 
Common stock warrants
   
-
     
(14,065
)      
-
     
(28,128
)
                                   
Total net loss for purpose of calculating diluted net loss per common share
  $
(5,418
)   $
(3,097
)     $
(12,854
)   $
(19,544
)
                                   
Number of shares used in per common share calculations:
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
Total shares for purposes of calculating basic net loss per common share
   
252,924,027
     
250,806,152
       
252,935,792
     
264,740,245
 
Weighted-average effect of dilutive securities:
                                 
Common stock warrants
   
-
     
13,418,629
       
-
     
12,481,487
 
                                   
Total shares for purpose of calculating diluted
net loss per common share
   
252,924,027
     
264,224,781
       
252,935,792
     
277,221,732
 
                                   
Net income (loss) per common share:
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
Basic
  $
(0.02
)   $
0.04
      $
(0.05
)   $
0.03
 
Diluted
  $
(0.02
)   $
(0.01
)     $
(0.05
)   $
(0.07
)
 
 
Correction
of
2016
Diluted Net Loss Per Share
The diluted net loss per share for the period ended
September 30, 2016
has been corrected. In accordance with U.S. generally accepted accounting principles, when calculating diluted earnings or loss per share, if the effects are dilutive, companies are required to add back to net income or loss the effects of the change in derivative liabilities related to warrants. Additionally, if the effects of the change in derivative liabilities are added back to net income or loss, companies are required to include the warrants outstanding related to the derivative liability in the calculation of the weighted average dilutive shares.
 
For the period ended
September 30, 2016,
as originally reported, we did
not
add back the effects of the change in the derivative liability in computing dilutive income or loss per share. The dilutive loss per share for the
three
and
nine
months ended
September 30, 2016
in the table above has been revised to correct this error.
 
The table below reflects the diluted net
loss per share as originally reported and net loss per share as corrected for the
three
and
nine
months ended
September 30, 2016.
 
   
As originally reported
   
As corrected
 
                 
Diluted net income (loss) per common share (three months)
  $
0.04
    $
(0.01
)
Diluted net income (loss) per common share (nine months)
  $
0.03
    $
(0.07
)
Weighted average shares oustanding - diluted (three months)
   
258,565,687
     
264,224,781
 
Weighted average shares oustanding - diluted (nine months)
   
275,633,914
     
277,221,732
 
 
 
The errors were corrected as of
December 31, 2016,
but since the adjustments were
not
material to any of the quarters
previously reported, the Form
10
-Qs for those periods were
not
amended. Management has determined the effects to be neither quantitatively or qualitatively material to the financial statements included in any of the Form
10
-Qs filed during
2016.
 
Significant Concentration of Credit Risk
Sales to our top
three
customers a
ggregated to approximately
33%
and
25%
of total sales for the
three
months ended
September 30, 2017
and
2016,
respectively, and
27%
and
26%
of total sales for the
nine
months ended
September 30, 2017
and
2016,
respectively. Sales to
one
of those customers were approximately
13%
and
11%
of total sales for the
three
months ended
September 30, 2017
and
2016,
respectively, and
12%
and
11%
of total sales for the
nine
months ended
September 30, 2017
and
2016,
respectively. Accounts receivable from these customers were approximately
55%
and
29%
of total accounts receivable as of
September 30, 2017
and
December 31, 2016,
respectively.
 
Recent Accounting Pronouncements
In
May
2017,
FASB amended its guidance regarding the scope of modification accounting for share-based compensation arrangements. The amendments provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic
718.
For public entities, the amendments in this update are effective for fiscal years beginning after
December 
15,
2017,
including interim periods within those fiscal years, with early adoption permitted. The amendments in this update should be applied prospectively to an award modified on or after the adoption date.
We do
not
expect the new guidance to have a significant impact on our condensed consolidated financial statements or related disclosures.
 
In
January 2017,
FASB issued ASU
No.
2017
-
04,
“Simplifying the Test for Goodwill Impairment (Topic
350
)” which removes Step
2
of the goodwill impairment test that requires a hypothetical purchase price allocation.  A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value,
not
to exceed the carrying amount of goodwill.  The amendments in this ASU are effective for fiscal years beginning after
December 15, 2019.  
Early adoption is permitted after
January 1, 2017.  
We do
not
expect the new guidance to have a significant impact on our condensed consolidated financial statements or related disclosures.
 
In
February 2016,
FASB issued ASU
No
.
2016
-
02,
“Leases (Topic
842
)”. The amendments in this ASU revise the accounting related to lessee accounting. Under the new guidance, lessees will be required to recognize a lease liability and a right-of-use asset for all leases with terms greater than
12
months affecting the pattern of expense recognition in the income statement. Leases previously defined as operating leases will be defined as financing leases and capitalized if the term is greater than
one
year. The amendments in this ASU are effective for fiscal years beginning after
December 15, 2018
and are to be applied through a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Early adoption is permitted. We are performing an assessment of our leases and have begun preparations for implementation and retrospective application to the earliest reporting period. As a result, financing leases will be recorded as an asset and a corresponding liability at the present value of the total lease payments. The asset will be decremented over the life of the lease on a pro-rata basis resulting in lease expense while the liability will be decremented using the interest method (ie. principal and interest). As such, we expect the new guidance will materially impact the asset and liability balances of our consolidated financial statements and related disclosures at the time of adoption.
 
Although there are several other new accounting pronouncements issued or proposed by FASB, which we have adopted or will adopt, as applicable, we do
not
believe any of these accounting pronouncements has had or will have a material impact on our
condensed consolidated financial position or results of operations.
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 2 - Going Concern
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Substantial Doubt about Going Concern [Text Block]
NOTE
2
– GOING CONCERN
 
The accompanying
condensed consolidated financial statements have been prepared on a going concern basis, which assumes continuity of operations and realization of assets and liabilities in the ordinary course of business. In most periods since our formation, we have generated losses from operations. At
September 30, 2017,
we had an accumulated deficit of
$237,326.
Historical losses are primarily attributable to lower than planned sales resulting from low fill rates on demand due to limitations of our working capital, delayed product introductions and postponed marketing activities, merger-related and other restructuring costs, and interest and refinancing charges associated with our debt refinancing. Losses have been funded primarily through issuance of common stock and
third
-party or related party debt.
 
Because of
our history of operating losses, significant interest expense on our debt, and the recording of significant derivative liabilities, we have a working capital deficiency of
$8,531
at
September 30, 2017.
We also have
$17,091
of debt, net of discount, due within the next
12
months. These continuing conditions, among others, raise substantial doubt about our ability to continue as a going concern.
 
Management has addressed operating issues through the following actions: focusing on growing the core business and brands; continuing emphasis on major customers and key products; reducing manufacturing and operating costs and continuing to negotiate lower prices from major suppliers.
We believe that we
may
need additional capital to execute our business plan. If additional funding is required, there can be
no
assurance that sources of funding will be available when needed on acceptable terms or at all.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 3 - Inventories
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Inventory Disclosure [Text Block]
NOTE
3
– INVENTORIES
 
Inventories
consisted of the following at:
 
   
September 30,
   
December 31,
 
   
2017
   
2016
 
                 
Raw materials
  $
6,348
    $
4,912
 
Work in process
   
2,013
     
1,189
 
Finished goods
   
12,411
     
13,438
 
     
20,772
     
19,539
 
Reserve for obsolete inventory
   
(2,404
)    
(1,938
)
    $
18,368
    $
17,601
 
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 4 - Property and Equipment
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Property, Plant and Equipment Disclosure [Text Block]
NOTE
4
– PROPERTY AND EQUIPMENT
 
Property and equipment consisted of the following at:
 
   
September 30,
   
December 31,
 
   
2017
   
2016
 
                 
Machinery and equipment
  $
12,156
    $
10,885
 
Computers and other
   
9,500
     
9,119
 
Aquifer
   
482
     
482
 
Leasehold improvements
   
1,518
     
1,518
 
     
23,656
     
22,004
 
Accumulated depreciation and amortization
   
(20,416
)    
(18,476
)
    $
3,240
    $
3,528
 
 
 
Assets held under capital leases are included in
machinery and equipment and amounted to
$1,082
and
$1,142
as of
September 30, 2017
and
December 31, 2016,
respectively.
 
Depreciation and amortization expense totale
d
$222
and
$221
for the
three
months ended
September 30, 2017
and
2016,
respectively, and totaled
$669
and
$567
for the
nine
months ended
September 30, 2017
and
2016,
respectively
.
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 5 - Intangible Assets
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Intangible Assets Disclosure [Text Block]
NOTE
5
– INTANGIBLE ASSETS
 
Intangible assets
consisted of the following at:
 
   
September 30,
   
December 31,
 
   
2017
   
2016
 
                 
Trademarks
  $
12,166
    $
12,166
 
Indefinite-lived intangible assets
   
5,900
     
5,900
 
Customer relationships
   
19,110
     
19,110
 
Other
   
753
     
753
 
     
37,929
     
37,929
 
Accumulated amortization
   
(9,479
)    
(7,732
)
    $
28,450
    $
30,197
 
 
 
Trademarks are amortized over period
s ranging from
3
to
30
years, customer relationships are amortized over periods ranging from
15
to
16
years, and other intangible assets are amortized over
3
years. Amortization expense was
$582
and
$557
for the
three
months ended
September 30, 2017
and
2016,
respectively, and was
$1,747
and
$1,645
for the
nine
months ended
September 30, 2017
and
2016,
respectively.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 6 - Debt
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Debt Disclosure [Text Block]
NOTE
6
– DEBT
 
Debt
consisted of the following at:
 
   
September 30,
   
December 31,
 
   
2017
   
2016
 
                 
Related-Party Debt:
               
July 2014 note payable to Little Harbor, LLC, net of unamortized discount of $0 and $206 as of September 30, 2017 and December 31, 2016, respectively
  $
3,267
    $
3,061
 
July 2016 note payable to Little Harbor, LLC
   
4,770
     
4,770
 
January 2016 note payable to Great Harbor Capital, LLC
   
2,500
     
2,500
 
March 2016 note payable to Great Harbor Capital, LLC
   
7,000
     
7,000
 
December 2016 note payable to Great Harbor Capital, LLC
   
2,500
     
2,500
 
August 2017 note payable to Great Harbor Capital, LLC
   
3,000
     
-
 
January 2016 note payable to Golisano Holdings LLC
   
2,500
     
2,500
 
March 2016 note payable to Golisano Holdings LLC
   
7,000
     
7,000
 
July 2016 note payable to Golisano Holdings LLC
   
4,770
     
4,770
 
December 2016 note payable to Golisano Holdings LLC
   
2,500
     
2,500
 
March 2017 note payable to Golisano Holdings LLC
   
3,267
     
-
 
November 2014 note payable to Golisano Holdings LLC (formerly payble to Penta
               
Mezzanine SBIC Fund I, L.P.), net of discount and unamortized loan fees in the aggregate of $1,694 and $2,304 as of September 30, 2017 and December 31, 2016, respectively
   
6,306
     
5,696
 
January 2015 note payable to Golisano Holdings LLC (formerly payable to JL-BBNC
               
Mezz Utah, LLC), net of discount and unamortized loan fees in the aggregate of $2,058 as of September 30, 2017
   
2,942
     
-
 
February 2015 note payable to Golisano Holdings LLC (formerly payable to Penta
               
Mezzanine SBIC Fund I, L.P.), net of discount and unamortized loan fees in the aggregate of $148 and $201 as of September 30, 2017 and December 31, 2016, respectively
   
1,852
     
1,799
 
Total related-party debt
   
54,174
     
44,096
 
                 
Senior Credit Facility with Midcap, net of unamortized loan fees of $73 and $293 as of September 30, 2017 and December 31, 2016, respectively
   
14,901
     
13,035
 
                 
Other Debt:
               
January 2015 note payable to JL-BBNC Mezz Utah, LLC, net of discount and unamortized loan fees in the aggregate of $2,744 as of December 31, 2016
   
-
     
2,256
 
April 2016 note payable to JL-Utah Sub, LLC
   
396
     
500
 
Capital lease obligations
   
1,582
     
2,732
 
Huntington Holdings
   
3,200
     
-
 
Total other debt
   
5,178
     
5,488
 
                 
Total debt
   
74,253
     
62,619
 
Less current portion
   
(17,091
)    
(11,631
)
Long-term debt
  $
57,162
    $
50,988
 
 
Related-Party Debt
 
July 2014
Note Payable to Little Harbor, LLC
Pursuant to a
July 2014
Debt Repayment Agreement with Little Harbor, LLC (“Little Harbor”), an entity owned by certain stockholders of the Company, we are obligated to pay such party
$4,900
per year in structured monthly payments for
3
years provided that such payment obligations will terminate at such earlier time as the trailing
ninety
day volume weighted average closing sales price of the Company
’s common stock on all domestic securities exchanges on which such stock is listed equals or exceeds
$5.06
per share. This note is unsecured and matured on
July 25, 2017
however this note remains outstanding and principal payment has been deferred to
2018.
This note was non-interest bearing, accordingly, using an imputed interest rate of
16.2%,
we recorded a note discount in
July 2014,
which has been amortized into interest expense based on the effective interest rate method over the term of the note.
 
July 2016
Note Payable to Little Harbor, LLC
On
July 21, 2016,
we issued an Unsecured Delayed Draw Promissory Note in favor of Little Harbor, pursuant to which Little Harbor
may,
in its sole discretion and pursuant to draw requests made by the Company, loan us up to the maximum principal amount of
$4,770.
This note is unsecured and matures on
January 28, 2019.
This note bears interest at an annual rate of
8.5%,
with the principal payable at maturity. If Little Harbor, in its discretion, accepts a draw request made by the Company under this note, Little Harbor shall
not
transfer cash to the Company, but rather Little Harbor shall irrevocably agree to accept the principal amount of any monthly delayed draw under this note in lieu and in complete satisfaction of the obligation to make an equivalent dollar amount of periodic cash payments otherwise due
to Little Harbor under the
July 2014
note payable. During the year ended
December 31, 2016,
we requested and Little Harbor LLC approved, draws totaling
$4,770.
We issued a warrant into escrow in connection with this loan (see Little Harbor Escrow Warrants in Note
7
).
 
January 2016
Note Payable to Great Harbor Capital, LLC
Pursuant to a
January 28, 2016
Unsecured Promissory Note with Great Harbor Capital, LLC (“GH”), an affiliate of a member of our Board of Directors, GH lent us
$2,500.
The note matures on
January 28, 2019,
bears interest at an annual rate of
8.5%,
with the principal payable in
24
monthly installments of
$104
which was to commence on
February 28, 2017
but has been deferred to
January 28, 2018.
We issued a warrant into escrow in connection with this loan (see GH Escrow Warrants in Note
7
).
 
March 2016
Note Payable to Great Harbor Capital, LLC
Pursuant to a
March 21, 2016
Unsecured Promissory Note, GH lent us
$7,000.
The note matures on
March 21, 2019,
bears interest at an annual rate of
8.5%,
with the principal payable in
24
monthly installments of
$292
which was to commence on
April 21, 2017
but has been deferred to
January 21, 2018.
We issued a warrant into escrow in connection with this loan (see GH Escrow Warrants in Note
7
).
 
December 2016
Note Payable to Great Harbor Capital, LLC
Pursuant to a
December 31, 2016
Unsecured Promissory Note, GH lent us
$2,500.
The note matures on
December 3
0,
2019,
bears interest at an annual rate of
8.5%,
with the principal payable at maturity. We issued a warrant into escrow in connection with this loan (see GH Escrow Warrants in Note
7
).
 
August 2017
Note Payable to Great Harbor Capital, LLC
Pursuant to a
n
August 30, 2017
Unsecured Promissory Note, GH lent us
$3,000.
The note matures on
August 29, 2020,
bears interest at an annual rate of
8.5%,
with the principal payable at maturity. We issued a warrant into escrow in connection with this loan (see GH Escrow Warrants in Note
7
).
 
November 2014
Note Payable to Golisano Holdings LLC (formerly payable to Penta Mezzanine SBIC Fund I, L.P.)
On
November 13, 2014,
we raised proceeds of
$8,000,
less certain fees and expenses, from the issuance of a secured note to Penta Mezzanine SBIC Fund I, L.P. (“Penta”). The Managing Director of Penta, an institutional investor, is also a director of our Company. We granted Penta a security interest in our assets and pledged the shares of our subsidiaries as security for the note.
On
March 8, 2017,
Golisano Holdings LLC (“Golisano LLC”) acquired this note payable from Penta. Interest on the outstanding principal accrued at a rate of
12%
per year from date of issuance to
March 8, 2017,
and decreased to
8%
per year thereafter, payable monthly
. The note matures on
November 13, 2019.
On
August 30, 2017,
we entered into an amendment with Golisano LLC which extended payment of principal to maturity. We issued a warrant to Penta to purchase
4,960,740
shares of the Company’s common stock in connection with this loan (see Penta Warrants in Note
7
). The estimated fair value of the warrant at the date of issuance was
$3,770,
which was recorded as a note discount and is being amortized into interest expense over the term of this loan. Additionally, we had incurred loan fees of
$273,
which is also being amortized into interest expense over the term of this loan.
 
January 2015
Note Payable to Golisano Holdings LLC (formerly payable to JL-Mezz Utah, LLC-f/k/a JL-BBNC Mezz Utah, LLC)
On
January 22, 2015,
we raised proceeds of
$5,000,
less certain fees and expenses, from the sale of a note to JL-Mezz Utah, LLC (f/k/a JL-BBNC Mezz Utah, LLC) (“JL-US”). The proceeds were restricted to pay a portion of the
Nutricap Labs, LLC (“Nutricap”) asset acquisition. We granted JL a security interest in the Company’s assets, including real estate and pledged the shares of our subsidiaries as security for the note. On
March 8, 2017,
Golisano LLC acquired this note payable from JL.
Interest on the outstanding principal accrued at a rate of
12%
per year
from date of issuance to
March 8, 2017,
and decreased to
8%
per year thereafter, payable monthly
. The note matures on
November 13, 2019.
On
August 30, 2017,
we entered into an amendment with Golisano LLC which extended payment of principal to maturity. We issued a warrant to JL to purchase
2,329,400
shares of the Company’s common stock on
January 22, 2015
and
434,809
shares of the Company’s common stock on
February 4, 2015 (
see JL Warrants in Note
7
). The estimated fair value of these warrants at the date of issuances was
$4,389,
which was recorded as a note discount and is being amortized into interest expense over the term of these loans. Additionally, we had incurred loan fees of
$152
relating to this loan, which is also being amortized into interest expense over the term of these loans.
 
February 2015
Note Payable to Golisano Holdings LLC (formerly payable to Penta Mezzanine SBIC Fund I, L.P.)
On
February 6, 2015,
we raised proceeds of
$2,000,
less certain fees and expenses, from the issuance of a secured note payable to Penta. The proceeds were restricted to pay a portion of the acquisition of the customer r
elationships of Nutricap. On
March 8, 2017,
Golisano LLC acquired this note payable from Penta. Interest on the outstanding principal accrued at a rate of
12%
per year from date of issuance to
March 8, 2017,
and decreased to
8%
per year thereafter, payable monthly
. The note matures on
November 13, 2019.
On
August 30, 2017,
we entered into an amendment with Golisano LLC which extended payment of principal to maturity. We issued a warrant to Penta to purchase
869,618
shares of the Company’s common stock in connection with this loan (see Penta Warrants in Note
7
). The estimated fair value of these warrants at the date of issuances totaled
$250,
which was recorded as a note discount and is being amortized into interest expense over the term of this loan. Additionally, we had incurred loan fees of
$90,
which is also being amortized into interest expense over the term of these loans.
 
January 2016
Note Payable to Golisano Holdings LLC
Pursuant to a
January 28, 2016
Unsecured Promissory Note with Golisano LLC, an affiliate of a member of our Board of Directors, Golisano LLC lent us
$2,500.
The note matures on
January 28, 2019,
bears interest at an annual rate of
8.5%,
with the principal payable in
24
monthly installments of
$104
which was to commence on
February 28, 2017
but has been deferred to
January 28, 2018.
We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note
7
).
 
March 2016
Note Payable to Golisano Holdings LLC
Pursuant to a
March 21, 2016
Unsecured Promissory Note, Golisano LLC lent us
$7,000.
The note matures on
March 21, 2019,
bears interest at an annual rate of
8.5%,
with the principal payable in
24
monthly installments of
$292
which was to commence on
April 21, 2017
but has been deferred to
January 21, 2018.
We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note
7
).
 
July 2016
Note Payable to Golisano Holdings LLC
On
July 21, 2016,
we issued an Unsecured Delayed Draw Promissory Note in favor of Golisano LLC pursuant to which Golisano LLC
may,
in its sole discretion and pursuant to draw requests made by the Company, loan the Company up to the maximum principal amount of
$4,770
(the “Golisano LLC
July 2016
Note”). The Golisano LLC
July 2016
Note matures on
January 28, 2019.
Interest on the outstanding principal accrues at a rate of
8.5%
per year. The principal of the Golisano LLC
July 2016
Note is payable at maturity. We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note
7
). During the year ended
December 31, 2016,
we requested and Golisano LLC approved, draws totaling
$4,770.
 
December 2016
Note Payable to Golisano Holdings LLC
Pursuant to a
December 31, 2016
Unsecured Promissory Note, Golisano LLC lent
us
$2,500.
The note matures on
December 30, 2019,
bears interest at an annual rate of
8.5%,
with the principal payable at maturity. We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note
7
).
 
March
201
7
Note Payable to Golisano Holdings LLC
Pursuant to a
March 14, 2017
Unsecured Promissory Note, Golisano LLC lent us
$3,267.
The note matures on
December 30, 2019,
bears interest at an annual rate of
8.5%,
with the principal payable at maturity. We issued a warrant into escrow in connection with this loan (see Golisano Escrow Warrants in Note
7
).
 
Senior Credit Facility
 
On
January 22, 2015,
we entered into a
three
-year
$15,000
revolving credit facility (the “Senior Credit Facility”) based on our accounts receivable and inventory, increasable to up to
$20,000,
with MidCap Financial Trust, which subsequently assigned the agreement to an affiliate, Midcap Funding
X
Trust (“MidCap”). On
September 2, 2016,
we entered into an amendment with Midcap to increase the Senior Credit Facility to
$17,000
and extend our facility an additional
12
months. We granted MidCap a
first
priority security interest in certain of our assets and pledged the shares of our subsidiaries as security for amounts owed under the credit facility. We are required to pay Midcap an unused line fee of
0.50%
per annum, a collateral management fee of
1.20%
per month and interest of LIBOR plus
5%
per annum, which was
6.24%
per annum as of
September 30, 2017.
We issued a warrant to Midcap to purchase
500,000
shares of the Company’s common stock (see Midcap Warrant in Note
7
). The estimated fair value of these warrants at the date of issuance was
$130,
which was recorded as a note discount and is being amortized into interest expense over the term of the Senior Credit Facility. Additionally, we have incurred loan fees totaling
$540
relating to the Senior Credit Facility and any subsequent amendments, which is also being amortized into interest expense over the term of the Senior Credit Facility.
 
Other Debt
 
 
April 2016
Note Payable to
JL-Utah Sub, LLC
Pursuant to an
April 5
,
2016
Unsecured Promissory Note, JL-Utah Sub, LLC lent us
$500.
The note matures on
March 21, 2019,
bears interest at an annual rate of
8.5%,
with the principal payable in
24
monthly installments of
$21
commencing on
April 21, 2017.
 
Capital Lease Obligations
Our capital lease obligations pertain to various leasing agreements with Essex Capital Corporation (“Essex”), a related party to the Company as Essex
’s principal owner is a director of the Company.
 
Huntington Holdings
, LLC
On
August 6, 2016,
the
18
-month anniversary of the closing of a share purchase agreement, we were required to pay the purchaser of the common stock the difference between
$2.29
per share and either a defined market price or a price per share determined by a valuation firm acceptable to both parties.
Based on an outside professional valuation performed on the Company’s common stock, the Company estimated the stock price guarantee payment to be
$3,210.
Accordingly, the Company recorded a loss on the stock purchase price guarantee of
$3,210
and a corresponding liability for the same amount in
2016,
which was included in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheet as of
December 31, 2016.
On
June 2, 2017,
the
two
parties came to an agreement in which we were required to issue an Unsecured Promissory Note (“Huntington Note”) in favor of Huntington Holdings, LLC (“Huntington”). The Huntington Note matures on
June 2, 2019
with the principal amount of
$3,200
payable at maturity. Interest on the outstanding principal accrues at a rate of
8.5%
per year from
August 6, 2016
to
August 15, 2017,
and increases to
10%
per year thereafter. We paid
$50
to Huntington related to accrued interest from
August 6, 2016
through the date of issuance of the Huntington Note. Huntington was required to return
778,385
shares of the Company’s common stock which were issued into escrow. We were required to provide certain piggyback registration rights to Huntington in regards to the remaining
749,999
shares of the Company’s common stock held by Huntington. If the Huntington Note was paid off prior to
August 14, 2017,
the
778,385
shares held in escrow were to be released from escrow and transferred to the Company for
no
additional consideration. If the note remained outstanding on
August 15, 2017,
we had the right, but
not
the obligation, to pay
$140
to Huntington to purchase
764,192
of the shares held in escrow (the “Subject Shares”). Upon the exercise of this purchase option, the Subject Shares were to be released from escrow and transferred to the Company. If the note remained outstanding on
August 15, 2017
and we did
not
exercise the option to purchase the shares, the shares were to be returned from escrow to Huntington and we would
no
longer have repurchase rights. On
August 15, 2017,
the note was outstanding and we did
not
excerise the repurchase right. The
778,385
shares were returned from escrow to Huntington. Pursuant to the agreement, we were also required to enter into a
four
-year lease agreement with the purchaser related to our premises occupied by Nutricap.
 
Financial Covenants
 
Certain of the foregoing debt agreements
, as amended, require us to meet certain affirmative and negative covenants, including maintenance of specified ratios. We amended our debt agreements with MidCap, Penta and JL, effective
July 29, 2016,
to, among other things, reset the financial covenants of each debt agreement. As of
September 30, 2017,
management believes we are in compliance with our financial covenants for each debt agreement.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 7 - Warrants and Registration Rights Agreements
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Warrants Disclosure [Text Block]
NOTE
7
WARRANTS
AND REGISTRATION RIGHTS AGREEMENT
S
 
The following table presents a summary of the status of our issued warrants
as of
September 30, 2017,
and changes during the
nine
months then ended:
 
   
 
 
 
 
Weighted Average
 
   
Shares
   
Exercise Price
 
                 
                 
Outstanding, December 31, 2016
   
15,855,017
     
0.18
 
                 
Granted
   
-
     
-
 
Canceled / Expired
   
-
     
-
 
Exercised
   
-
     
-
 
Outstanding, September 30, 2017
   
15,855,017
     
0.18
 
 
 
Warrants Issued
 
Midcap Warrant
In connection with the line of credit agreement
with MidCap described in Note
6,
we issued MidCap a warrant, exercisable through
January 22, 2018,
for an aggregate of
500,000
shares of the Company’s common stock at an exercise price of
$0.76
per share (the “MidCap Warrant”). We entered into a Registration Rights Agreement with Midcap, dated as of
January 22, 2015,
granting MidCap certain registration rights, commencing
October 1, 2015,
for the shares of common stock issuable on exercise of the MidCap Warrant.
 
Penta Warrants
Pursuant to a stock purchase agreement dated
June 30, 2015,
a warrant was issued to Penta to purchase an aggregate
807,018
shares of our common stock at a price of
$0.01
per share at any time prior to the close of business on
June 30, 2020.
We granted Penta certain registration rights, commencing
October 1, 2015,
for the shares of common stock issuable upon exercise of the warrant.
 
JL Warrants
Pursuant to a
June 30, 2015
stock purchase agreement, a warrant was issued to JL to purchase an aggregate
403,509
shares of the Company
’s common stock at a price of
$0.01
per share at any time prior to the close of business on
June 30, 2020,
subject to certain adjustments. We granted JL certain registration rights, commencing
October 1, 2015,
for the shares of common stock issuable upon exercise of the warrant. The warrant was subsequently assigned by JL to
two
individuals.
 
Essex Warrants
In connection with the guarantee of a note payable issued in the Nutricap asset acquisition and equipment financing by Essex discussed in Note
6,
Essex was issued a warrant exercisable for an aggregate
1,428,571
shares of the Company’s common stock at a purchase price of
$0.77
per share, at any time prior to the close of business on
June 30, 2020.
The number of shares issuable upon the exercise of the warrant is subject to adjustment on terms and conditions customary for a transaction of this nature in the event of (i) reorganization, recapitalization, stock split-up, combination of shares, mergers, consolidations and (ii) sale of all or substantially all of our assets or property. Essex subsequently assigned warrants for
350,649
shares to another company.
 
JL Properties, Inc. Warrants
In
April 2015,
we entered into an office lease agreement which requires a
$1,000
security deposit, subject to reduction if we achieve certain market capitalization metrics at certain dates. On
April 30, 2015,
we entered into a reimbursement agreement with JL Properties, Inc. (“JL Properties”) pursuant to which JL Properties agreed to arrange for and provide an unconditional, irrevocable, transferable, and negotiable commercial letter of credit to serve as the security deposit. As partial consideration for the entry by JL Properties into the reimbursement agreement and the provision of the letter of credit, we issued JL Properties
two
warrants to purchase shares of the Company
’s common stock.
 
The
first
warrant is exercisable for an aggregate of
465,880
shares of
common stock, subject to certain adjustments, at an aggregate purchase price of
$0.01,
at any time prior to
April 30, 2020.
In addition to adjustments on terms and conditions customary for a transaction of this nature in the event of (i) reorganization, recapitalization, stock split-up, combination of shares, mergers, consolidations and (ii) sale of all or substantially all of our assets or property, the number of shares of common stock issuable pursuant to the warrant will be increased in the event our consolidated audited adjusted EBITDA (as defined in the warrant agreement) for the fiscal year ending
December 31, 2018
does
not
equal or exceed
$19,250.
JL Properties subsequently assigned the warrant to
two
individuals.
 
The
second
warrant is exercisable for an aggregate of
86,962
shares of
common stock, at a per share purchase price of
$1.00,
at any time prior to
April 30, 2020.
The number of shares issuable upon exercise of the
second
warrant is subject to adjustment on terms and conditions customary for a transaction of this nature in the event of (i) reorganization, recapitalization, stock split-up, combination of shares, mergers, consolidations and (ii) sale of all or substantially all of our assets or property.
 
We
have granted JL Properties certain registration rights, commencing
October 1, 2015,
for the shares of common stock issuable on exercise of the
two
warrants.
 
Golisano
LLC
Warrants (formerly
Penta Warrants
)
In connection with the
November 13, 2014
note for
$8,000
(see Note
6
), Penta was issued a warrant to acquire
4,960,740
shares of the Company’s common stock at an aggregate exercise price of
$0.01,
through
November 13, 2019.
In connection with Penta’s consent to the terms of additional debt obtained by us, we also granted Penta a warrant to acquire an additional
869,618
shares of common stock at a purchase price of
$1.00
per share, through
November 13, 2019.
Both warrant agreements grant Penta certain registration rights, commencing
October 1, 2015,
for the shares of common stock issuable on exercise of the warrants. Penta has the right, under certain circumstances, to require us to purchase all or any portion of the equity interest in the Company issued or represented by the warrant to acquire
4,960,740
shares at a price based on the greater of (i) the product of (
x
)
ten
times our adjusted EBITDA with respect to the
twelve
months preceding the exercise of the put right multiplied by (y) the investor’s percentage ownership in the Company assuming full exercise of the warrant; or (ii) the fair market value of the investor’s equity interest underlying the warrant. In the event (i) we do
not
have the funds available to repurchase the equity interest under the warrant or (ii) such repurchase is
not
lawful, adjustments to the principal of the note purchased by Penta will be made or, under certain circumstances, interest will be charged on the amount otherwise due for such repurchase. We have the right, under certain circumstances, to require Penta to sell to us all or any portion of the equity interest issued or represented by the warrant to acquire
4,960,740
shares. The price for such repurchase will be the greater of (i) the product of (
x
)
eleven
times our adjusted EBITDA with respect to the
twelve
months preceding the exercise of the call right multiplied by (y) the investor’s percentage ownership in the company assuming full exercise of the warrant; or (ii) the fair market value of the equity interests underlying the warrant; or (iii)
$3,750.
In connection with Golisano LLC’s acquisition of the note payable from Penta on
March 8, 2017 (
see Note
6
above for additional information), these warrants were assigned to Golisano LLC.
 
Golisano
LLC
Warrants (formerly
JL Warrants
)
In connection with the
January 22, 2015
note payable to JL, we
issued JL warrants to purchase an aggregate of
2,329,400
shares of the Company’s common stock, at an aggregate exercise price of
$0.01,
through
February 13, 2020.
On
February 4, 2015,
we also granted to JL a warrant to acquire a total of
434,809
shares of common stock at a purchase price of
$1.00
per share, through
February 13, 2020.
Both warrant agreements grant JL certain registration rights, commencing
October 1, 2015,
for the shares of common stock issuable upon exercise of the warrants. These warrants were subsequently assigned to
two
individuals. During the year ended
December 31, 2016,
these individuals exercised warrants for a total of
1,187,995
shares of the Company’s common stock for total proceeds to the Company of less than
$1.
In connection with Golisano LLC’s acquisition of the note payable from JL on
March 8, 2017 (
see Note
6
above for additional information), the remaining portions of these warrants were assigned to Golisano LLC.
 
Golisano
LLC
Warrants
Pursuant to an
October 2015
Securities Purchase Agreement with Golisano LLC, we issued Golisano LLC a warrant (the “Golisano Warrant”), which Golisano Warrant is intended to maintain, following each future issuance of shares of common stock pursuant to the conversion, exercise or exchange of certain currently outstanding warrants to purchase shares of common stock held by
third
-parties (the “Outstanding Warrants”), Golisano LLC’s proportional ownership of our issued and outstanding common stock so that it is the same thereafter as on
October 5, 2015.
We have reserved
12,697,977
shares of common stock for issuance under the Golisano Warrant. The purchase price for any shares of common stock issuable upon exercise of the Golisano Warrant is
$.001
per share. The Golisano Warrant is exercisable immediately and up to and including the date which is
sixty
days after the later to occur of the termination, expiration, conversion, exercise or exchange of all of the Outstanding Warrants and our delivery of notice thereof to Golisano LLC. The Golisano Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets. In addition, if any payments are made to a holder of an Outstanding Warrant in consideration for the termination of or agreement
not
to exercise such Outstanding Warrant, Golisano LLC will be entitled to equal treatment. We have entered into a registration rights agreement with Golisano LLC, dated as of
October 5, 2015,
granting Golisano LLC certain registration rights for the shares of common stock issuable on exercise of the Golisano Warrant. On
February 6, 2016,
Golisano LLC exercised the Golisano Warrant in part for
509,141
shares of the Company’s common stock for an aggregate purchase price of
$1.
During the year ended
December 31, 2016,
the Golisano Warrant was cancelled in part for
6,857,143
shares pursuant to the cancellation of a portion of the Outstanding Warrants. As of
September 30, 2017,
we have reserved
4,756,505
shares of its common stock for issuance under the Golisano Warrant.
 
Warrants Issued into Escrow
 
Golisano
Escrow
Warrants
In connection with a
January 28, 2016
Unsecured Promissory Note, we
issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of
1,136,363
shares of the Company’s common stock at an exercise price of
$0.01
per share (the
“January 2016
Golisano Warrant”). The
January 2016
Golisano Warrant will
not
be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the related promissory note and any accrued and unpaid interest thereon as of
January 28, 2019
or such earlier date as is required pursuant to an Acceleration Notice (as defined in the related note agreement). We have reserved
1,136,363
shares of the Company’s common stock for issuance under the
January 2016
Golisano Warrant. The
January 2016
Golisano Warrant, if exercisable, expires on
February 28, 2022.
The
January 2016
Golisano Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.
 
In connection with a
March 21, 2016
Unsecured Promissory Note, we
issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of
3,181,816
shares of the Company’s common stock at an exercise price of
$0.01
per share (the
“March 2016
Golisano Warrant”). The
March 2016
Golisano Warrant will
not
be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the related promissory note and any accrued and unpaid interest thereon as of
March 21, 2019
or such earlier date as is required pursuant to an Acceleration Notice (as defined in the related note agreement). We have reserved
3,181,816
shares of the Company’s common stock for issuance under the
March 2016
Golisano Warrant. The
March 2016
Golisano Warrant, if exercisable, expires on
March 21, 2022.
The
March 2016
Golisano Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.
In connection with t
he Golisano LLC
July 2016
Note, we issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of
2,168,178
shares of the Company’s common stock, at an exercise price of
$0.01
per share (the “Golisano
July 2016
Warrant”). The Golisano
July 2016
Warrant will
not
be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the Golisano
July 2016
Note and any accrued and unpaid interest thereon as of
January 28, 2019
or such earlier date as is required pursuant to an Acceleration Notice (as defined in the Golisano LLC
July 2016
Note). We have reserved
2,168,178
shares of the Company’s common stock for issuance under the Golisano
July 2016
Warrant. The Golisano
July 2016
Warrant, if exercisable, expires on
July 21, 2022.
The Golisano
July 2016
Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.
 
In connection with t
he Golisano LLC
December 2016
Note, we issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of
1,136,363
shares of the Company’s common stock, at an exercise price of
$0.01
per share (the “Golisano
December 2016
Warrant”). The Golisano
December 2016
Warrant will
not
be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the Golisano
December 2016
Note and any accrued and unpaid interest thereon as of
December 30, 2019
or such earlier date as is required pursuant to an Acceleration Notice (as defined in the Golisano LLC
December 2016
Note). We have reserved
1,136,363
shares of the Company’s common stock for issuance under the Golisano
December 2016
Warrant. The Golisano
December 2016
Warrant, if exercisable, expires on
December 30, 2022.
The Golisano
December 2016
Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.
 
In connection with t
he Golisano LLC
March 2017
Note, we issued into escrow in the name of Golisano LLC a warrant to purchase an aggregate of
1,484,847
shares of the Company’s common stock, at an exercise price of
$0.01
per share (the “Golisano
March 2017
Warrant”). The Golisano
March 2017
Warrant will
not
be released from escrow or be exercisable unless and until we fail to pay Golisano LLC the entire unamortized principal amount of the Golisano
March 2017
Note and any accrued and unpaid interest thereon as of
December 30, 2019
or such earlier date as is required pursuant to an Acceleration Notice (as defined in the Golisano LLC
March 2017
Note). We have reserved
1,484,847
shares of the Company’s common stock for issuance under the Golisano
March 2017
Warrant. The Golisano
March 2017
Warrant, if exercisable, expires on
March 14, 2023.
The Golisano
March 2017
Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.
 
We
previously entered into a registration rights agreement with Golisano LLC, dated as of
October 5, 2015 (
the “Registration Rights Agreement”), granting Golisano LLC certain registration rights for certain shares of the Company’s common stock. The shares of common stock issuable pursuant to the above warrants are also entitled to the benefits of the Registration Rights Agreement.
 
GH Escrow Warrants
In connection with a
January 28, 2016
Unsecured Promissory Note, we
issued into escrow in the name of GH a warrant to purchase an aggregate of
1,136,363
shares of the Company’s common stock at an exercise price of
$0.01
per share (the
“January 2016
GH Warrant”). The
January 2016
GH Warrant will
not
be released from escrow or be exercisable unless and until we fail to pay GH the entire unamortized principal amount of the related promissory note and any accrued and unpaid interest thereon as of
January 28, 2019
or such earlier date as is required pursuant to an Acceleration Notice (as defined in the related note agreement). We have reserved
1,136,363
shares of the Company’s common stock for issuance under the
January 2016
GH warrant. The
January 2016
GH Warrant, if exercisable, expires on
February 28, 2022.
The
January 2016
GH Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.
 
In connection with a
March 21, 2016
Unsecured Promissory Note, we
issued into escrow in the name of GH a warrant to purchase an aggregate of
3,181,816
shares of the Company’s common stock at an exercise price of
$0.01
per share (the
“March 2016
GH Warrant”). The
March 2016
GH Warrant will
not
be released from escrow or be exercisable unless and until we fail to pay GH the entire unamortized principal amount of the related promissory note and any accrued and unpaid interest thereon as of
March 21, 2019
or such earlier date as is required pursuant to an Acceleration Notice (as defined in the related note agreement). We have reserved
3,181,816
shares of the Company’s common stock for issuance under the
March 2016
GH Warrant. The
March 2016
GH Warrant, if exercisable, expires on
March 21, 2022.
The
March 2016
GH Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.
 
In connection with t
he GH
December 2016
Note, we issued into escrow in the name of GH a warrant to purchase an aggregate of
1,136,363
shares of the Company’s common stock, at an exercise price of
$0.01
per share (the
“December 2016
GH Warrant”). The
December 2016
GH Warrant will
not
be released from escrow or be exercisable unless and until we fail to pay GH the entire unamortized principal amount of the
December 2016
GH Warrant and any accrued and unpaid interest thereon as of
December 30, 2019
or such earlier date as is required pursuant to an Acceleration Notice (as defined in the
December 2016
GH Warrant). We have reserved
1,136,363
shares of common stock for issuance under the
December 2016
GH Warrant. The
December 2016
GH Warrant, if exercisable, expires on
December 30, 2022.
The
December 2016
GH Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.
 
In connection with t
he GH
August 2017
Note, we issued into escrow in the name of GH a warrant to purchase an aggregate of
1,363,636
shares of the Company’s common stock, at an exercise price of
$0.01
per share (the
“August 2017
GH Warrant”). The
August 2017
GH Warrant will
not
be released from escrow or be exercisable unless and until we fail to pay GH the entire unamortized principal amount of the
August 2017
GH Warrant and any accrued and unpaid interest thereon as of
August 29, 2020
or such earlier date as is required pursuant to an Acceleration Notice (as defined in the
August 2017
GH Warrant). We have reserved
1,363,636
shares of common stock for issuance under the
August 2017
GH Warrant. The
August 2017
GH Warrant, if exercisable, expires on
August 30, 2023.
The
August 2017
GH Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.
 
JL-US Escrow Warrant
In connection with an
April 5, 2016
Unsecured Promissory Note, we issued into escrow in the name of JL-US a warrant to purchase an aggregate of
227,273
shares of the Company
’s common stock at an exercise price of
$0.01
per share (the “JL-US Warrant”). The JL-US Warrant will
not
be released from escrow or be exercisable unless and until we fail to pay JL-US the entire unamortized principal amount of the JL-US Note and any accrued and unpaid interest thereon as of
March 21, 2019
or such earlier date as is required pursuant to an Acceleration Notice (as defined in the JL-US Note). We have reserved
227,273
shares of the Company’s common stock for issuance under the JL-US Warrant. The JL-US Warrant, if exercisable, expires on
March 21, 2022.
The JL-US Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets.
 
Little Harbor Escrow Warrant
The Little Harbor
July 2016
Note provides that we issue into escrow in the name of Little Harbor a warrant to purchase an aggregate of
2,168,178
shares of common stock at an exercise price of
$0.01
per share (the “Little Harbor
July 2016
Warrant”). The Little Harbor
July 2016
Warrant will
not
be released from escrow or be exercisable unless and until we fail to pay Little Harbor the entire unamortized principal amount of the Little Harbor
July 2016
Note and any accrued and unpaid interest thereon as of
January 28, 2019
or such earlier date as is required pursuant to an Acceleration Notice (as defined in the Little Harbor
July 2016
Note). We have reserved
2,168,178
shares of the Company’s common stock for issuance under the Little Harbor
July 2016
Warrant. The Little Harbor
July 2016
Warrant, if exercisable, expires on
July 21, 2022.
The Little Harbor
July 2016
Warrant is also subject to customary adjustments upon any recapitalization, capital reorganization or reclassification, consolidation, merger or transfer of all or substantially all of our assets. The Little Harbor
July 2016
Warrant grants Little Harbor certain registration rights for the shares of the Company’s common stock issuable upon exercise of the Little Harbor
July 2016
Warrant.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 8 - Derivative Liabilities
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Derivatives and Fair Value [Text Block]
NOTE
8
– DERIVATIVE LIABILIT
IES
 
The number of shares of common stock issuable pursuant to certain warrants issued in
2015
will be increased
if our adjusted EBITDA or the market price of the Company’s common stock does
not
meet certain defined amounts. We have recorded the estimated fair value of the warrants as of the date of issuance. Due to the variable terms of the warrant agreements, the warrants are recorded as derivative liabilities with a corresponding charge to our consolidated statements of comprehensive loss for changes in the estimated fair value of the warrants from the date of issuance to each balance sheet reporting date. As of
September 30, 2017,
we have estimated the total fair value of the derivative liabilities to be
$8,143
as compared to
$6,455
as of
December 31, 2016.
We had the following activity in our derivative liabilities account since
December 31, 2016:
 
   
Nine Months Ended
 
   
September 30,
 
   
2017
 
Derivative liabilities at December 31, 2016
  $
6,455
 
         
Loss on change in fair value of derivative liabilities
   
1,688
 
Derivative liabilities at September 30, 2017
  $
8,143
 
 
The value of the derivative liabilities is generally estimated using an options lattice model with multiple inputs and assumptions, including the market price of the Company
’s common stock, stock price volatility and other assumptions to project EBITDA and other reset events. These inputs and assumptions are subject to management’s judgment and can vary materially from period to period.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 9 - Stockholders' Equity (Deficit)
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
NOTE
9
STOCKHOLDERS’
EQUITY
(
DEFICIT
)
 
Preferred Stock
The Company has
authorized
500,000,000
shares of preferred stock with a par value of
$0.001
per share.
No
shares of the preferred stock have been issued.
 
Twinlab Consolidation Corporation
2013
Stock Incentive Plan
The only equity compensation plan currently in effect is the Twinlab Consolidation Corporation
2013
Stock Incentive Plan (the “TCC Plan”), which was assumed by the Company on
September 16, 2014.
The TCC Plan originally established a pool of
20,000,000
shares of common stock for issuance as incentive awards to employees for the purposes of attracting and retaining qualified employees who will aid in the success of the Company.
From
January
through
December 2015,
the Company granted restricted stock units to certain employees of the Company pursuant to the TCC Plan. Each restricted stock unit relates to
one
share of the Company’s common stock. The restricted stock unit awards vest
25%
each annually on various dates through
2019.
The Company estimated the grant date fair market value per share of the restricted stock units and is amortizing the total estimated grant date value over the vesting periods. During the
nine
months ended
September 30, 2017,
there were
not
any shares of common stock issued to employees pursuant to the vesting of restricted stock units.
As of
September 30, 2017,
6,060,943
shares remain available for use in the TCC Plan.
 
Common Stock Repurchase
On
January 5, 2017,
pursuant to a repurchase agreement,
642,366
shares of the Company
’s common stock were repurchased for an aggregate repurchase price of less than
$1.
 
Stock Subscription Receivable
and Loss on Stock Price Guarantee
At
September 30, 2017,
the stock subscription receivable dated
August 1, 2014
for the purchase of
1,528,384
shares of the Company’s common stock had a principal balance of
$30
and bears interest at an annual rate of
5%.
 
On
August 6, 2016,
the
18
-month anniversary of the closing of a share purchase agreement, we were required to pay the purchaser of the common stock the difference between
$2.29
per share and either a defined market price or a price per share determined by a valuation firm acceptable to both parties.
Based on an outside professional valuation performed on the Company’s common stock, the Company estimated the stock price guarantee payment to be
$3,210.
Accordingly, the Company recorded a loss on the stock purchase price guarantee of
$3,210
and a corresponding liability for the same amount in
2016,
which was included in accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheet as of
December 31, 2016.
On
June 2, 2017,
the
two
parties came to an agreement in which we were required to issue the Huntington Note in favor of Huntington. The Huntington Note matures on
June 2, 2019
with the principal amount of
$3,200
payable at maturity. Interest on the outstanding principal accrues at a rate of
8.5%
per year from
August 6, 2016
to
August 15, 2017,
and increases to
10%
per year thereafter. We paid
$50
to Huntington related to accrued interest from
August 6, 2016
through the date of issuance of the Huntington Note.
Huntington was required to return
778,385
shares of the Company’s common stock which were issued into escrow. We were required to provide certain piggyback registration rights to Huntington in regards to the remaining
749,999
shares of the Company’s common stock held by Huntington. If the Huntington Note was paid off prior to
August 14, 2017,
the
778,385
shares held in escrow were to be released from escrow and transferred to the Company for
no
additional consideration. If the note remained outstanding on
August 15, 2017,
we had the right, but
not
the obligation, to pay
$140
to Huntington to purchase
764,192
of the Subject Shares held in escrow. Upon the exercise of this purchase option, the Subject Shares were to be released from escrow and transferred to the Company. If the note remained outstanding on
August 15, 2017
and we did
not
exercise the option to purchase the shares, the shares were to be returned from escrow to Huntington and we would
no
longer have repurchase rights. On
August 15, 2017,
the note was outstanding and we did
not
excerise the repurchase right. The
778,385
shares were returned from escrow to Huntington. Pursuant to the agreement, we were also required to enter into a
four
-year lease agreement with the purchaser related to our premises occupied by Nutricap.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.8.0.1
Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2017
Accounting Policies [Abstract]  
Organization [Policy Text Block]
Organization
Twinlab Consolidated Holdings, Inc. (the “Company”
, “Twinlab,” “we,” “our” and “us”) was incorporated on
October 24, 2013
under the laws of the State of Nevada as Mirror Me, Inc. On
August 7, 2014,
we amended our articles of incorporation and changed our name to Twinlab Consolidated Holdings, Inc.
Nature of Operations [Policy Text Block]
Nature of Operations
We are
an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold to and through domestic health and natural food stores, mass market retailers, specialty stores retailers, on-line retailers and websites. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers.
 
Our
products include vitamins, minerals, specialty supplements and sports nutrition products sold under the Twinlab® brand name (including the Twinlab® Fuel brand of sports nutrition products); a market leader in the healthy aging and beauty from within categories sold under the Reserveage™ Nutrition and ResVitale® brand names; diet and energy products sold under the Metabolife® brand name; the Re-Body® brand name; and a full line of herbal teas sold under the Alvita® brand name. To accommodate consumer preferences, our products come in various formulations and delivery forms, including capsules, tablets, softgels, chewables, liquids, sprays and powders. These products are sold primarily through health and natural food stores and on-line retailers, supermarkets, and mass-market retailers.
 
We also perform contract manufacturing services for private label products.
  Our contract manufacturing business involves the manufacture of custom products to the specifications of a customer who requires finished product under the customer’s own brand name.  We do
not
market these private label products as our business is to manufacture and sell the products to the customer, who then markets and sells the products to retailers or end consumers.
Consolidation, Policy [Policy Text Block]
Principles of Consolidation
The
condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.
Basis of Accounting, Policy [Policy Text Block]
Basis of Presentation and Unaudited Information
The condensed consolidated interim financial statements included herein have been prepared by the Company in accordance with United States generally accepted accounting principles, without audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”).
Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations, although we believe that the disclosures are adequate to make the information presented
not
misleading. These statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management, are necessary for fair presentation of the information contained herein. Financial results for any interim period are
not
necessarily indicative of financial results that
may
be expected for the fiscal year. The unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form
10
-K for the year ended
December 31, 2016
filed with the SEC on
March 31, 2017.
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant management estimates include those with respect to returns and allowances, allowance for doubtful accounts, reserves for inventory obsolescence, the recoverability of long-lived assets, intangibles and goodwill and the estimated value of warrants and derivative liabilities.
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition
Revenue from product sales, net of estimated returns and allowances, is recognized when evidence of an arrangement is in place, related prices are fixed and determinable, contractual obligations have been satisfied, title and risk of loss have been transferred to the customer and collection of the resulting receivable is reasonably assured. Shipping terms are generally
freight on board shipping point. We sell predominately in the North American and European markets, with international sales transacted in U.S. dollars.
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair
V
alue of
F
inancial
I
nstruments
We apply the following fair value hierarchy, which prioritizes the inputs used to measure fair value into
three
levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
 
Level
1
– inputs are quoted prices in active markets for identical assets that the reporting entity has the ability to access at the measurement date.
 
Level
2
– inputs are other than quoted prices included within Level
1
that are observable for the asset, either directly or indirectly.
 
Level
3
– inputs are unobservable inputs for the asset that are supported by little or
no
market activity and that are significant to the fair value of the underlying asset or liability.
 
The following table summarizes our financial instruments that are measured at fair value on a recurring basis as of
September 30, 2017
and
December 31, 2016:
 
September 30, 2017
 
Total
   
Level 1
   
Level 2
   
Level 3
 
                                 
Derivative liabilities
  $
8,143
    $
-
    $
-
    $
8,143
 
 
December 31, 2016
 
Total
   
Level 1
   
Level 2
   
Level 3
 
                                 
Derivative liabilities
  $
6,455
    $
-
    $
-
    $
6,455
 
Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]
Accounts Receivable and Allowances
We
grant credit to customers and generally do
not
require collateral or other security. We perform credit evaluations of our customers and provide for expected claims related to promotional items; customer discounts; shipping shortages; damages; and doubtful accounts based upon historical bad debt and claims experience. As of
September 30, 2017,
total allowances amounted to
$2,777,
of which
$314
was related to doubtful accounts receivable. As of
December 31, 2016,
total allowances amounted to
$2,365,
of which
$481
was related to doubtful accounts receivable.
Inventory, Policy [Policy Text Block]
Inventories
Inventories are stated at the
lower of cost or net realizable value and are reduced by an estimated reserve for obsolete inventory.
Property, Plant and Equipment, Policy [Policy Text Block]
Property and Equipment
Property and equipment are stated at cost, less accumulated depreciation and amortization. Depreciation, including amounts amortized under capital leases, is calculated on the straight-line method over the estimated useful lives of the related assets, which are
7
to
10
years for machinery and equipment,
8
years for furniture and fixtures and
3
years for computers. Leasehold improvements are amortized over the shorter of the useful life of the asset or the term of the lease.
 
 
Normal repairs and maintenance are expensed as incurred. When assets are retired or otherwise disposed of, the related cost and accumulated depreciation or amortization is removed from the accounts and any gain or loss is included in the results of operations.
Goodwill and Intangible Assets, Policy [Policy Text Block]
Intangible Assets
Intangible assets consist primarily of trademarks and customer relationships, which are amortized on a straight-line basis over their estimated useful lives ranging from
3
to
30
years. The valuation and classification of these assets and the assignment of amortizable lives involve significant judgment and the use of estimates.
 
We believe that our long-term growth strategy supports our fair value conclusions. For intangible assets, the recoverability of these amounts is dependent upon achievement of our projections and the execution of key initiatives related to revenue growth and improved profitability.
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]
Goodwill
Goodwill is
not
subject to amortization, but is reviewed for impairment annually, or more frequently whenever events or changes in circumstances indicate the carrying value of goodwill
may
not
be recoverable. An impairment charge would be recorded to the extent the carrying value of goodwill exceeds its estimated fair value. The testing of goodwill under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]
Impairment of Long-Lived Assets
Long-lived assets, including intangible assets subject to amortization, are reviewed for impairment when changes in circumstances indicate that the carrying amount of the asset
may
not
be recoverable. If the carrying amount of the asset exceeds the expected undiscounted cash flows of the asset, an impairment charge is recognized equal to the amount by which the carrying amount exceeds fair value. The testing of these intangibles under established guidelines for impairment requires significant use of judgment and assumptions. Changes in forecasted operations and other assumptions could materially affect the estimated fair values. Changes in business conditions could potentially require adjustments to these asset valuations.
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]
Indefinite-Lived Intangible Assets
Indefinite-lived intangible assets relating to the asset acquisition of Organic Holdings
, LLC (“Organic Holdings”), a market leader in the healthy aging and beauty from within categories and owner of the award-winning Reserveage
™ Nutrition brand, are determined to have an indefinite useful economic life and as such are
not
amortized. Indefinite-lived intangible assets are tested for impairment annually which consists of a comparison of the fair value of the asset with its carrying value. The total indefinite-lived intangible assets as of
September 30, 2017
and
December 31, 2016
was
$5,900
.
Fair Value of Warrants Issued, Policy [Policy Text Block]
Value of Warrants Issued with Debt
We estimate the grant date value of certain warrants issued with debt, using an outside professional valuation firm, which uses the
Monte Carlo option lattice model. We record
the amounts as interest expense or debt discount, depending on the terms of the agreement. These estimates involve multiple inputs and assumptions, including the market price of the Company’s common stock, stock price volatility and other assumptions to project
earnings before interest, taxes, depreciation and amortization (“EBITDA”) and other reset events. These inputs and assumptions are subject to management’s judgment and can vary materially from period to period.
Derivatives, Policy [Policy Text Block]
Derivative Liabilities
We have recorded certain warrants as derivative liabilities at estimated fair value, as determined based on our use of an outside professional valuation firm, due to the variable terms of the warrant agreements.
The value of the derivative liabilities is generally estimated using the Monte Carlo option lattice model with multiple inputs and assumptions, including the market price of the Company’s common stock, stock price volatility and other assumptions to project EBITDA and other reset events. These inputs and assumptions are subject to management’s judgment and can vary materially from period to period.
Sale Leaseback Transactions, Policy [Policy Text Block]
Deferred gain on sale of assets
We
entered into a sale-leaseback arrangement relating to our office facilities in
2013.
Under the terms of the arrangement, we sold an office building and surrounding land and then leased the property back under a
15
-year operating lease. We recorded a deferred gain for the amount of the gain on the sale of the asset, to be recognized as a reduction of rent expense over the life of the lease. Accordingly, we recorded amortization of deferred gain as a reduction of rental expense of
$40
and
$41
for the
three
months ended
September 30, 2017
and
2016,
respectively. For the
nine
months ended
September 30, 2017
and
2016,
we recorded amortization of
$121
and
$122,
respectively. As of
September 30, 2017
and
December 31, 2016,
unamortized deferred gain on sale of assets was
$1,606
and
$1,727,
respectively.
Earnings Per Share, Policy [Policy Text Block]
Net Loss per Common Share
Basic net income or loss per common share (Basic EPS) is computed by dividing net income or loss by the weighted average number of common shares outstanding.
Diluted net income or loss per common share (Diluted EPS) is computed by dividing net income or loss by the sum of the weighted average number of common shares outstanding and the dilutive potential common shares then outstanding. Potential dilutive common share equivalents consist of total shares issuable upon the exercise of outstanding stock options and warrants to acquire common stock using the treasury stock method and the average market price per share during the period.
The common shares used in the computation of our basic and diluted net loss per share are reconciled as follows:
 
   
Three Months Ended
 
Nine Months Ended
 
   
September 30,
 
September 30,
 
   
2017
   
2016
     
2017
   
2016
 
           
(as corrected)
             
(as corrected)
 
Numerator:
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
Net income (loss)
  $
(5,418
)   $
10,968
      $
(12,854
)   $
8,584
 
Effect of dilutive securities on net income (loss):
                                 
Common stock warrants
   
-
     
(14,065
)      
-
     
(28,128
)
                                   
Total net loss for purpose of calculating diluted net loss per common share
  $
(5,418
)   $
(3,097
)     $
(12,854
)   $
(19,544
)
                                   
Number of shares used in per common share calculations:
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
Total shares for purposes of calculating basic net loss per common share
   
252,924,027
     
250,806,152
       
252,935,792
     
264,740,245
 
Weighted-average effect of dilutive securities:
                                 
Common stock warrants
   
-
     
13,418,629
       
-
     
12,481,487
 
                                   
Total shares for purpose of calculating diluted
net loss per common share
   
252,924,027
     
264,224,781
       
252,935,792
     
277,221,732
 
                                   
Net income (loss) per common share:
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
Basic
  $
(0.02
)   $
0.04
      $
(0.05
)   $
0.03
 
Diluted
  $
(0.02
)   $
(0.01
)     $
(0.05
)   $
(0.07
)
 
 
Correction
of
2016
Diluted Net Loss Per Share
The diluted net loss per share for the period ended
September 30, 2016
has been corrected. In accordance with U.S. generally accepted accounting principles, when calculating diluted earnings or loss per share, if the effects are dilutive, companies are required to add back to net income or loss the effects of the change in derivative liabilities related to warrants. Additionally, if the effects of the change in derivative liabilities are added back to net income or loss, companies are required to include the warrants outstanding related to the derivative liability in the calculation of the weighted average dilutive shares.
 
For the period ended
September 30, 2016,
as originally reported, we did
not
add back the effects of the change in the derivative liability in computing dilutive income or loss per share. The dilutive loss per share for the
three
and
nine
months ended
September 30, 2016
in the table above has been revised to correct this error.
 
The table below reflects the diluted net
loss per share as originally reported and net loss per share as corrected for the
three
and
nine
months ended
September 30, 2016.
 
   
As originally reported
   
As corrected
 
                 
Diluted net income (loss) per common share (three months)
  $
0.04
    $
(0.01
)
Diluted net income (loss) per common share (nine months)
  $
0.03
    $
(0.07
)
Weighted average shares oustanding - diluted (three months)
   
258,565,687
     
264,224,781
 
Weighted average shares oustanding - diluted (nine months)
   
275,633,914
     
277,221,732
 
 
 
The errors were corrected as of
December 31, 2016,
but since the adjustments were
not
material to any of the quarters
previously reported, the Form
10
-Qs for those periods were
not
amended. Management has determined the effects to be neither quantitatively or qualitatively material to the financial statements included in any of the Form
10
-Qs filed during
2016.
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Significant Concentration of Credit Risk
Sales to our top
three
customers a
ggregated to approximately
33%
and
25%
of total sales for the
three
months ended
September 30, 2017
and
2016,
respectively, and
27%
and
26%
of total sales for the
nine
months ended
September 30, 2017
and
2016,
respectively. Sales to
one
of those customers were approximately
13%
and
11%
of total sales for the
three
months ended
September 30, 2017
and
2016,
respectively, and
12%
and
11%
of total sales for the
nine
months ended
September 30, 2017
and
2016,
respectively. Accounts receivable from these customers were approximately
55%
and
29%
of total accounts receivable as of
September 30, 2017
and
December 31, 2016,
respectively.
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
In
May
2017,
FASB amended its guidance regarding the scope of modification accounting for share-based compensation arrangements. The amendments provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic
718.
For public entities, the amendments in this update are effective for fiscal years beginning after
December 
15,
2017,
including interim periods within those fiscal years, with early adoption permitted. The amendments in this update should be applied prospectively to an award modified on or after the adoption date.
We do
not
expect the new guidance to have a significant impact on our condensed consolidated financial statements or related disclosures.
 
In
January 2017,
FASB issued ASU
No.
2017
-
04,
“Simplifying the Test for Goodwill Impairment (Topic
350
)” which removes Step
2
of the goodwill impairment test that requires a hypothetical purchase price allocation.  A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value,
not
to exceed the carrying amount of goodwill.  The amendments in this ASU are effective for fiscal years beginning after
December 15, 2019.  
Early adoption is permitted after
January 1, 2017.  
We do
not
expect the new guidance to have a significant impact on our condensed consolidated financial statements or related disclosures.
 
In
February 2016,
FASB issued ASU
No
.
2016
-
02,
“Leases (Topic
842
)”. The amendments in this ASU revise the accounting related to lessee accounting. Under the new guidance, lessees will be required to recognize a lease liability and a right-of-use asset for all leases with terms greater than
12
months affecting the pattern of expense recognition in the income statement. Leases previously defined as operating leases will be defined as financing leases and capitalized if the term is greater than
one
year. The amendments in this ASU are effective for fiscal years beginning after
December 15, 2018
and are to be applied through a modified retrospective transition approach for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements. Early adoption is permitted. We are performing an assessment of our leases and have begun preparations for implementation and retrospective application to the earliest reporting period. As a result, financing leases will be recorded as an asset and a corresponding liability at the present value of the total lease payments. The asset will be decremented over the life of the lease on a pro-rata basis resulting in lease expense while the liability will be decremented using the interest method (ie. principal and interest). As such, we expect the new guidance will materially impact the asset and liability balances of our consolidated financial statements and related disclosures at the time of adoption.
 
Although there are several other new accounting pronouncements issued or proposed by FASB, which we have adopted or will adopt, as applicable, we do
not
believe any of these accounting pronouncements has had or will have a material impact on our
condensed consolidated financial position or results of operations.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2017
Notes Tables  
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
September 30, 2017
 
Total
   
Level 1
   
Level 2
   
Level 3
 
                                 
Derivative liabilities
  $
8,143
    $
-
    $
-
    $
8,143
 
December 31, 2016
 
Total
   
Level 1
   
Level 2
   
Level 3
 
                                 
Derivative liabilities
  $
6,455
    $
-
    $
-
    $
6,455
 
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
   
Three Months Ended
 
Nine Months Ended
 
   
September 30,
 
September 30,
 
   
2017
   
2016
     
2017
   
2016
 
           
(as corrected)
             
(as corrected)
 
Numerator:
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
Net income (loss)
  $
(5,418
)   $
10,968
      $
(12,854
)   $
8,584
 
Effect of dilutive securities on net income (loss):
                                 
Common stock warrants
   
-
     
(14,065
)      
-
     
(28,128
)
                                   
Total net loss for purpose of calculating diluted net loss per common share
  $
(5,418
)   $
(3,097
)     $
(12,854
)   $
(19,544
)
                                   
Number of shares used in per common share calculations:
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
Total shares for purposes of calculating basic net loss per common share
   
252,924,027
     
250,806,152
       
252,935,792
     
264,740,245
 
Weighted-average effect of dilutive securities:
                                 
Common stock warrants
   
-
     
13,418,629
       
-
     
12,481,487
 
                                   
Total shares for purpose of calculating diluted
net loss per common share
   
252,924,027
     
264,224,781
       
252,935,792
     
277,221,732
 
                                   
Net income (loss) per common share:
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
Basic
  $
(0.02
)   $
0.04
      $
(0.05
)   $
0.03
 
Diluted
  $
(0.02
)   $
(0.01
)     $
(0.05
)   $
(0.07
)
Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
   
As originally reported
   
As corrected
 
                 
Diluted net income (loss) per common share (three months)
  $
0.04
    $
(0.01
)
Diluted net income (loss) per common share (nine months)
  $
0.03
    $
(0.07
)
Weighted average shares oustanding - diluted (three months)
   
258,565,687
     
264,224,781
 
Weighted average shares oustanding - diluted (nine months)
   
275,633,914
     
277,221,732
 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 3 - Inventories (Tables)
9 Months Ended
Sep. 30, 2017
Notes Tables  
Schedule of Inventory, Current [Table Text Block]
   
September 30,
   
December 31,
 
   
2017
   
2016
 
                 
Raw materials
  $
6,348
    $
4,912
 
Work in process
   
2,013
     
1,189
 
Finished goods
   
12,411
     
13,438
 
     
20,772
     
19,539
 
Reserve for obsolete inventory
   
(2,404
)    
(1,938
)
    $
18,368
    $
17,601
 
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 4 - Property and Equipment (Tables)
9 Months Ended
Sep. 30, 2017
Notes Tables  
Property, Plant and Equipment [Table Text Block]
   
September 30,
   
December 31,
 
   
2017
   
2016
 
                 
Machinery and equipment
  $
12,156
    $
10,885
 
Computers and other
   
9,500
     
9,119
 
Aquifer
   
482
     
482
 
Leasehold improvements
   
1,518
     
1,518
 
     
23,656
     
22,004
 
Accumulated depreciation and amortization
   
(20,416
)    
(18,476
)
    $
3,240
    $
3,528
 
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 5 - Intangible Assets (Tables)
9 Months Ended
Sep. 30, 2017
Notes Tables  
Schedule of Finite-Lived Intangible Assets [Table Text Block]
   
September 30,
   
December 31,
 
   
2017
   
2016
 
                 
Trademarks
  $
12,166
    $
12,166
 
Indefinite-lived intangible assets
   
5,900
     
5,900
 
Customer relationships
   
19,110
     
19,110
 
Other
   
753
     
753
 
     
37,929
     
37,929
 
Accumulated amortization
   
(9,479
)    
(7,732
)
    $
28,450
    $
30,197
 
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 6 - Debt (Tables)
9 Months Ended
Sep. 30, 2017
Notes Tables  
Schedule of Debt [Table Text Block]
   
September 30,
   
December 31,
 
   
2017
   
2016
 
                 
Related-Party Debt:
               
July 2014 note payable to Little Harbor, LLC, net of unamortized discount of $0 and $206 as of September 30, 2017 and December 31, 2016, respectively
  $
3,267
    $
3,061
 
July 2016 note payable to Little Harbor, LLC
   
4,770
     
4,770
 
January 2016 note payable to Great Harbor Capital, LLC
   
2,500
     
2,500
 
March 2016 note payable to Great Harbor Capital, LLC
   
7,000
     
7,000
 
December 2016 note payable to Great Harbor Capital, LLC
   
2,500
     
2,500
 
August 2017 note payable to Great Harbor Capital, LLC
   
3,000
     
-
 
January 2016 note payable to Golisano Holdings LLC
   
2,500
     
2,500
 
March 2016 note payable to Golisano Holdings LLC
   
7,000
     
7,000
 
July 2016 note payable to Golisano Holdings LLC
   
4,770
     
4,770
 
December 2016 note payable to Golisano Holdings LLC
   
2,500
     
2,500
 
March 2017 note payable to Golisano Holdings LLC
   
3,267
     
-
 
November 2014 note payable to Golisano Holdings LLC (formerly payble to Penta
               
Mezzanine SBIC Fund I, L.P.), net of discount and unamortized loan fees in the aggregate of $1,694 and $2,304 as of September 30, 2017 and December 31, 2016, respectively
   
6,306
     
5,696
 
January 2015 note payable to Golisano Holdings LLC (formerly payable to JL-BBNC
               
Mezz Utah, LLC), net of discount and unamortized loan fees in the aggregate of $2,058 as of September 30, 2017
   
2,942
     
-
 
February 2015 note payable to Golisano Holdings LLC (formerly payable to Penta
               
Mezzanine SBIC Fund I, L.P.), net of discount and unamortized loan fees in the aggregate of $148 and $201 as of September 30, 2017 and December 31, 2016, respectively
   
1,852
     
1,799
 
Total related-party debt
   
54,174
     
44,096
 
                 
Senior Credit Facility with Midcap, net of unamortized loan fees of $73 and $293 as of September 30, 2017 and December 31, 2016, respectively
   
14,901
     
13,035
 
                 
Other Debt:
               
January 2015 note payable to JL-BBNC Mezz Utah, LLC, net of discount and unamortized loan fees in the aggregate of $2,744 as of December 31, 2016
   
-
     
2,256
 
April 2016 note payable to JL-Utah Sub, LLC
   
396
     
500
 
Capital lease obligations
   
1,582
     
2,732
 
Huntington Holdings
   
3,200
     
-
 
Total other debt
   
5,178
     
5,488
 
                 
Total debt
   
74,253
     
62,619
 
Less current portion
   
(17,091
)    
(11,631
)
Long-term debt
  $
57,162
    $
50,988
 
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 7 - Warrants and Registration Rights Agreements (Tables)
9 Months Ended
Sep. 30, 2017
Notes Tables  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
   
 
 
 
 
Weighted Average
 
   
Shares
   
Exercise Price
 
                 
                 
Outstanding, December 31, 2016
   
15,855,017
     
0.18
 
                 
Granted
   
-
     
-
 
Canceled / Expired
   
-
     
-
 
Exercised
   
-
     
-
 
Outstanding, September 30, 2017
   
15,855,017
     
0.18
 
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 8 - Derivative Liabilities (Tables)
9 Months Ended
Sep. 30, 2017
Notes Tables  
Schedule of Derivative Liabilities at Fair Value [Table Text Block]
   
Nine Months Ended
 
   
September 30,
 
   
2017
 
Derivative liabilities at December 31, 2016
  $
6,455
 
         
Loss on change in fair value of derivative liabilities
   
1,688
 
Derivative liabilities at September 30, 2017
  $
8,143
 
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2017
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2017
USD ($)
Sep. 30, 2016
USD ($)
Dec. 31, 2016
USD ($)
Allowance for Doubtful Accounts Receivable, Current $ 2,777   $ 2,777   $ 2,365
Allowance for Accounts Receivable, Current, Doubtful Accounts 314   314   481
Indefinite-Lived Intangible Assets (Excluding Goodwill) 5,900   $ 5,900   5,900
Lessor, Operating Lease, Term of Contract     15 years    
Amortization of Deferred Gain on Sale of Assets 40 $ 41 $ 121 $ 122  
Deferred Gain on Sale of Property $ 1,606   $ 1,606   $ 1,727
Sales Revenue, Net [Member] | One of Top Three Customers [Member] | Customer Concentration Risk [Member]          
Number of Major Customers 1 1      
Concentration Risk, Percentage 13.00% 11.00% 12.00% 11.00%  
Sales Revenue, Net [Member] | Top Three Customers [Member] | Customer Concentration Risk [Member]          
Number of Major Customers 3 3      
Concentration Risk, Percentage 33.00% 25.00% 27.00% 26.00%  
Accounts Receivable [Member] | Customer Concentration Risk [Member]          
Concentration Risk, Percentage     55.00%   29.00%
Minimum [Member] | Trademarks and Customer Relationships [Member]          
Finite-Lived Intangible Asset, Useful Life     3 years    
Maximum [Member] | Trademarks and Customer Relationships [Member]          
Finite-Lived Intangible Asset, Useful Life     30 years    
Machinery and Equipment [Member] | Minimum [Member]          
Property, Plant and Equipment, Useful Life     7 years    
Machinery and Equipment [Member] | Maximum [Member]          
Property, Plant and Equipment, Useful Life     10 years    
Furniture and Fixtures [Member]          
Property, Plant and Equipment, Useful Life     8 years    
Computer Equipment [Member]          
Property, Plant and Equipment, Useful Life     3 years    
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Financial Instruments Measured at Fair Value on a Recurring Basis (Details) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Derivative liabilities $ 8,143 $ 6,455
Fair Value, Measurements, Recurring [Member]    
Derivative liabilities 8,143 6,455
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]    
Derivative liabilities 0 0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]    
Derivative liabilities 0 0
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]    
Derivative liabilities $ 8,143 $ 6,455
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Basic and Diluted Net Loss Per Common Share (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Net income (loss) $ (5,418) $ 10,968 $ (12,854) $ 8,584
Common stock warrants (14,065) (28,128)
Total net loss for purpose of calculating diluted net loss per common share $ (5,418) $ (3,097) $ (12,854) $ (19,544)
Total shares for purposes of calculating basic net loss per common share (in shares) 252,924,027 250,806,152 252,935,792 264,740,245
Common stock warrants (in shares) 13,418,629 12,481,487
Total shares for purpose of calculating diluted net loss per common share (in shares) 252,924,027 264,224,781 252,935,792 277,221,732
Basic (in dollars per share) $ (0.02) $ 0.04 $ (0.05) $ 0.03
Diluted (in dollars per share) $ (0.02) $ (0.01) $ (0.05) $ (0.07)
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Restatement of 2016 Diluted Net Loss Per Share (Details) - $ / shares
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Diluted net income (loss) per common share (three months) (in dollars per share) $ (0.02) $ (0.01) $ (0.05) $ (0.07)
Weighted average shares oustanding - diluted (three months) (in shares) 252,924,027 264,224,781 252,935,792 277,221,732
Scenario, Previously Reported [Member]        
Diluted net income (loss) per common share (three months) (in dollars per share)   $ 0.04   $ 0.03
Weighted average shares oustanding - diluted (three months) (in shares)   258,565,687   275,633,914
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 2 - Going Concern (Details Textual) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Retained Earnings (Accumulated Deficit) $ (237,326) $ (224,472)
Working Capital Deficiency 8,531  
Long-term Debt, Current Maturities $ 17,091 $ 11,631
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 3 - Inventories - Summary of Inventories (Details) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Raw materials $ 6,348 $ 4,912
Work in process 2,013 1,189
Finished goods 12,411 13,438
20,772 19,539
Reserve for obsolete inventory (2,404) (1,938)
$ 18,368 $ 17,601
XML 40 R29.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 4 - Property and Equipment (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Depreciation $ 222 $ 221 $ 669 $ 567  
Machinery and Equipment [Member]          
Capital Leased Assets, Gross $ 1,082   $ 1,082   $ 1,142
XML 41 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 4 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Property and equipment $ 23,656 $ 22,004
Accumulated depreciation and amortization (20,416) (18,476)
3,240 3,528
Machinery and Equipment [Member]    
Property and equipment 12,156 10,885
Computers and Other [Member]    
Property and equipment 9,500 9,119
Aquifer [Member]    
Property and equipment 482 482
Leasehold Improvements [Member]    
Property and equipment $ 1,518 $ 1,518
XML 42 R31.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 5 - Intangible Assets (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Amortization of Intangible Assets $ 582 $ 557 $ 1,747 $ 1,645  
Other Intangible Assets [Member]          
Finite-Lived Intangible Asset, Useful Life         3 years
Minimum [Member] | Trademarks [Member]          
Finite-Lived Intangible Asset, Useful Life         3 years
Minimum [Member] | Customer Relationships [Member]          
Finite-Lived Intangible Asset, Useful Life         15 years
Maximum [Member] | Trademarks [Member]          
Finite-Lived Intangible Asset, Useful Life         30 years
Maximum [Member] | Customer Relationships [Member]          
Finite-Lived Intangible Asset, Useful Life         16 years
XML 43 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 5 - Intangible Assets - Summary of Intangible Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Indefinite-lived intangible assets $ 5,900 $ 5,900
37,929 37,929
Accumulated amortization (9,479) (7,732)
28,450 30,197
Trademarks [Member]    
Intangible assets 12,166 12,166
Customer Relationships [Member]    
Intangible assets 19,110 19,110
Other Intangible Assets [Member]    
Intangible assets $ 753 $ 753
XML 44 R33.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 6 - Debt (Details Textual) - USD ($)
3 Months Ended 7 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Jun. 02, 2019
Jun. 02, 2017
Mar. 14, 2017
Dec. 31, 2016
Sep. 02, 2016
Aug. 06, 2016
Jul. 21, 2016
Apr. 05, 2016
Mar. 21, 2016
Jan. 28, 2016
Feb. 06, 2015
Jan. 22, 2015
Nov. 13, 2014
Sep. 30, 2017
Sep. 30, 2016
Aug. 15, 2017
Sep. 30, 2017
Sep. 29, 2017
Sep. 30, 2016
Jun. 02, 2017
Dec. 31, 2016
Aug. 30, 2017
Mar. 09, 2017
Feb. 04, 2015
Class of Warrant or Right, Number of Securities Called by Warrants or Rights       15,855,017                   15,855,017     15,855,017       15,855,017      
Loss on Stock Purchase Guarantees                               $ 3,210,000   $ 3,210,000      
Interest Paid                                 $ 982,000   $ 3,818,000          
Common Stock, Shares Subscribed but Unissued, Return                               778,385                
Common Stock, Shares Subscribed but Unissued                           1,528,384     1,528,384              
Revolving Credit Facility [Member] | Midcap Funding X Trust [Member]                                                
Debt Instrument, Term                       3 years                        
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                       500,000                        
Warrants Not Settleable in Cash, Fair Value Disclosure                       $ 130,000                        
Debt Instrument, Fee Amount                       540,000                        
Line of Credit Facility, Maximum Borrowing Capacity         $ 17,000,000             $ 15,000,000                        
Line of Credit Facility, Potential Maximum Borrowing Capacity         $ 20,000,000                                      
Percentage of Unused Line Fee Per Month         0.50%                                      
Percentage of Management Fee Per Month                       1.20%                        
Debt Instrument, Basis Spread on Variable Rate                       5.00%         6.24%              
Related Party Debt July 2016 Note Payable to Little Harbor LLC [Member]                                                
Debt Instrument, Interest Rate, Stated Percentage             8.50%                                  
Debt Instrument, Face Amount             $ 4,770,000                                  
Proceeds from Related Party Debt                                         $ 4,770,000      
Debt Instrument, Maturity Date             Jan. 28, 2019                                  
Little Harbor [Member]                                                
Debt Instrument, Periodic Payment                                 $ 4,900,000              
Debt Instrument, Term                                 3 years              
Debt Instrument, Obligation Termination, Stock Price Trigger                           5.06     5.06              
Debt Instrument, Interest Rate, Stated Percentage                           16.20%     16.20%              
Great Harbor Capital, LLC [Member] | Notes Payable, Other Payables [Member]                                                
Debt Instrument, Interest Rate, Stated Percentage       8.50%         8.50% 8.50%                     8.50% 8.50%    
Debt Instrument, Face Amount       $ 2,500,000         $ 7,000,000 $ 2,500,000                     $ 2,500,000 $ 3,000,000    
Debt Instrument, Periodic Payment, Principal                 $ 292,000 $ 104,000                            
Debt Instrument, Maturity Date       Dec. 30, 2019         Mar. 21, 2019 Jan. 28, 2019                            
Debt Instrument, Date of First Required Payment                 Apr. 21, 2017 Feb. 28, 2017             Jan. 21, 2018 Jan. 28, 2018            
Golisano Holdings LLC [Member]                                                
Debt Instrument, Interest Rate, Stated Percentage                     12.00% 12.00% 12.00%                   8.00%  
Debt Instrument, Face Amount                     $ 2,000,000                          
Proceeds from Notes Payable                       $ 5,000,000 $ 8,000,000                      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                       2,329,400 4,960,740                     434,809
Warrants Not Settleable in Cash, Fair Value Disclosure                     250,000 $ 4,389,000 $ 3,770,000                      
Debt Instrument, Fee Amount                     $ 90,000 $ 152,000 $ 273,000                      
Debt Instrument, Maturity Date                     Nov. 13, 2019   Nov. 13, 2019                      
Golisano Holdings LLC [Member] | Warrants Issued on January 22, 2015[Member]                                                
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                     869,618                          
Golisano Holdings LLC [Member] | Unsecured Promissory Note [Member]                                                
Debt Instrument, Interest Rate, Stated Percentage     8.50% 8.50%         8.50% 8.50%                     8.50%      
Debt Instrument, Face Amount     $ 3,267,000 $ 2,500,000         $ 7,000,000 $ 2,500,000                     $ 2,500,000      
Debt Instrument, Periodic Payment, Principal                 $ 292,000 $ 104,000                            
Debt Instrument, Maturity Date     Dec. 30, 2019 Dec. 30, 2019         Mar. 21, 2019 Jan. 28, 2019                            
Debt Instrument, Date of First Required Payment                 Apr. 21, 2017 Feb. 28, 2017             Jan. 21, 2018 Jan. 28, 2018            
Golisano Holdings LLC [Member] | Unsecured Delayed Draw Promissory Note [Member]                                                
Debt Instrument, Interest Rate, Stated Percentage             8.50%                                  
Debt Instrument, Face Amount             $ 4,770,000                                  
Proceeds from Related Party Debt                                         $ 4,770,000      
Debt Instrument, Maturity Date             Jan. 28, 2019                                  
JL [Member]                                                
Debt Instrument, Date of First Required Payment                       Mar. 08, 2017                        
JL [Member] | Notes Payable Maturing in March 2019 [Member]                                                
Debt Instrument, Interest Rate, Stated Percentage               8.50%                                
Debt Instrument, Periodic Payment, Principal               $ 21,000                                
Notes Payable to Bank, Noncurrent               $ 500,000                                
Debt Instrument, Maturity Date               Mar. 21, 2019                                
Debt Instrument, Date of First Required Payment               Apr. 21, 2017                                
Huntington Holdings, LLC [Member]                                                
Common Stock Subscription Price Per Share           $ 2.29                                    
Stock Price Guarantee Payment           $ 3,210,000                                    
Common Stock, Shares Subscribed but Unissued, Return                           778,385   778,385 778,385              
Common Stock, Shares Subscribed but Unissued                           749,999     749,999              
Common Stock, Shares Subscribed but Unissued, Option to Purchase Shares Price                           $ 140,000   $ 140,000 $ 140,000              
Common Stock, Shares Subscribed but Unissued, Option to Purchase Shares                           764,192   764,192 764,192              
Lessee, Operating Lease, Term of Contract                               4 years 4 years              
Huntington Holdings, LLC [Member] | Unsecured Promissory Note [Member]                                                
Debt Instrument, Interest Rate, Stated Percentage                               8.50%                
Debt Instrument, Face Amount   $ 3,200,000                                   $ 3,200,000        
Interest Paid           $ 50,000                           $ 50,000        
Debt Instrument, Maturity Date   Jun. 02, 2019                                            
Huntington Holdings, LLC [Member] | Unsecured Promissory Note [Member] | Scenario, Forecast [Member]                                                
Debt Instrument, Interest Rate, Increase (Decrease) 10.00%                                              
XML 45 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 6 - Debt - Summary of Debt (Details) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Long-term debt, net $ 54,174 $ 44,096
Other debt 5,178 5,488
Capital lease obligations 1,582 2,732
Total debt 74,253 62,619
Less current portion (17,091) (11,631)
Long-term debt 57,162 50,988
January, 2015 Note Payable to JL-BBNC Mezz Utah, LLC [Member]    
Other debt 2,256
April 2016 Note Payable To JL-Utah Sub, LLC [Member]    
Other debt 396 500
Senior Credit Facility With Midcap [Member]    
Long-term debt, net 14,901 13,035
Related Party July 2014 Note Payable to Little Harbor, LLC, [Member]    
Long-term debt, net 3,267 3,061
Related Party Debt July 2016 Note Payable to Little Harbor LLC [Member]    
Long-term debt, net 4,770 4,770
Related-Party Debt January 2016 Note Payable to Great Harbor Hospital, LLC [Member]    
Long-term debt, net 2,500 2,500
Related-Party Debt March 2016 Note Payable to Great Harbor Capital, LLC [Member]    
Long-term debt, net 7,000 7,000
Related-Party Debt December 2016 Note Payable to Great Harbor Hospital, LLC [Member]    
Long-term debt, net 2,500 2,500
Related Party August 2017 Note Payable to Great Harbor LLC [Member]    
Long-term debt, net 3,000
Related-Party Debt January 2016 Note payable to Golisano Holdings LLC [Member]    
Long-term debt, net 2,500 2,500
Related-Party Debt March 2016 note payable to Golisano Holdings LLC [Member]    
Long-term debt, net 7,000 7,000
Related Part Debt July 2016 Note Payable To Golisano Holdings LLC [Member]    
Long-term debt, net 4,770 4,770
Related Part Debt December 2016 Note Payable To Golisano Holdings LLC [Member]    
Long-term debt, net 2,500 2,500
Related-party Debt March 2017 Note payable to Golisano Holdings LLC [Member]    
Long-term debt, net 3,267
Related Party Debt November 2014 Note Payable to Golisano Holdings LLC (Formerly Penta Mezzanine SBIC Fund I, L.P.) [Member]    
Long-term debt, net 6,306 5,696
Related-Party Debt January 2015 Note Payable to Golisano Holdings LLC (Formerly Payable to JL-BBNC Mezz Utah, LLC) [Member]    
Long-term debt, net 2,942
February 2015 Note Payable to Golisano Holdings LLC (Formerly Payable to Penta Mezzanine SBIC Fund I, L.P.) [Member]    
Long-term debt, net 1,852 1,799
Unsecured Promissory Note with Huntington Holdings, LLC [Member]    
Long-term debt, net $ 3,200
XML 46 R35.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 6 - Debt - Summary of Debt (Details) (Parentheticals) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
January, 2015 Note Payable to JL-BBNC Mezz Utah, LLC [Member]    
Debt instrument, unamortized discount $ 2,744
Senior Credit Facility With Midcap [Member]    
Debt instrument, unamortized discount 73 293
Related Party July 2014 Note Payable to Little Harbor, LLC, [Member]    
Debt instrument, unamortized discount 0 206
Related Party Debt November 2014 Note Payable to Golisano Holdings LLC (Formerly Penta Mezzanine SBIC Fund I, L.P.) [Member]    
Debt instrument, unamortized discount 1,694 2,304
Related-Party Debt January 2015 Note Payable to Golisano Holdings LLC (Formerly Payable to JL-BBNC Mezz Utah, LLC) [Member]    
Debt instrument, unamortized discount 2,058
February 2015 Note Payable to Golisano Holdings LLC (Formerly Payable to Penta Mezzanine SBIC Fund I, L.P.) [Member]    
Debt instrument, unamortized discount $ 148 $ 201
XML 47 R36.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 7 - Warrants and Registration Rights Agreements (Details Textual) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2016
Jul. 31, 2016
Apr. 05, 2016
Mar. 21, 2016
Feb. 06, 2016
Jan. 28, 2016
Nov. 13, 2014
Apr. 30, 2015
Mar. 31, 2017
Sep. 30, 2017
Sep. 30, 2016
Dec. 31, 2016
Aug. 30, 2017
Oct. 31, 2015
Jun. 30, 2015
Feb. 06, 2015
Feb. 04, 2015
Jan. 22, 2015
Class of Warrant or Right, Number of Securities Called by Warrants or Rights 15,855,017                 15,855,017   15,855,017            
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.18                 $ 0.18   $ 0.18            
Class of Warrant or Right, Exercised During Period, Number of Securities Called by Warrants or Rights                                  
Proceeds from Warrant Exercises                   $ 1,000              
Essex Capital Corporation [Member]                                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                             1,428,571      
Class of Warrant or Right, Exercise Price of Warrants or Rights                             $ 0.77      
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right                   350,649                
Golisano Holdings LLC [Member]                                    
Class of Warrant or Right, Exercise Price of Warrants or Rights         $ 1                 $ 0.001        
Common Stock, Capital Shares Reserved for Future Issuance                   4,756,505       12,697,977        
Number of Warrants Expired         509,141                          
Number of Warrants Cancelled                       6,857,143            
January 2016 Golisano Warrant [Member]                                    
Class of Warrant or Right, Exercise Price of Warrants or Rights           $ 0.01                        
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right           1,136,363                        
Common Stock, Capital Shares Reserved for Future Issuance           1,136,363                        
Class of Warrant or Right, Expiration Date           Feb. 28, 2022                        
March 2016 Golisano Warrant [Member]                                    
Class of Warrant or Right, Exercise Price of Warrants or Rights       $ 0.01                            
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right       3,181,816                            
Common Stock, Capital Shares Reserved for Future Issuance       3,181,816                            
Class of Warrant or Right, Expiration Date       Mar. 21, 2022                            
Little Harbor July 2016 Warrant [Member]                                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   2,168,178                                
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 0.01                                
Common Stock, Capital Shares Reserved for Future Issuance   2,168,178                                
Class of Warrant or Right, Expiration Date   Jul. 21, 2022                                
Golisano LLC December 2016 Warrant [Member]                                    
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.01                     $ 0.01            
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right 1,136,363                     1,136,363            
Common Stock, Capital Shares Reserved for Future Issuance 1,136,363                     1,136,363            
Class of Warrant or Right, Expiration Date Dec. 30, 2022                                  
Golisano LLC March 2017 Warrant [Member]                                    
Class of Warrant or Right, Exercise Price of Warrants or Rights                 $ 0.01                  
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right                 1,484,847                  
Common Stock, Capital Shares Reserved for Future Issuance                 1,484,847                  
Class of Warrant or Right, Expiration Date                 Mar. 14, 2023                  
December 2016 GH Warrant [Member]                                    
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.01                     $ 0.01            
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right 1,136,363                     1,136,363            
Common Stock, Capital Shares Reserved for Future Issuance 1,136,363                     1,136,363            
Class of Warrant or Right, Expiration Date Dec. 30, 2022                                  
August 2017 GH Warrant [Member]                                    
Class of Warrant or Right, Exercise Price of Warrants or Rights                         $ 0.01          
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right                         1,363,636          
Common Stock, Capital Shares Reserved for Future Issuance                         1,363,636          
JL Warrants [Member]                                    
Class of Warrant or Right, Exercise Price of Warrants or Rights     $ 0.01                              
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right     227,273                              
Common Stock, Capital Shares Reserved for Future Issuance     227,273                              
Class of Warrant or Right, Expiration Date     Mar. 21, 2022                              
Golisano Warrants [Member]                                    
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 0.01                                
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right   2,168,178                                
Common Stock, Capital Shares Reserved for Future Issuance   2,168,178                                
Class of Warrant or Right, Expiration Date   Jul. 21, 2022                                
Midcap Funding X Trust [Member]                                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                                   500,000
Class of Warrant or Right, Exercise Price of Warrants or Rights                                   $ 0.76
Penta Mezzanine SBIC Fund I, L.P. [Member]                                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                   4,960,740           4,960,740    
Class of Warrant or Right, Exercise Price of Warrants or Rights                               $ 0.01    
Proceeds from Notes Payable             $ 8,000,000                      
Class of Warrant or Right, Minimum Repurchase Price, Under Agreement                   $ 3,750,000                
Penta Mezzanine SBIC Fund I, L.P. [Member] | Warrants Issued on June 30, 2015 [Member]                                    
Class of Warrant or Right, Exercise Price of Warrants or Rights                             $ 0.01      
Class of Warrant or Right, Cancelled, Number of Securities Called by Warrants or Rights                             807,018      
Penta Mezzanine SBIC Fund I, L.P. [Member] | Warrants Issued on January 22, 2015[Member]                                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                                   869,618
Class of Warrant or Right, Exercise Price of Warrants or Rights                                   $ 1
JL-BBNC Mezz Utah, LLC [Member]                                    
Class of Warrant or Right, Exercised During Period, Number of Securities Called by Warrants or Rights                       1,187,995            
Proceeds from Warrant Exercises                       $ 1            
JL-BBNC Mezz Utah, LLC [Member] | Warrants Issued on June 30, 2015 [Member]                                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                             403,509      
Class of Warrant or Right, Exercise Price of Warrants or Rights                             $ 0.01      
JL-BBNC Mezz Utah, LLC [Member] | Warrants Issued on January 22, 2015[Member]                                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                                   2,329,400
Class of Warrant or Right, Exercise Price of Warrants or Rights                                   $ 0.01
JL-BBNC Mezz Utah, LLC [Member] | Warrants Issued on February 4, 2015 [Member]                                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                                 434,809  
Class of Warrant or Right, Exercise Price of Warrants or Rights                                 $ 1  
JL Properties, Inc. [Member]                                    
Deposits Assets               $ 1,000,000                    
JL Properties, Inc. [Member] | First Warrant [Member]                                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights               465,880                    
Class of Warrant or Right, Exercise Price of Warrants or Rights               $ 0.01                    
Adjustments on Warrants Trigger Event, Minimum Adjusted EBITDA               $ 19,250,000                    
JL Properties, Inc. [Member] | Second Warrant [Member]                                    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights               86,962                    
Class of Warrant or Right, Exercise Price of Warrants or Rights               $ 1                    
XML 48 R37.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 7 - Warrants and Registration Rights Agreements - Summary of the Warrants Issued and Changes (Details)
9 Months Ended
Sep. 30, 2017
$ / shares
shares
Outstanding, beginning balance (in shares) | shares 15,855,017
Outstanding, weighted average exercise price (in dollars per share) | $ / shares $ 0.18
Granted (in shares) | shares
Granted, , weighted average exercise price (in dollars per share) | $ / shares
Canceled / Expired (in shares) | shares
Canceled / expired, , weighted average exercise price (in dollars per share) | $ / shares
Exercised (in shares) | shares
Exercised, weighted average exercise price (in dollars per share) | $ / shares
Outstanding, ending balance (in shares) | shares 15,855,017
Outstanding, weighted average exercise price (in dollars per share) | $ / shares $ 0.18
XML 49 R38.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 8 - Derivative Liabilities (Details Textual) - USD ($)
$ in Thousands
Sep. 30, 2017
Dec. 31, 2016
Derivative Liability $ 8,143 $ 6,455
XML 50 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 8 - Derivative Liabilities - Activity in Derivative Liabilities Account (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Sep. 30, 2017
Sep. 30, 2016
Derivative liabilities     $ 6,455  
Loss on change in fair value of derivative liabilities $ 393 $ (14,065) 1,688 $ (28,128)
Derivative liabilities $ 8,143   $ 8,143  
XML 51 R40.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 9 - Stockholders' Equity (Deficit) (Details Textual) - USD ($)
3 Months Ended 7 Months Ended 9 Months Ended 10 Months Ended 12 Months Ended
Jun. 02, 2019
Jan. 05, 2017
Aug. 06, 2016
Sep. 30, 2017
Sep. 30, 2016
Aug. 15, 2017
Sep. 30, 2017
Sep. 30, 2016
Jun. 02, 2017
Dec. 31, 2016
Preferred Stock, Shares Authorized       500,000,000     500,000,000     500,000,000
Preferred Stock, Par or Stated Value Per Share       $ 0.001     $ 0.001     $ 0.001
Preferred Stock, Shares Issued       0     0     0
Stock Issued During Period, Shares, Restricted Stock Award, Gross             0      
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant       6,060,943     6,060,943      
Stock Issued During Period Shares Warrants Exercised   642,366                
Stock Issued During Period Value Warrants Exercised   $ 1                
Common Stock, Shares Subscribed but Unissued       1,528,384     1,528,384      
Common Stock, Share Subscribed but Unissued, Subscriptions Receivable       $ 30,000     $ 30,000     $ 30,000
Subscription Receivable Annual Interest Rate       5.00%     5.00%      
Loss on Stock Purchase Guarantees         $ 3,210,000   $ 3,210,000
Interest Paid             $ 982,000 $ 3,818,000    
Common Stock, Shares Subscribed but Unissued, Return           778,385        
Huntington Holdings, LLC [Member]                    
Common Stock, Shares Subscribed but Unissued       749,999     749,999      
Common Stock Subscription Price Per Share     $ 2.29              
Stock Price Guarantee Payment     $ 3,210,000              
Common Stock, Shares Subscribed but Unissued, Return       778,385   778,385 778,385      
Common Stock, Shares Subscribed but Unissued, Option to Purchase Shares Price       $ 140,000   $ 140,000 $ 140,000      
Common Stock, Shares Subscribed but Unissued, Option to Purchase Shares       764,192   764,192 764,192      
Lessee, Operating Lease, Term of Contract           4 years 4 years      
Huntington Holdings, LLC [Member] | Unsecured Promissory Note [Member]                    
Debt Instrument, Face Amount                 $ 3,200,000  
Debt Instrument, Interest Rate, Stated Percentage           8.50%        
Interest Paid     $ 50,000           $ 50,000  
Huntington Holdings, LLC [Member] | Unsecured Promissory Note [Member] | Scenario, Forecast [Member]                    
Debt Instrument, Interest Rate, Increase (Decrease) 10.00%                  
TCC Plan [Member]                    
Common Stock, Capital Shares Reserved for Future Issuance       20,000,000     20,000,000      
TCC Plan [Member] | Restricted Stock Units (RSUs) [Member]                    
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage             25.00%      
EXCEL 52 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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
  •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how.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 54 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 56 FilingSummary.xml IDEA: XBRL DOCUMENT 3.8.0.1 html 190 220 1 false 74 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.twinlab.com/20170930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.twinlab.com/20170930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.twinlab.com/20170930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://www.twinlab.com/20170930/role/statement-condensed-consolidated-statements-of-comprehensive-loss-unaudited Condensed Consolidated Statements of Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.twinlab.com/20170930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 5 false false R6.htm 005 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies Sheet http://www.twinlab.com/20170930/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies Note 1 - Nature of Operations and Summary of Significant Accounting Policies Notes 6 false false R7.htm 006 - Disclosure - Note 2 - Going Concern Sheet http://www.twinlab.com/20170930/role/statement-note-2-going-concern Note 2 - Going Concern Notes 7 false false R8.htm 007 - Document - Note 3 - Inventories Sheet http://www.twinlab.com/20170930/role/statement-note-3-inventories Note 3 - Inventories Uncategorized 8 false false R9.htm 008 - Disclosure - Note 4 - Property and Equipment Sheet http://www.twinlab.com/20170930/role/statement-note-4-property-and-equipment Note 4 - Property and Equipment Uncategorized 9 false false R10.htm 009 - Disclosure - Note 5 - Intangible Assets Sheet http://www.twinlab.com/20170930/role/statement-note-5-intangible-assets Note 5 - Intangible Assets Uncategorized 10 false false R11.htm 010 - Disclosure - Note 6 - Debt Sheet http://www.twinlab.com/20170930/role/statement-note-6-debt Note 6 - Debt Uncategorized 11 false false R12.htm 011 - Disclosure - Note 7 - Warrants and Registration Rights Agreements Sheet http://www.twinlab.com/20170930/role/statement-note-7-warrants-and-registration-rights-agreements Note 7 - Warrants and Registration Rights Agreements Uncategorized 12 false false R13.htm 012 - Disclosure - Note 8 - Derivative Liabilities Sheet http://www.twinlab.com/20170930/role/statement-note-8-derivative-liabilities Note 8 - Derivative Liabilities Uncategorized 13 false false R14.htm 013 - Disclosure - Note 9 - Stockholders' Equity (Deficit) Sheet http://www.twinlab.com/20170930/role/statement-note-9-stockholders-equity-deficit Note 9 - Stockholders' Equity (Deficit) Uncategorized 14 false false R15.htm 014 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.twinlab.com/20170930/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Uncategorized 15 false false R16.htm 015 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables) Sheet http://www.twinlab.com/20170930/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-tables Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables) Uncategorized 16 false false R17.htm 016 - Disclosure - Note 3 - Inventories (Tables) Sheet http://www.twinlab.com/20170930/role/statement-note-3-inventories-tables Note 3 - Inventories (Tables) Uncategorized 17 false false R18.htm 017 - Disclosure - Note 4 - Property and Equipment (Tables) Sheet http://www.twinlab.com/20170930/role/statement-note-4-property-and-equipment-tables Note 4 - Property and Equipment (Tables) Uncategorized 18 false false R19.htm 018 - Disclosure - Note 5 - Intangible Assets (Tables) Sheet http://www.twinlab.com/20170930/role/statement-note-5-intangible-assets-tables Note 5 - Intangible Assets (Tables) Uncategorized 19 false false R20.htm 019 - Disclosure - Note 6 - Debt (Tables) Sheet http://www.twinlab.com/20170930/role/statement-note-6-debt-tables Note 6 - Debt (Tables) Uncategorized 20 false false R21.htm 020 - Disclosure - Note 7 - Warrants and Registration Rights Agreements (Tables) Sheet http://www.twinlab.com/20170930/role/statement-note-7-warrants-and-registration-rights-agreements-tables Note 7 - Warrants and Registration Rights Agreements (Tables) Uncategorized 21 false false R22.htm 021 - Disclosure - Note 8 - Derivative Liabilities (Tables) Sheet http://www.twinlab.com/20170930/role/statement-note-8-derivative-liabilities-tables Note 8 - Derivative Liabilities (Tables) Uncategorized 22 false false R23.htm 022 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual) Sheet http://www.twinlab.com/20170930/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-details-textual Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual) Uncategorized 23 false false R24.htm 023 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Sheet http://www.twinlab.com/20170930/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-financial-instruments-measured-at-fair-value-on-a-recurring-basis-details Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Financial Instruments Measured at Fair Value on a Recurring Basis (Details) Uncategorized 24 false false R25.htm 024 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Basic and Diluted Net Loss Per Common Share (Details) Sheet http://www.twinlab.com/20170930/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-basic-and-diluted-net-loss-per-common-share-details Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Basic and Diluted Net Loss Per Common Share (Details) Uncategorized 25 false false R26.htm 025 - Disclosure - Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Restatement of 2016 Diluted Net Loss Per Share (Details) Sheet http://www.twinlab.com/20170930/role/statement-note-1-nature-of-operations-and-summary-of-significant-accounting-policies-restatement-of-2016-diluted-net-loss-per-share-details Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Restatement of 2016 Diluted Net Loss Per Share (Details) Uncategorized 26 false false R27.htm 026 - Disclosure - Note 2 - Going Concern (Details Textual) Sheet http://www.twinlab.com/20170930/role/statement-note-2-going-concern-details-textual Note 2 - Going Concern (Details Textual) Uncategorized 27 false false R28.htm 027 - Disclosure - Note 3 - Inventories - Summary of Inventories (Details) Sheet http://www.twinlab.com/20170930/role/statement-note-3-inventories-summary-of-inventories-details Note 3 - Inventories - Summary of Inventories (Details) Uncategorized 28 false false R29.htm 028 - Disclosure - Note 4 - Property and Equipment (Details Textual) Sheet http://www.twinlab.com/20170930/role/statement-note-4-property-and-equipment-details-textual Note 4 - Property and Equipment (Details Textual) Uncategorized 29 false false R30.htm 029 - Disclosure - Note 4 - Property and Equipment - Summary of Property and Equipment (Details) Sheet http://www.twinlab.com/20170930/role/statement-note-4-property-and-equipment-summary-of-property-and-equipment-details Note 4 - Property and Equipment - Summary of Property and Equipment (Details) Uncategorized 30 false false R31.htm 030 - Disclosure - Note 5 - Intangible Assets (Details Textual) Sheet http://www.twinlab.com/20170930/role/statement-note-5-intangible-assets-details-textual Note 5 - Intangible Assets (Details Textual) Uncategorized 31 false false R32.htm 031 - Disclosure - Note 5 - Intangible Assets - Summary of Intangible Assets (Details) Sheet http://www.twinlab.com/20170930/role/statement-note-5-intangible-assets-summary-of-intangible-assets-details Note 5 - Intangible Assets - Summary of Intangible Assets (Details) Uncategorized 32 false false R33.htm 032 - Disclosure - Note 6 - Debt (Details Textual) Sheet http://www.twinlab.com/20170930/role/statement-note-6-debt-details-textual Note 6 - Debt (Details Textual) Uncategorized 33 false false R34.htm 033 - Disclosure - Note 6 - Debt - Summary of Debt (Details) Sheet http://www.twinlab.com/20170930/role/statement-note-6-debt-summary-of-debt-details Note 6 - Debt - Summary of Debt (Details) Uncategorized 34 false false R35.htm 034 - Disclosure - Note 6 - Debt - Summary of Debt (Details) (Parentheticals) Sheet http://www.twinlab.com/20170930/role/statement-note-6-debt-summary-of-debt-details-parentheticals Note 6 - Debt - Summary of Debt (Details) (Parentheticals) Uncategorized 35 false false R36.htm 035 - Disclosure - Note 7 - Warrants and Registration Rights Agreements (Details Textual) Sheet http://www.twinlab.com/20170930/role/statement-note-7-warrants-and-registration-rights-agreements-details-textual Note 7 - Warrants and Registration Rights Agreements (Details Textual) Uncategorized 36 false false R37.htm 036 - Disclosure - Note 7 - Warrants and Registration Rights Agreements - Summary of the Warrants Issued and Changes (Details) Sheet http://www.twinlab.com/20170930/role/statement-note-7-warrants-and-registration-rights-agreements-summary-of-the-warrants-issued-and-changes-details Note 7 - Warrants and Registration Rights Agreements - Summary of the Warrants Issued and Changes (Details) Uncategorized 37 false false R38.htm 037 - Disclosure - Note 8 - Derivative Liabilities (Details Textual) Sheet http://www.twinlab.com/20170930/role/statement-note-8-derivative-liabilities-details-textual Note 8 - Derivative Liabilities (Details Textual) Uncategorized 38 false false R39.htm 038 - Disclosure - Note 8 - Derivative Liabilities - Activity in Derivative Liabilities Account (Details) Sheet http://www.twinlab.com/20170930/role/statement-note-8-derivative-liabilities-activity-in-derivative-liabilities-account-details Note 8 - Derivative Liabilities - Activity in Derivative Liabilities Account (Details) Uncategorized 39 false false R40.htm 039 - Disclosure - Note 9 - Stockholders' Equity (Deficit) (Details Textual) Sheet http://www.twinlab.com/20170930/role/statement-note-9-stockholders-equity-deficit-details-textual Note 9 - Stockholders' Equity (Deficit) (Details Textual) Uncategorized 40 false false All Reports Book All Reports tlcc-20170930.xml tlcc-20170930.xsd tlcc-20170930_cal.xml tlcc-20170930_def.xml tlcc-20170930_lab.xml tlcc-20170930_pre.xml http://xbrl.sec.gov/dei/2014-01-31 http://fasb.org/us-gaap/2017-01-31 true true ZIP 58 0001437749-17-019266-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-17-019266-xbrl.zip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

    F/H$ M[@$T\)W;L,96R%,,OR'[2U>::SF20PV%9&F^CS'*U#&(=2X!#5RB.ZXA9=>C M.*@0;VW*:A8TH"C:%%@(B;S,B.T!V5U*60E>2RL)&O G_$)KS0 #O!WNF'JX M/O1946A[+CU.B+=857SVDV,] ;:!Y9LSB\ 7LP!?:QOP:B^84J( M*:M6P%] M SX1..:*Z-'HHT)"/')3'M&Y*OO>"M0&G@!Y-Q M+*528J];>K/ 7G_/JG 6WQCO?TJ@"D\%"A*LWO&B=7O2W+F$Z^R:FF7-I1$H3&E&\TZ4NO33.4_/\#Z' MIFP[0Y.P4'@5;J;>CF!A;AQ[C$X+*KP+[^).FU.'9O09/"=T&N]<,@/KM^3/ M[5>(H;8YON79QQ:6,<3V^B"P%H][GJ^2Q)97Q,1WLQ: WB*W1C[*_(OC1L'M M[>@1/97 G><$[)MX?VU>-5+!8&WGV7&S2)U\1MD8L 1:-Z"Y;D=7+@&/[XNF MTSOO'!^X 00WK.V[=%S7>0:V #\0+O'GN5'8H"FK?Z0?1(.0>X)Z'N]._196 M6N2]GVWXF8:NS3 W"[?^^]$-/']M/I)?,L=$*Z;93E@GJ0;RXX?R$SI/V[)@ M9WL6W.2M6W%8A\MA:J<_2)!KZ<4IJ#SO-HSY0G[[&FATOV&M"*RI@>RJ/;ZR M5)+KN0J&W6%=O83*@$>^54NX.['6K*8R:%5-K*5RT 1T+<[6UD&)M53/F02 M9WCY 'S7_,!%Q3HC;)O0VS>(50+4(FP%^UILG(#A+,8& M8]:0"S<%(TU':KB-,#K"3P9V@IC#P(>0#;URET"PC*TL0+(AR) !]]J![X:) M'O#R9Q"$T4+_1*A@(YGA5PB'C$"'GSS'HAX\7N)/7"<80ZSM3#<Z4)T2R( MO?&WZ,:1 QX_!%\N(C6%T"(*X")X$-<9AC46^!7LPN1OCMU$HBV^HD]_)D// MA"#R7+K&*(FE'3'0@" ^#A'QPI@*9!^D,_CFH!E>FJ2ZER([@%H]>]*@S1YZ MLXK>?QNX!6=5XB5C20.(]4%I3$U,(\ _05%8:7[+K+^'75[>@D4R?$_[A6G& M(6S,H@1UR?@]XRY@ARF1WJ03%DN7?@F(%5X/LLA]Y4\@Z1$K6T3#-YLLP\+X M;RYI8Y;=,J0AT0(_C+(Q_047ZJP?S21+L-]#O.\^$0CDHR!>4=7WTO<8 GPB M7/0OU+.,<^_@&8DI%%@ M61)5!$ RD-$AR)P/(4WV=1<6+GC>D\ZE1Y!BG6:%C+ .R<.&

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�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�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

    &UL4$L! A0#% @ MF%UN2Y-C#F+300 D, % !4 ( !W:(! '1L8V,M,C Q-S Y @,S!?<')E+GAM;%!+!08 !@ & (H! #CY $ ! end